Zyl13的个人主页 - 老虎社区

Zyl13

Zyl13

暂无个人介绍

IP属地：未知

61关注

1粉丝

0主题

0勋章

2021-08-26

Nice

Johnson & Johnson Announces Data to Support Boosting its Single-Shot COVID-19 Vaccine

2021-08-26

Up

Snowflake Beats Revenue Estimates and Gives Upbeat Forecast

2021-08-22

Up

Bitcoin rises 5 percent to $49,106

2021-08-21

Wow

抱歉，原内容已删除

2021-08-09

Like

Slowly but surely, bipartisan infrastructure bill passes another hurdle

2021-08-08

Like

US IPO Week Ahead: 2 banks test the waters amid annual summer slowdown

2021-08-05

Wow

AMD stock scores sixth straight record high as more data shows gains against Intel

2021-08-03

Buy because it’s going to the moon

抱歉，原内容已删除

2021-08-03

Wow

Is Snowflake Stock A Buy? Software Maker Sets Path To $10 Billion In Revenue By 2028

2021-08-03

Nice

抱歉，原内容已删除

2021-08-03

$McDonald's(MCD)$Mekdonald

2021-04-29

Wow

McDonald's Reports First Quarter 2021 Results

2021-04-20

Buy

Apple Earnings Preview: Smashing Quarter For The iPhone

2021-04-19

Buy

Tesla stock falls 1.7% premarket, after surging 19.6% over the previous 3 sessions

2021-02-08

Wow interesting

Moderna Gets Added to Southeast Asia’s Vaccine Arsenal

2021-02-08

Hahaahah

抱歉，原内容已删除

2021-02-06

Wow

抱歉，原内容已删除

2021-02-06

Wow

抱歉，原内容已删除

2021-02-04

To the moon!! diamonds hands

抱歉，原内容已删除

2021-02-04

Wow

抱歉，原内容已删除

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3573940420673790","uuid":"3573940420673790","gmtCreate":1610858835784,"gmtModify":1612435019972,"name":"Zyl13","pinyin":"zyl13","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/abc0f03108ec1f9a9c459181df989db8","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":1,"headSize":61,"tweetSize":20,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"35ec162348d5460f88c959321e554969-2","templateUuid":"35ec162348d5460f88c959321e554969","name":"宗师交易员","description":"证券或期货账户累计交易次数达到100次","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.03.23","exceedPercentage":"80.46%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.06.06","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":810900970,"gmtCreate":1629937255290,"gmtModify":1633681361020,"author":{"id":"3573940420673790","authorId":"3573940420673790","name":"Zyl13","avatar":"https://static.tigerbbs.com/abc0f03108ec1f9a9c459181df989db8","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573940420673790","idStr":"3573940420673790"},"themes":[],"htmlText":"&nbsp;Nice","listText":"&nbsp;Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/810900970","repostId":"2162539710","repostType":4,"repost":{"id":"2162539710","pubTimestamp":1629934200,"share":"https://www.laohu8.com/m/news/2162539710?lang=&edition=full","pubTime":"2021-08-26 07:30","market":"us","language":"en","title":"Johnson & Johnson  Announces Data to Support Boosting its Single-Shot COVID-19 Vaccine","url":"https://stock-news.laohu8.com/highlight/detail?id=2162539710","media":"StreetInsider","summary":"Johnson & Johnson (NYSE: JNJ) (the Company) today announced data supporting the use of its COVID-19 ","content":"<p>Johnson &amp; Johnson (NYSE: JNJ) (the Company) today announced data supporting the use of its COVID-19 vaccine as a booster shot for people previously vaccinated with the single-shot Johnson &amp; Johnson vaccine.</p>\n<p>In July, the Company reported interim Phase 1/2a data published in the <i>New England Journal of Medicine</i> that demonstrated neutralizing antibody responses generated by the Johnson &amp; Johnson single-shot COVID-19 vaccine were strong and stable through eight months after immunization.</p>\n<p>In anticipation of the potential need for boosters, the Company conducted two Phase 1/2a studies in individuals previously vaccinated with its single-shot vaccine. New interim data from these studies demonstrate that a booster dose of the Johnson &amp; Johnson COVID-19 vaccine generated a rapid and robust increase in spike-binding antibodies, nine-fold higher than 28 days after the primary single-dose vaccination. Significant increases in binding antibody responses were observed in participants between ages 18 and 55, and in those 65 years and older who received a lower booster dose. The study summaries were submitted to <i>medRxiv</i> on August 24.</p>\n<p>\"We have established that a single shot of our COVID-19 vaccine generates strong and robust immune responses that are durable and persistent through eight months. With these new data, we also see that a booster dose of the Johnson &amp; Johnson COVID-19 vaccine further increases antibody responses among study participants who had previously received our vaccine,\" said Mathai Mammen, M.D., Ph.D., Global Head, Janssen Research &amp; Development, Johnson &amp; Johnson. \"We look forward to discussing with public health officials a potential strategy for our Johnson &amp; Johnson COVID-19 vaccine, boosting eight months or longer after the primary single-dose vaccination.\"</p>\n<p>The Company is engaging with the U.S. Food and Drug Administration (FDA), U.S. Centers for Disease Control and Prevention (CDC), European Medicines Agency (EMA) and other health authorities regarding boosting with the Johnson &amp; Johnson COVID-19 vaccine. Johnson &amp; Johnson continues to diligently generate and evaluate data from ongoing trials as well as emerging real-world evidence.</p>\n<p>The Phase 1/2a clinical trials (VAC31518COV1001 and VAC31518COV2001) have been funded in part with federal funds from the U.S. Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority (BARDA), under other transaction authority (\"OTA\") agreement No. HHSO100201700018C.</p>\n<p>For more information on the Company's multi-pronged approach to helping combat the pandemic, visit: www.jnj.com/covid-19.</p>\n<p><b>Authorized Use </b>The Janssen COVID-19 vaccine is authorized for use in the U.S. under an Emergency Use Authorization (EUA) for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 18 years of age and older.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Johnson & Johnson  Announces Data to Support Boosting its Single-Shot COVID-19 Vaccine</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJohnson & Johnson  Announces Data to Support Boosting its Single-Shot COVID-19 Vaccine\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-26 07:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=18860180><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Johnson & Johnson (NYSE: JNJ) (the Company) today announced data supporting the use of its COVID-19 vaccine as a booster shot for people previously vaccinated with the single-shot Johnson & Johnson ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18860180\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生"},"source_url":"https://www.streetinsider.com/dr/news.php?id=18860180","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2162539710","content_text":"Johnson & Johnson (NYSE: JNJ) (the Company) today announced data supporting the use of its COVID-19 vaccine as a booster shot for people previously vaccinated with the single-shot Johnson & Johnson vaccine.\nIn July, the Company reported interim Phase 1/2a data published in the New England Journal of Medicine that demonstrated neutralizing antibody responses generated by the Johnson & Johnson single-shot COVID-19 vaccine were strong and stable through eight months after immunization.\nIn anticipation of the potential need for boosters, the Company conducted two Phase 1/2a studies in individuals previously vaccinated with its single-shot vaccine. New interim data from these studies demonstrate that a booster dose of the Johnson & Johnson COVID-19 vaccine generated a rapid and robust increase in spike-binding antibodies, nine-fold higher than 28 days after the primary single-dose vaccination. Significant increases in binding antibody responses were observed in participants between ages 18 and 55, and in those 65 years and older who received a lower booster dose. The study summaries were submitted to medRxiv on August 24.\n\"We have established that a single shot of our COVID-19 vaccine generates strong and robust immune responses that are durable and persistent through eight months. With these new data, we also see that a booster dose of the Johnson & Johnson COVID-19 vaccine further increases antibody responses among study participants who had previously received our vaccine,\" said Mathai Mammen, M.D., Ph.D., Global Head, Janssen Research & Development, Johnson & Johnson. \"We look forward to discussing with public health officials a potential strategy for our Johnson & Johnson COVID-19 vaccine, boosting eight months or longer after the primary single-dose vaccination.\"\nThe Company is engaging with the U.S. Food and Drug Administration (FDA), U.S. Centers for Disease Control and Prevention (CDC), European Medicines Agency (EMA) and other health authorities regarding boosting with the Johnson & Johnson COVID-19 vaccine. Johnson & Johnson continues to diligently generate and evaluate data from ongoing trials as well as emerging real-world evidence.\nThe Phase 1/2a clinical trials (VAC31518COV1001 and VAC31518COV2001) have been funded in part with federal funds from the U.S. Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority (BARDA), under other transaction authority (\"OTA\") agreement No. HHSO100201700018C.\nFor more information on the Company's multi-pronged approach to helping combat the pandemic, visit: www.jnj.com/covid-19.\nAuthorized Use The Janssen COVID-19 vaccine is authorized for use in the U.S. under an Emergency Use Authorization (EUA) for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 18 years of age and older.","news_type":1},"isVote":1,"tweetType":1,"viewCount":56,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":810077946,"gmtCreate":1629937226185,"gmtModify":1633681361868,"author":{"id":"3573940420673790","authorId":"3573940420673790","name":"Zyl13","avatar":"https://static.tigerbbs.com/abc0f03108ec1f9a9c459181df989db8","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573940420673790","idStr":"3573940420673790"},"themes":[],"htmlText":"Up","listText":"Up","text":"Up","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/810077946","repostId":"2162507820","repostType":4,"repost":{"id":"2162507820","pubTimestamp":1629934288,"share":"https://www.laohu8.com/m/news/2162507820?lang=&edition=full","pubTime":"2021-08-26 07:31","market":"us","language":"en","title":"Snowflake Beats Revenue Estimates and Gives Upbeat Forecast","url":"https://stock-news.laohu8.com/highlight/detail?id=2162507820","media":"Bloomberg","summary":"(Bloomberg) -- Snowflake Inc., the software company with 2020’s biggest U.S. initial public offering","content":"<p>(Bloomberg) -- <a href=\"https://laohu8.com/S/SNOW\">Snowflake</a> Inc., the software company with 2020’s biggest U.S. initial public offering, delivered better-than-expected results and a rosy forecast for the current quarter.</p>\n<p>Product sales, which make up more than 90% of Snowflake’s revenue, will be $280 million to $285 million this quarter, the company said on Wednesday. Analysts have projected $271.4 million on average. Revenue also topped projections in the second quarter, and Snowflake posted a narrower loss than predicted.</p>\n<p>Snowflake, which makes software for warehousing data in the cloud, is benefiting from companies modernizing their corporate applications and networks. Customers also are seeking ways to manage and analyze ever-increasing volumes of information from multiple locations. And Snowflake is facing less of a threat from a rival Amazon Web Services product called Redshift, according to <a href=\"https://laohu8.com/S/UGBLF\">UBS AG</a>.</p>\n<p>Snowflake makes software that pulls in, stores and analyzes information from multiple systems. Its customers include BlackRock Inc. and McKesson Corp. Product revenue climbed to $254.6 million last quarter, compared with an average analyst estimate of $240.1 million. Snowflake reported a loss of 64 cents a share, narrower than the 70 cents projected.</p>\n<p>At its analyst day in June, Snowflake said it is aiming for $10 billion in sales by fiscal 2029. Analysts expect annual sales to top $1 billion in the current fiscal year, 2022.</p>\n<p>Snowflake listed on the New York Stock Exchange in September in the largest IPO ever for a software maker. The stock has more than doubled since then. It climbed as much as 5.3% to $298.75 in late trading Wednesday, before paring the gains.</p>\n<p>The onetime Silicon Valley company said in May that it no longer has a corporate headquarters because its workforce is distributed. It currently lists Bozeman, Montana -- where Chief Executive Officer Frank Slootman and Chief Financial Officer Mike Scarpelli live -- as its principal executive office.</p>\n<p>Snowflake&nbsp;shares&nbsp;rose&nbsp;nearly&nbsp;4%&nbsp;in&nbsp;after-hour&nbsp;trading.</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Snowflake Beats Revenue Estimates and Gives Upbeat Forecast</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSnowflake Beats Revenue Estimates and Gives Upbeat Forecast\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-26 07:31 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/snowflake-beats-revenue-estimates-gives-202528632.html><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Bloomberg) -- Snowflake Inc., the software company with 2020’s biggest U.S. initial public offering, delivered better-than-expected results and a rosy forecast for the current quarter.\nProduct sales,...</p>\n\n<a href=\"https://finance.yahoo.com/news/snowflake-beats-revenue-estimates-gives-202528632.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://finance.yahoo.com/news/snowflake-beats-revenue-estimates-gives-202528632.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2162507820","content_text":"(Bloomberg) -- Snowflake Inc., the software company with 2020’s biggest U.S. initial public offering, delivered better-than-expected results and a rosy forecast for the current quarter.\nProduct sales, which make up more than 90% of Snowflake’s revenue, will be $280 million to $285 million this quarter, the company said on Wednesday. Analysts have projected $271.4 million on average. Revenue also topped projections in the second quarter, and Snowflake posted a narrower loss than predicted.\nSnowflake, which makes software for warehousing data in the cloud, is benefiting from companies modernizing their corporate applications and networks. Customers also are seeking ways to manage and analyze ever-increasing volumes of information from multiple locations. And Snowflake is facing less of a threat from a rival Amazon Web Services product called Redshift, according to UBS AG.\nSnowflake makes software that pulls in, stores and analyzes information from multiple systems. Its customers include BlackRock Inc. and McKesson Corp. Product revenue climbed to $254.6 million last quarter, compared with an average analyst estimate of $240.1 million. Snowflake reported a loss of 64 cents a share, narrower than the 70 cents projected.\nAt its analyst day in June, Snowflake said it is aiming for $10 billion in sales by fiscal 2029. Analysts expect annual sales to top $1 billion in the current fiscal year, 2022.\nSnowflake listed on the New York Stock Exchange in September in the largest IPO ever for a software maker. The stock has more than doubled since then. It climbed as much as 5.3% to $298.75 in late trading Wednesday, before paring the gains.\nThe onetime Silicon Valley company said in May that it no longer has a corporate headquarters because its workforce is distributed. It currently lists Bozeman, Montana -- where Chief Executive Officer Frank Slootman and Chief Financial Officer Mike Scarpelli live -- as its principal executive office.\nSnowflake shares rose nearly 4% in after-hour trading.","news_type":1},"isVote":1,"tweetType":1,"viewCount":153,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":832114359,"gmtCreate":1629598071471,"gmtModify":1633683874416,"author":{"id":"3573940420673790","authorId":"3573940420673790","name":"Zyl13","avatar":"https://static.tigerbbs.com/abc0f03108ec1f9a9c459181df989db8","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573940420673790","idStr":"3573940420673790"},"themes":[],"htmlText":"Up","listText":"Up","text":"Up","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/832114359","repostId":"2161149745","repostType":4,"repost":{"id":"2161149745","pubTimestamp":1629498960,"share":"https://www.laohu8.com/m/news/2161149745?lang=&edition=full","pubTime":"2021-08-21 06:36","market":"us","language":"en","title":"Bitcoin rises 5 percent to $49,106","url":"https://stock-news.laohu8.com/highlight/detail?id=2161149745","media":"StreetInsider","summary":"(Reuters) - Bitcoin rose 5.01 % to $49,106.4 at 22:04 GMT on Friday, adding $2,342.1 to its previous","content":"<p><img src=\"https://static.tigerbbs.com/e0b53399a7d28656bb2d3f7824cf0bea\" tg-width=\"200\" tg-height=\"135\" referrerpolicy=\"no-referrer\"></p>\n<p>(Reuters) - Bitcoin rose 5.01 % to $49,106.4 at 22:04 GMT on Friday, adding $2,342.1 to its previous close.</p>\n<p>Bitcoin, the world's biggest and best-known cryptocurrency, is up 77.4% from the year's low of $27,734 on Jan. 4.</p>\n<p>Ether, the coin linked to the ethereum blockchain network, rose 3.03% to $3,281.82 on Friday, adding $96.64 to its previous close.</p>\n<p>(Reporting by Radhika Anilkumar in Bengaluru; Editing by Sonya Hepinstall)</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Bitcoin rises 5 percent to $49,106</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBitcoin rises 5 percent to $49,106\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-21 06:36 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=18847810><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Reuters) - Bitcoin rose 5.01 % to $49,106.4 at 22:04 GMT on Friday, adding $2,342.1 to its previous close.\nBitcoin, the world's biggest and best-known cryptocurrency, is up 77.4% from the year's low ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18847810\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GBTC":"Grayscale Bitcoin Trust","COIN":"Coinbase Global, Inc."},"source_url":"https://www.streetinsider.com/dr/news.php?id=18847810","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2161149745","content_text":"(Reuters) - Bitcoin rose 5.01 % to $49,106.4 at 22:04 GMT on Friday, adding $2,342.1 to its previous close.\nBitcoin, the world's biggest and best-known cryptocurrency, is up 77.4% from the year's low of $27,734 on Jan. 4.\nEther, the coin linked to the ethereum blockchain network, rose 3.03% to $3,281.82 on Friday, adding $96.64 to its previous close.\n(Reporting by Radhika Anilkumar in Bengaluru; Editing by Sonya Hepinstall)","news_type":1},"isVote":1,"tweetType":1,"viewCount":100,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":836556302,"gmtCreate":1629509510206,"gmtModify":1633684370886,"author":{"id":"3573940420673790","authorId":"3573940420673790","name":"Zyl13","avatar":"https://static.tigerbbs.com/abc0f03108ec1f9a9c459181df989db8","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573940420673790","idStr":"3573940420673790"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/836556302","repostId":"2161743232","repostType":4,"isVote":1,"tweetType":1,"viewCount":59,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":898132894,"gmtCreate":1628477147418,"gmtModify":1633746870785,"author":{"id":"3573940420673790","authorId":"3573940420673790","name":"Zyl13","avatar":"https://static.tigerbbs.com/abc0f03108ec1f9a9c459181df989db8","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573940420673790","idStr":"3573940420673790"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/898132894","repostId":"1190850891","repostType":4,"repost":{"id":"1190850891","pubTimestamp":1628474246,"share":"https://www.laohu8.com/m/news/1190850891?lang=&edition=full","pubTime":"2021-08-09 09:57","market":"us","language":"en","title":"Slowly but surely, bipartisan infrastructure bill passes another hurdle","url":"https://stock-news.laohu8.com/highlight/detail?id=1190850891","media":"Market Watch","summary":"Vote to end debate approved, 68-29; final passage could be pushed to Tuesday.\nWASHINGTON — Senators ","content":"<p><i>Vote to end debate approved, 68-29; final passage could be pushed to Tuesday.</i></p>\n<p>WASHINGTON — Senators hoisted the $1 trillion bipartisan infrastructure package over another hurdle late Sunday, a coalition of Democrats and Republicans pushing it closer to passage despite a few holdouts trying to derail one of President Joe Biden’s top priorities.</p>\n<p>The rare bipartisan momentum was holding steady, a reflection of the bill’s popularity and the eagerness of senators to show voters back home they can deliver. One of the biggest investments of its kind in years, the package promises to unleash billions of dollars to upgrade roads, bridges, broadband internet, water pipes and other public works systems undergirding the nation.</p>\n<p>Senators easily overcame another 60-vote hurdle on a vote of 68-29. Final passage could drag into early Tuesday as a single GOP senator, Tennessee’s Bill Hagerty, refused to relent on the mandatory debate time.</p>\n<p>Majority Leader Chuck Schumer, D-N.Y., stressed to colleagues that they could proceed the “easy way or the hard way,” as the Senate slogged through its second consecutive weekend session.</p>\n<p>“We’ll keep proceeding until we get this bill done,” Schumer said.</p>\n<p>The Infrastructure Investment and Jobs Act would provide what Biden has called a “historic investment” in public works programs, the first part of the president’s his rebuilding agenda. As many as 20 Republicans are expected to join Democrats in the evenly split Senate for what would be a robust final tally. If approved, it would go to the House.</p>\n<p>“We’re on the cusp of seeing that move through the Senate,” Transportation Secretary Pete Buttigieg said on “Fox News Sunday,” citing “a remarkable coalition” that includes business, labor and lawmakers from both parties. “I think we’re about to get this done.”</p>\n<p>Once voting wraps up, senators immediately will turn to the budget outline for&nbsp;a $3.5 trillion package&nbsp;of child care, elder care and other programs that is a much more partisan undertaking and expected to draw only Democratic support.</p>\n<p>Despite the momentum, action ground to a halt over the weekend when Hagerty, an ally of Donald Trump, forced the Senate to run out the clock on debate time, refusing to consent to speeding up the process.</p>\n<p>Hagerty, who had been Trump’s ambassador to Japan, was leading the effort to take as much time as needed to debate and amend the bipartisan bill, in part because he wants to slow the march toward Biden’s next big bill, which plans $3.5 trillion for child care, an expansion of Medicare for seniors and other so-called soft infrastructure needs.</p>\n<p>Trump called Hagerty on Sunday morning, said a person familiar with the call who requested anonymity to discuss it. Hagerty said later Sunday in a speech on the Senate floor that he was trying to prevent a “socialist debt bomb” of new government spending.</p>\n<p>The former president has been publicly critical of the bipartisan bill and criticizing Biden and the senators from both parties who support it, though it’s unclear whether Trump’s broadsides will have much sway with Republican senators. He celebrated Hagerty’s stand in a statement Sunday.</p>\n<p>Senate Republican leader Mitch McConnell, R-Ky., has so far allowed the bill to progress, despite the name-calling and criticism coming his way from Trump. “This is a compromise,” McConnell said.</p>\n<p>As the weekend standoff dragged on, Republicans who helped negotiate the compromise spoke up Sunday commending the former president for having sparked infrastructure talks when he was in the White House even if those bills never panned out.</p>\n<p>Sen. Rob Portman of Ohio, the lead Republican negotiator, said it’s time overdue to improve the nation’s public works systems.</p>\n<p>“The American people deserve to have good roads and bridges and infrastructure to drive on, travel on,” he said.</p>\n<p>Another negotiator, Sen. Mitt Romney, R-Utah, acknowledged that no compromise is perfect, but doing nothing when there was a bill before them was not an option.</p>\n<p>“Every president in the modern era has proposed an infrastructure package,” he said. “This was an effort to say let’s break the logjam.”</p>\n<p>Biden, who was spending the weekend in Delaware, said the bipartisan package offers an investment on par with the building of the transcontinental railroad or interstate highway system.</p>\n<p>Senators have spent the past week processing nearly two dozen amendments to the 2,700-page package, but so far none has substantially changed its framework.</p>\n<p>More amendments have been offered as senators seek to revise a section on cryptocurrency, a long-shot effort by defense hawks to add $50 billion for defense-related infrastructure and a bipartisan amendment to repurpose a portion of the untapped COVID-19 relief aid that had been sent to the states. But it’s unclear if they will be considered for votes.</p>\n<p>Senators have found much to like in the bill, even though it does not fully satisfy liberals, who view it as too small, or conservatives, who find it too large. It would provide federal money for projects many states and cities could not afford on their own.</p>\n<p>An analysis of the bill from the Congressional Budget Office drew concerns, particularly from Republicans. It&nbsp;concluded that the legislation would increase deficits by about $256 billion&nbsp;over the next decade.</p>\n<p>But the bill’s backers argued that the budget office was unable to take into account certain revenue streams — including from future economic growth. Additional analysis released Saturday by the budget office suggested infrastructure spending overall could boost productivity and lower the ultimate costs.</p>\n<p>Paying for the package has been a pressure point throughout the months of negotiations after Democrats objected to an increase in the gas tax paid at the pump and Republicans resisted a plan to bolster the IRS to go after tax scofflaws.</p>\n<p>Unlike Biden’s bigger $3.5 trillion package, which would be paid for by higher tax rates for corporations and the wealthy, the bipartisan package is funded by repurposing other money, including untapped COVID-19 aid, and other spending cuts and revenue streams.</p>\n<p>The House is in recess and is expected to consider both Biden infrastructure packages when it returns in September.</p>","source":"lsy1616996754749","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Slowly but surely, bipartisan infrastructure bill passes another hurdle </title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSlowly but surely, bipartisan infrastructure bill passes another hurdle \n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-09 09:57 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.marketwatch.com/story/slow-progress-but-progress-nonetheless-on-bipartisan-infrastructure-bill-01628453793><strong>Market Watch</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Vote to end debate approved, 68-29; final passage could be pushed to Tuesday.\nWASHINGTON — Senators hoisted the $1 trillion bipartisan infrastructure package over another hurdle late Sunday, a ...</p>\n\n<a href=\"https://www.marketwatch.com/story/slow-progress-but-progress-nonetheless-on-bipartisan-infrastructure-bill-01628453793\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index",".DJI":"道琼斯"},"source_url":"https://www.marketwatch.com/story/slow-progress-but-progress-nonetheless-on-bipartisan-infrastructure-bill-01628453793","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1190850891","content_text":"Vote to end debate approved, 68-29; final passage could be pushed to Tuesday.\nWASHINGTON — Senators hoisted the $1 trillion bipartisan infrastructure package over another hurdle late Sunday, a coalition of Democrats and Republicans pushing it closer to passage despite a few holdouts trying to derail one of President Joe Biden’s top priorities.\nThe rare bipartisan momentum was holding steady, a reflection of the bill’s popularity and the eagerness of senators to show voters back home they can deliver. One of the biggest investments of its kind in years, the package promises to unleash billions of dollars to upgrade roads, bridges, broadband internet, water pipes and other public works systems undergirding the nation.\nSenators easily overcame another 60-vote hurdle on a vote of 68-29. Final passage could drag into early Tuesday as a single GOP senator, Tennessee’s Bill Hagerty, refused to relent on the mandatory debate time.\nMajority Leader Chuck Schumer, D-N.Y., stressed to colleagues that they could proceed the “easy way or the hard way,” as the Senate slogged through its second consecutive weekend session.\n“We’ll keep proceeding until we get this bill done,” Schumer said.\nThe Infrastructure Investment and Jobs Act would provide what Biden has called a “historic investment” in public works programs, the first part of the president’s his rebuilding agenda. As many as 20 Republicans are expected to join Democrats in the evenly split Senate for what would be a robust final tally. If approved, it would go to the House.\n“We’re on the cusp of seeing that move through the Senate,” Transportation Secretary Pete Buttigieg said on “Fox News Sunday,” citing “a remarkable coalition” that includes business, labor and lawmakers from both parties. “I think we’re about to get this done.”\nOnce voting wraps up, senators immediately will turn to the budget outline for a $3.5 trillion package of child care, elder care and other programs that is a much more partisan undertaking and expected to draw only Democratic support.\nDespite the momentum, action ground to a halt over the weekend when Hagerty, an ally of Donald Trump, forced the Senate to run out the clock on debate time, refusing to consent to speeding up the process.\nHagerty, who had been Trump’s ambassador to Japan, was leading the effort to take as much time as needed to debate and amend the bipartisan bill, in part because he wants to slow the march toward Biden’s next big bill, which plans $3.5 trillion for child care, an expansion of Medicare for seniors and other so-called soft infrastructure needs.\nTrump called Hagerty on Sunday morning, said a person familiar with the call who requested anonymity to discuss it. Hagerty said later Sunday in a speech on the Senate floor that he was trying to prevent a “socialist debt bomb” of new government spending.\nThe former president has been publicly critical of the bipartisan bill and criticizing Biden and the senators from both parties who support it, though it’s unclear whether Trump’s broadsides will have much sway with Republican senators. He celebrated Hagerty’s stand in a statement Sunday.\nSenate Republican leader Mitch McConnell, R-Ky., has so far allowed the bill to progress, despite the name-calling and criticism coming his way from Trump. “This is a compromise,” McConnell said.\nAs the weekend standoff dragged on, Republicans who helped negotiate the compromise spoke up Sunday commending the former president for having sparked infrastructure talks when he was in the White House even if those bills never panned out.\nSen. Rob Portman of Ohio, the lead Republican negotiator, said it’s time overdue to improve the nation’s public works systems.\n“The American people deserve to have good roads and bridges and infrastructure to drive on, travel on,” he said.\nAnother negotiator, Sen. Mitt Romney, R-Utah, acknowledged that no compromise is perfect, but doing nothing when there was a bill before them was not an option.\n“Every president in the modern era has proposed an infrastructure package,” he said. “This was an effort to say let’s break the logjam.”\nBiden, who was spending the weekend in Delaware, said the bipartisan package offers an investment on par with the building of the transcontinental railroad or interstate highway system.\nSenators have spent the past week processing nearly two dozen amendments to the 2,700-page package, but so far none has substantially changed its framework.\nMore amendments have been offered as senators seek to revise a section on cryptocurrency, a long-shot effort by defense hawks to add $50 billion for defense-related infrastructure and a bipartisan amendment to repurpose a portion of the untapped COVID-19 relief aid that had been sent to the states. But it’s unclear if they will be considered for votes.\nSenators have found much to like in the bill, even though it does not fully satisfy liberals, who view it as too small, or conservatives, who find it too large. It would provide federal money for projects many states and cities could not afford on their own.\nAn analysis of the bill from the Congressional Budget Office drew concerns, particularly from Republicans. It concluded that the legislation would increase deficits by about $256 billion over the next decade.\nBut the bill’s backers argued that the budget office was unable to take into account certain revenue streams — including from future economic growth. Additional analysis released Saturday by the budget office suggested infrastructure spending overall could boost productivity and lower the ultimate costs.\nPaying for the package has been a pressure point throughout the months of negotiations after Democrats objected to an increase in the gas tax paid at the pump and Republicans resisted a plan to bolster the IRS to go after tax scofflaws.\nUnlike Biden’s bigger $3.5 trillion package, which would be paid for by higher tax rates for corporations and the wealthy, the bipartisan package is funded by repurposing other money, including untapped COVID-19 aid, and other spending cuts and revenue streams.\nThe House is in recess and is expected to consider both Biden infrastructure packages when it returns in September.","news_type":1},"isVote":1,"tweetType":1,"viewCount":34,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":891694914,"gmtCreate":1628384842538,"gmtModify":1633751363298,"author":{"id":"3573940420673790","authorId":"3573940420673790","name":"Zyl13","avatar":"https://static.tigerbbs.com/abc0f03108ec1f9a9c459181df989db8","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573940420673790","idStr":"3573940420673790"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/891694914","repostId":"1157428986","repostType":4,"repost":{"id":"1157428986","pubTimestamp":1628296262,"share":"https://www.laohu8.com/m/news/1157428986?lang=&edition=full","pubTime":"2021-08-07 08:31","market":"us","language":"en","title":"US IPO Week Ahead: 2 banks test the waters amid annual summer slowdown","url":"https://stock-news.laohu8.com/highlight/detail?id=1157428986","media":"renaissancecap...","summary":"The IPO market is getting a breather as the August lull continues to set in, with just two banks sch","content":"<p>The IPO market is getting a breather as the August lull continues to set in, with just two banks scheduled for the week ahead.</p>\n<p>Utah-based digital bank&nbsp;<b>FinWise Bancorp</b>(FINW) plans to raise $58 million at a $183 million market cap. FinWise Bank makes loans to and takes deposits from consumers and small businesses across the US. As of 3/31/21, FinWise Bancorp had total assets of $330 million, total loans of $245 million, total deposits of $189 million, and total shareholders’ equity of $52 million.</p>\n<p>Alabama bank&nbsp;<b>Southern States Bancshares</b>(SSBK) plans to raise $40 million at a $174 million market cap. Southern States Bank is a full service community bank, serving businesses and individuals through 15 branches across Alabama and Georgia. As of 3/31/21, Southern States had total assets of $1.5 billion, total loans of $1.1 billion, total deposits of $1.3 billion, and total shareholders’ equity of $145 million.</p>\n<p><img src=\"https://static.tigerbbs.com/8919c8c9b4257f3c84869f14fa89bcab\" tg-width=\"1414\" tg-height=\"356\" width=\"100%\" height=\"auto\"></p>","source":"lsy1619493174116","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US IPO Week Ahead: 2 banks test the waters amid annual summer slowdown</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS IPO Week Ahead: 2 banks test the waters amid annual summer slowdown\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-07 08:31 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.renaissancecapital.com/IPO-Center/News/85076/US-IPO-Week-Ahead-2-banks-test-the-waters-amid-annual-summer-slowdown><strong>renaissancecap...</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The IPO market is getting a breather as the August lull continues to set in, with just two banks scheduled for the week ahead.\nUtah-based digital bank FinWise Bancorp(FINW) plans to raise $58 million ...</p>\n\n<a href=\"https://www.renaissancecapital.com/IPO-Center/News/85076/US-IPO-Week-Ahead-2-banks-test-the-waters-amid-annual-summer-slowdown\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"FINW":"Finwise Bancorp","SSBK":"Southern States Bancshares, Inc."},"source_url":"https://www.renaissancecapital.com/IPO-Center/News/85076/US-IPO-Week-Ahead-2-banks-test-the-waters-amid-annual-summer-slowdown","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1157428986","content_text":"The IPO market is getting a breather as the August lull continues to set in, with just two banks scheduled for the week ahead.\nUtah-based digital bank FinWise Bancorp(FINW) plans to raise $58 million at a $183 million market cap. FinWise Bank makes loans to and takes deposits from consumers and small businesses across the US. As of 3/31/21, FinWise Bancorp had total assets of $330 million, total loans of $245 million, total deposits of $189 million, and total shareholders’ equity of $52 million.\nAlabama bank Southern States Bancshares(SSBK) plans to raise $40 million at a $174 million market cap. Southern States Bank is a full service community bank, serving businesses and individuals through 15 branches across Alabama and Georgia. As of 3/31/21, Southern States had total assets of $1.5 billion, total loans of $1.1 billion, total deposits of $1.3 billion, and total shareholders’ equity of $145 million.","news_type":1},"isVote":1,"tweetType":1,"viewCount":99,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":890573927,"gmtCreate":1628125939969,"gmtModify":1633753359597,"author":{"id":"3573940420673790","authorId":"3573940420673790","name":"Zyl13","avatar":"https://static.tigerbbs.com/abc0f03108ec1f9a9c459181df989db8","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573940420673790","idStr":"3573940420673790"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/890573927","repostId":"2157488863","repostType":4,"repost":{"id":"2157488863","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1628125479,"share":"https://www.laohu8.com/m/news/2157488863?lang=&edition=full","pubTime":"2021-08-05 09:04","market":"hk","language":"en","title":"AMD stock scores sixth straight record high as more data shows gains against Intel","url":"https://stock-news.laohu8.com/highlight/detail?id=2157488863","media":"Dow Jones","summary":"Shares have rallied 35% since earnings report showed chip maker succeeding against larger rival, and","content":"<p>Shares have rallied 35% since earnings report showed chip maker succeeding against larger rival, and new data shows market share wins in data center, microprocessors.</p>\n<p>Advanced Micro Devices Inc. shares closed at a sixth consecutive record high on Wednesday following continued indications that the chip maker is taking market share away from larger rival <a href=\"https://laohu8.com/S/INTC\">Intel</a>.</p>\n<p><a href=\"https://laohu8.com/S/AMD\">AMD</a> shares closed up 5.5% at a record $118.77 Wednesday, after carving out a new all-time intraday high of $122.49. Shares closed at a then-record $112.56 on Tuesday . The sixth straight day of record high closing prices coincides with a sixth straight day of gains of 2% or more. The last time AMD shares experienced such a streak was June 2, when the stock rose for seven days in a row, according to Dow Jones data.</p>\n<p>Coincidentally, AMD's streak began on July 28 shares, which closed down 0.3% Wednesday, have gained 1% since July 28.</p>\n<p>Additionally, the PHLX Semiconductor Index closed at its fourth record high in a row at 3,436.90, having finished at 3,396.66 on Tuesday. Chip stocks have been popular amid a global shortage of semiconductors that has pushed prices up.</p>\n<p>Citi Research analyst Christopher Danley, who has neutral ratings on both AMD and Intel, wrote in a Wednesday note that data from Mercury Research showed that while total microprocessor shipments had declined 3.1% quarter-over-quarter, AMD's total share of the market increased to 16.9% in the second quarter from 16.1% in the first quarter. Meanwhile, Intel's share fell to 83.1% in the second quarter from 83.9% in the first quarter.</p>\n<p>The data also showed gains for AMD in the important data-center category. The Mercury data showed AMD with 8.9% share in servers, up from 5.5% in the year-ago second quarter and 8.2% in this year's first quarter. That's compared with Intel's 91.1% share, down from 94.5% in the year-ago second quarter and 91.8% in the first quarter.</p>\n<p>Additionally, a Wednesday report from tech news site wccftech.com noted that AMD CPUs are still outselling Intel according to data compiled from MindFactory, Germany's largest tech retailer.</p>\n<p>On Tuesday, AMD announced its line of Radeon Pro W6000X series of GPUs Mac Pro can tack on up to another $10,000 to the workstation's sticker price.</p>\n<p>Another tailwind for AMD shares could be coming from a Bloomberg report $40 billion acquisition of Arm from Japan's SoftBank Group Corp. citing national security reasons, a development that could benefit AMD.</p>\n<p>-Wallace Witkowski</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AMD stock scores sixth straight record high as more data shows gains against Intel</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAMD stock scores sixth straight record high as more data shows gains against Intel\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-08-05 09:04</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shares have rallied 35% since earnings report showed chip maker succeeding against larger rival, and new data shows market share wins in data center, microprocessors.</p>\n<p>Advanced Micro Devices Inc. shares closed at a sixth consecutive record high on Wednesday following continued indications that the chip maker is taking market share away from larger rival <a href=\"https://laohu8.com/S/INTC\">Intel</a>.</p>\n<p><a href=\"https://laohu8.com/S/AMD\">AMD</a> shares closed up 5.5% at a record $118.77 Wednesday, after carving out a new all-time intraday high of $122.49. Shares closed at a then-record $112.56 on Tuesday . The sixth straight day of record high closing prices coincides with a sixth straight day of gains of 2% or more. The last time AMD shares experienced such a streak was June 2, when the stock rose for seven days in a row, according to Dow Jones data.</p>\n<p>Coincidentally, AMD's streak began on July 28 shares, which closed down 0.3% Wednesday, have gained 1% since July 28.</p>\n<p>Additionally, the PHLX Semiconductor Index closed at its fourth record high in a row at 3,436.90, having finished at 3,396.66 on Tuesday. Chip stocks have been popular amid a global shortage of semiconductors that has pushed prices up.</p>\n<p>Citi Research analyst Christopher Danley, who has neutral ratings on both AMD and Intel, wrote in a Wednesday note that data from Mercury Research showed that while total microprocessor shipments had declined 3.1% quarter-over-quarter, AMD's total share of the market increased to 16.9% in the second quarter from 16.1% in the first quarter. Meanwhile, Intel's share fell to 83.1% in the second quarter from 83.9% in the first quarter.</p>\n<p>The data also showed gains for AMD in the important data-center category. The Mercury data showed AMD with 8.9% share in servers, up from 5.5% in the year-ago second quarter and 8.2% in this year's first quarter. That's compared with Intel's 91.1% share, down from 94.5% in the year-ago second quarter and 91.8% in the first quarter.</p>\n<p>Additionally, a Wednesday report from tech news site wccftech.com noted that AMD CPUs are still outselling Intel according to data compiled from MindFactory, Germany's largest tech retailer.</p>\n<p>On Tuesday, AMD announced its line of Radeon Pro W6000X series of GPUs Mac Pro can tack on up to another $10,000 to the workstation's sticker price.</p>\n<p>Another tailwind for AMD shares could be coming from a Bloomberg report $40 billion acquisition of Arm from Japan's SoftBank Group Corp. citing national security reasons, a development that could benefit AMD.</p>\n<p>-Wallace Witkowski</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"INTC":"英特尔","AMD":"美国超微公司"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2157488863","content_text":"Shares have rallied 35% since earnings report showed chip maker succeeding against larger rival, and new data shows market share wins in data center, microprocessors.\nAdvanced Micro Devices Inc. shares closed at a sixth consecutive record high on Wednesday following continued indications that the chip maker is taking market share away from larger rival Intel.\nAMD shares closed up 5.5% at a record $118.77 Wednesday, after carving out a new all-time intraday high of $122.49. Shares closed at a then-record $112.56 on Tuesday . The sixth straight day of record high closing prices coincides with a sixth straight day of gains of 2% or more. The last time AMD shares experienced such a streak was June 2, when the stock rose for seven days in a row, according to Dow Jones data.\nCoincidentally, AMD's streak began on July 28 shares, which closed down 0.3% Wednesday, have gained 1% since July 28.\nAdditionally, the PHLX Semiconductor Index closed at its fourth record high in a row at 3,436.90, having finished at 3,396.66 on Tuesday. Chip stocks have been popular amid a global shortage of semiconductors that has pushed prices up.\nCiti Research analyst Christopher Danley, who has neutral ratings on both AMD and Intel, wrote in a Wednesday note that data from Mercury Research showed that while total microprocessor shipments had declined 3.1% quarter-over-quarter, AMD's total share of the market increased to 16.9% in the second quarter from 16.1% in the first quarter. Meanwhile, Intel's share fell to 83.1% in the second quarter from 83.9% in the first quarter.\nThe data also showed gains for AMD in the important data-center category. The Mercury data showed AMD with 8.9% share in servers, up from 5.5% in the year-ago second quarter and 8.2% in this year's first quarter. That's compared with Intel's 91.1% share, down from 94.5% in the year-ago second quarter and 91.8% in the first quarter.\nAdditionally, a Wednesday report from tech news site wccftech.com noted that AMD CPUs are still outselling Intel according to data compiled from MindFactory, Germany's largest tech retailer.\nOn Tuesday, AMD announced its line of Radeon Pro W6000X series of GPUs Mac Pro can tack on up to another $10,000 to the workstation's sticker price.\nAnother tailwind for AMD shares could be coming from a Bloomberg report $40 billion acquisition of Arm from Japan's SoftBank Group Corp. citing national security reasons, a development that could benefit AMD.\n-Wallace Witkowski","news_type":1},"isVote":1,"tweetType":1,"viewCount":43,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":804199007,"gmtCreate":1627943670509,"gmtModify":1633755161722,"author":{"id":"3573940420673790","authorId":"3573940420673790","name":"Zyl13","avatar":"https://static.tigerbbs.com/abc0f03108ec1f9a9c459181df989db8","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573940420673790","idStr":"3573940420673790"},"themes":[],"htmlText":"Buy because it’s going to the moon&nbsp;","listText":"Buy because it’s going to the moon&nbsp;","text":"Buy because it’s going to the moon","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/804199007","repostId":"1107596279","repostType":4,"isVote":1,"tweetType":1,"viewCount":54,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":804190336,"gmtCreate":1627943592725,"gmtModify":1633755162517,"author":{"id":"3573940420673790","authorId":"3573940420673790","name":"Zyl13","avatar":"https://static.tigerbbs.com/abc0f03108ec1f9a9c459181df989db8","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573940420673790","idStr":"3573940420673790"},"themes":[],"htmlText":"&nbsp;Wow","listText":"&nbsp;Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/804190336","repostId":"1131839624","repostType":4,"repost":{"id":"1131839624","pubTimestamp":1627917885,"share":"https://www.laohu8.com/m/news/1131839624?lang=&edition=full","pubTime":"2021-08-02 23:24","market":"us","language":"en","title":"Is Snowflake Stock A Buy? Software Maker Sets Path To $10 Billion In Revenue By 2028","url":"https://stock-news.laohu8.com/highlight/detail?id=1131839624","media":"investors","summary":"Think of Snowflake stock as a proxy on the torrid growth of cloud computing giantsAmazon.com(AMZN),M","content":"<p>Think of <a href=\"https://laohu8.com/S/SNOW\">Snowflake</a> stock as a proxy on the torrid growth of cloud computing giants<b><a href=\"https://laohu8.com/S/AMZN\">Amazon.com</a></b>(AMZN),<b><a href=\"https://laohu8.com/S/MSFT\">Microsoft</a></b>(MSFT) and<b><a href=\"https://laohu8.com/S/GOOG\">Alphabet</a></b>'s (GOOGL) Google.</p>\n<p>Many companies are turning to cloud computing services as part of \"digital transformation\" projects that aim to gain business insights from crunching massive volumes of data. The cloud computing titans offer their own data analytics and management tools.</p>\n<p>In a \"coopetition\" model, thecloud giantsgive their customers a green light to buy<b>Snowflake</b>'s (SNOW) software. The reason is Snowflake's tools are better at some key tasks, such as letting companies compile, view, analyze and share massive amounts of data in an easy way.</p>\n<p>Nearly two-fifths of Fortune 500 companies use Snowflake's software in the cloud as they move away from on-premise data warehousing products from<b><a href=\"https://laohu8.com/S/TDC\">Teradata</a></b>(TDC),<b><a href=\"https://laohu8.com/S/ORCL\">Oracle</a></b>(ORCL) and<b><a href=\"https://laohu8.com/S/IBM\">IBM</a></b>(IBM).&nbsp;One Snowflake customer is pharma giant<b><a href=\"https://laohu8.com/S/PFE\">Pfizer</a></b>(PFE). Pfizer uses Snowflake tools to forecast product sales and to gain insights into thedistribution of the Covid-19 vaccine.</p>\n<p>Stellar customer growth enabled SNOW stock to pull off the largest initial public offering ever by a software company in September 2020. The IPO raised $3.4 billion.</p>\n<p>But is Snowflake a buy right now? After a tough start to 2021, software growth stocks have rebounded. The iShares Expanded Tech-Software Sector ETF rose 3.4% in July and 8.7% in June.</p>\n<p><b>Snowflake Stock: Roadmap to $10 Billion In Revenue</b></p>\n<p>Snowflake stock hit an all-time high of 429 in early December. But SNOW stock swooned in late 2020 amid analyst concerns over its lofty valuation.</p>\n<p>At a June 10 analyst day, Snowflake laid out a path to $10 billion in product revenue by fiscal 2029, which coincides with calendar 2028. The $10 billion revenue target would result in a compound annual growth rate of 44%.</p>\n<p>The company said it expects to increase the number of customers with over $1 million in product revenue. Snowflake also guided to long-term operating margin of 10%-plus, lower than some analysts expected.</p>\n<p><b>Possible Threat From Amazon</b></p>\n<p>Snowflake in July announced support for digital advertising standard Unified ID 2.0. Advertising is <a href=\"https://laohu8.com/S/AONE.U\">one</a> of Snowflake's largest verticals with customers representing a large percentage of players in the space, noted a RBC Capital report. The move comes as Googlephases out internet cookies for targeted advertising.</p>\n<p>Whether Amazon Web Services ratchets up competition remains a concern for SNOW stock. Plus, competition with privately held Databricks is heating up. A February funding roundvalued Databricks at $28 billion.</p>\n<p>Databricks, which usesartificial intelligence, is expected to launch its own IPO.</p>\n<p>Snowflake stock bulls point to its seasoned management team as a strength no matter what unfolds.</p>\n<p><a href=\"https://laohu8.com/S/TWOA.U\">Two</a> former Oracle engineers — Benoit Dageville and Thierry Cruanes — along with Marcin Zukowski, former chief executive of startup Vectorwise, started Snowflake in 2012. The company holds patents in database architecture, data warehouses and other areas.</p>\n<p><b>SNOW Stock: <a href=\"https://laohu8.com/S/NOW\">ServiceNow</a> Veterans Lead Company</b></p>\n<p>Snowflake brought inFrank Slootman as chief executive&nbsp;in May 2019. Slootman had stepped down as CEO of ServiceNow in early 2017. Former ServiceNow Chief Financial Officer Mike Scarpelli in 2019 also joined Snowflake in the same CFO position.</p>\n<p>Unlike legacy, on-premise data management systems, Snowflake's platform was built from the ground up for cloud computing. It provides 100% of its software over the internet.</p>\n<p>Snowflake customers can share data with their partners across multiple online storage systems using the company's data warehouse. Snowflake also enables easily searchable data to be shared among applications.</p>\n<p>Snowflake's data analytics tools became available on Amazon Web Services in 2015, Microsoft's Azure in 2018 and on Google's cloud platform in 2020.</p>\n<p>In June, Snowflake partnered with<b>C3.ai</b>(AI). The two companies will cooperate in offering artificial intelligence tools to companies.</p>\n<p><b>Amazon Web Services A 'Frenemy'</b></p>\n<p>\"While Snowflake is multi-cloud, it derives some 85% of its revenues from data analytics jobs deployed on Amazon Web Services, which is also Snowflake's biggest rival with AWS Redshift,\" UBS analyst Karl Keirstead said in a recent note to clients.</p>\n<p>\"This 'frenemy' relationship is critical to Snowflake's success,\" Keirstead went on to say. \"AWS benefits far more from Snowflake spending on compute and storage infrastructure resources than they lose in the form of foregone AWS Redshift revenues. Snowflake represents a dream customer and partner for AWS and Microsoft Azure.\"</p>\n<p>Snowflake has focused on six core markets, including financial services, health care and life sciences, retail and consumer packaged goods, advertising media and entertainment, technology, and the government sector.</p>\n<p>When Snowflake went public in September it used a dual-class share structure that gave its CEO and insiderssuper-voting rights. However, Snowflake eliminated the dual-class structure in March.</p>\n<p>Snowflake had been based in San Mateo, Calif. Amid the shift to remote work spurred by the coronavirus emergency, Snowflake in May said it no longer has a corporate headquarters. It designated Bozeman, Mont., as its principal executive office. Slootman and Scarpelli are based in Bozeman.</p>\n<p><b>Snowflake Stock Fundamental Analysis</b></p>\n<p>Software stocks typically trade as a multiple of forward-looking revenue growth. Software-as-a-service, or SaaS, companies, such as<b><a href=\"https://laohu8.com/S/CRM\">Salesforce.com</a></b>(CRM), typically provide the highest revenue growth. Salesforce is a key marketing partner of SNOW stock.</p>\n<p>Snowflake also partners with consulting firms such as Deloitte and information technology firms such as privately held Informatica.</p>\n<p>Snowflake is not an SaaS company, however. Instead, it uses a consumption-based business model based on how much data its customers crunch and store.</p>\n<p>Snowflake's revenue growth stands out. <a href=\"https://laohu8.com/S/FBNC\">First</a>-quartersales jumped 110%to $228.9 million. But there's less transparency and predictability than with subscription-based, recurring-revenue SaaS business models, analysts say.</p>\n<p>\"SNOW has a consumption model, whereby customers contract for a certain amount of compute and storage capacity,\" <a href=\"https://laohu8.com/S/MFG\">Mizuho</a> Securities analyst Gregg Moskowitz said in a note. \"The company only records revenue, however, as that capacity is used, so there can be a lag of several months or more before revenue recognition begins.\"</p>\n<p>Snowflake is nearing an annual revenue run-rate of $1 billion. That's a big milestone for software growth companies. But SNOW stock is unprofitable on the two most common accounting standards.</p>\n<p>Many software companies are unprofitable using GAAP earnings, or generally accepted accounting principles, which includes stock-based compensation. But they're profitable on a non-GAAP or \"adjusted\" earnings basis.</p>\n<p><b>SNOW Stock Operates In The Red</b></p>\n<p>In the first quarter, Snowflake reported a GAAP operating loss of $205.6 million and a GAAP per-share loss of 70 cents. Snowflake stock subsequently fell. It recorded an adjusted operating loss of $35.8 million.</p>\n<p>Snowflake doesn't break out adjusted earnings. Analysts estimate it lost 11 cents on an adjusted basis in the first quarter.</p>\n<p>Snowflake operates in the red amid sizable investments, analysts say. For fiscal 2022, for example, Snowflake has told analysts it plans to hire 1,200 net new employees, which would represent 48% growth in head count.</p>\n<p>Still, investments are paying off in revenue growth. Snowflake had 4,532 customers as of April 30, up 67% from the year-earlier period. That includes 187 of the Fortune 500. In the April quarter, Snowflake added a record 27 customers with more than $1 million per year in product revenue, giving it 104 such customers overall.</p>\n<p><a href=\"https://laohu8.com/S/GS\">Goldman Sachs</a> analyst Kash Rangan is bullish on Snowflake's potential to dominate in cloud-based data analytics and management.</p>\n<p>\"We believe Snowflake will continue to replace incumbent warehousing solutions owing to their scalable and elastic cloud native data platform while also capitalizing on net new workloads and use cases as digital transformation drives greater digitization within the enterprise, and business intelligence and analytics remains a top priority for spending,\" he said in a note.</p>\n<p><b>SNOW Stock Technical Analysis</b></p>\n<p>Snowflake stock went public on Sept. 16 at 120 a share. At the time, software growth stocks were hot as investors sought recurring revenue amid the coronavirus emergency.</p>\n<p>SNOW stock popped as high as 319 on the first day of trading and closed 111.6% above the IPO price at 253.93. Shares pulled back as analysts debated Snowflake's valuation.</p>\n<p>Snowflake stock forged acup-with-handle baseover the next two months. The new base created an entry point of 301. SNOW stock blew past the buy point, hitting an all-time high of 429 on Dec. 8.</p>\n<p>Snowflake stock swooned in late 2020 amid questions over its valuation even as the IBD Computer-Software <a href=\"https://laohu8.com/S/EBTC\">Enterprise</a> group stayed resilient. The Computer-Software <a href=\"https://laohu8.com/S/EFSC\">Enterprise</a> group did not break down until mid-February amid a market rotation to value.</p>\n<p>Snowflake stock hit a low of 184.71 on May 13.</p>\n<p>Canaccord Genuity analyst David Hynes said in a note that one question for investors is whether SNOW stock will trade in concert with software growth stocks. Software growth stocks have sold off onworries over inflation and rising interest rates.</p>\n<p><b>Is Snowflake Stock A Buy Right Now?</b></p>\n<p>Snowflake stock still trades at a substantial premium as a multiple of forward-looking revenue growth. SNOW stock holds anIBD Composite Ratingof 37 out of a best possible 99, according toIBD Stock Checkup.</p>\n<p>IBD's Composite Rating combines five separate proprietary ratings into one easy-to-use rating. The best growth stocks have a Composite Rating of 90 or better.</p>\n<p>One plus is that Snowflake stock owns an Accumulation/Distribution Rating of B, according toIBD MarketSmithanalysis. That rating analyzes price and volume changes in a stock over the past 13 weeks of trading.</p>\n<p>The rating, on an A+ to E scale, measures institutional buying and selling in a stock. A+ signifies heavy institutional buying; E means heavy selling. Think of the C grade as neutral.</p>\n<p>SNOW stock has yet toform a basewith a proper entry point. Snowflake stock has clawed above its 50-day moving average. If it holds above the 50-day line that could kick-start the right side of a deep base.</p>\n<p>As of Aug. 2, Snowflake stock is not a buy.</p>","source":"lsy1610449120050","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Is Snowflake Stock A Buy? Software Maker Sets Path To $10 Billion In Revenue By 2028</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIs Snowflake Stock A Buy? Software Maker Sets Path To $10 Billion In Revenue By 2028\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-02 23:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.investors.com/news/technology/snowflake-snow-stock-buy-now/?src=A00220><strong>investors</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Think of Snowflake stock as a proxy on the torrid growth of cloud computing giantsAmazon.com(AMZN),Microsoft(MSFT) andAlphabet's (GOOGL) Google.\nMany companies are turning to cloud computing services ...</p>\n\n<a href=\"https://www.investors.com/news/technology/snowflake-snow-stock-buy-now/?src=A00220\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SNOW":"Snowflake"},"source_url":"https://www.investors.com/news/technology/snowflake-snow-stock-buy-now/?src=A00220","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1131839624","content_text":"Think of Snowflake stock as a proxy on the torrid growth of cloud computing giantsAmazon.com(AMZN),Microsoft(MSFT) andAlphabet's (GOOGL) Google.\nMany companies are turning to cloud computing services as part of \"digital transformation\" projects that aim to gain business insights from crunching massive volumes of data. The cloud computing titans offer their own data analytics and management tools.\nIn a \"coopetition\" model, thecloud giantsgive their customers a green light to buySnowflake's (SNOW) software. The reason is Snowflake's tools are better at some key tasks, such as letting companies compile, view, analyze and share massive amounts of data in an easy way.\nNearly two-fifths of Fortune 500 companies use Snowflake's software in the cloud as they move away from on-premise data warehousing products fromTeradata(TDC),Oracle(ORCL) andIBM(IBM). One Snowflake customer is pharma giantPfizer(PFE). Pfizer uses Snowflake tools to forecast product sales and to gain insights into thedistribution of the Covid-19 vaccine.\nStellar customer growth enabled SNOW stock to pull off the largest initial public offering ever by a software company in September 2020. The IPO raised $3.4 billion.\nBut is Snowflake a buy right now? After a tough start to 2021, software growth stocks have rebounded. The iShares Expanded Tech-Software Sector ETF rose 3.4% in July and 8.7% in June.\nSnowflake Stock: Roadmap to $10 Billion In Revenue\nSnowflake stock hit an all-time high of 429 in early December. But SNOW stock swooned in late 2020 amid analyst concerns over its lofty valuation.\nAt a June 10 analyst day, Snowflake laid out a path to $10 billion in product revenue by fiscal 2029, which coincides with calendar 2028. The $10 billion revenue target would result in a compound annual growth rate of 44%.\nThe company said it expects to increase the number of customers with over $1 million in product revenue. Snowflake also guided to long-term operating margin of 10%-plus, lower than some analysts expected.\nPossible Threat From Amazon\nSnowflake in July announced support for digital advertising standard Unified ID 2.0. Advertising is one of Snowflake's largest verticals with customers representing a large percentage of players in the space, noted a RBC Capital report. The move comes as Googlephases out internet cookies for targeted advertising.\nWhether Amazon Web Services ratchets up competition remains a concern for SNOW stock. Plus, competition with privately held Databricks is heating up. A February funding roundvalued Databricks at $28 billion.\nDatabricks, which usesartificial intelligence, is expected to launch its own IPO.\nSnowflake stock bulls point to its seasoned management team as a strength no matter what unfolds.\nTwo former Oracle engineers — Benoit Dageville and Thierry Cruanes — along with Marcin Zukowski, former chief executive of startup Vectorwise, started Snowflake in 2012. The company holds patents in database architecture, data warehouses and other areas.\nSNOW Stock: ServiceNow Veterans Lead Company\nSnowflake brought inFrank Slootman as chief executive in May 2019. Slootman had stepped down as CEO of ServiceNow in early 2017. Former ServiceNow Chief Financial Officer Mike Scarpelli in 2019 also joined Snowflake in the same CFO position.\nUnlike legacy, on-premise data management systems, Snowflake's platform was built from the ground up for cloud computing. It provides 100% of its software over the internet.\nSnowflake customers can share data with their partners across multiple online storage systems using the company's data warehouse. Snowflake also enables easily searchable data to be shared among applications.\nSnowflake's data analytics tools became available on Amazon Web Services in 2015, Microsoft's Azure in 2018 and on Google's cloud platform in 2020.\nIn June, Snowflake partnered withC3.ai(AI). The two companies will cooperate in offering artificial intelligence tools to companies.\nAmazon Web Services A 'Frenemy'\n\"While Snowflake is multi-cloud, it derives some 85% of its revenues from data analytics jobs deployed on Amazon Web Services, which is also Snowflake's biggest rival with AWS Redshift,\" UBS analyst Karl Keirstead said in a recent note to clients.\n\"This 'frenemy' relationship is critical to Snowflake's success,\" Keirstead went on to say. \"AWS benefits far more from Snowflake spending on compute and storage infrastructure resources than they lose in the form of foregone AWS Redshift revenues. Snowflake represents a dream customer and partner for AWS and Microsoft Azure.\"\nSnowflake has focused on six core markets, including financial services, health care and life sciences, retail and consumer packaged goods, advertising media and entertainment, technology, and the government sector.\nWhen Snowflake went public in September it used a dual-class share structure that gave its CEO and insiderssuper-voting rights. However, Snowflake eliminated the dual-class structure in March.\nSnowflake had been based in San Mateo, Calif. Amid the shift to remote work spurred by the coronavirus emergency, Snowflake in May said it no longer has a corporate headquarters. It designated Bozeman, Mont., as its principal executive office. Slootman and Scarpelli are based in Bozeman.\nSnowflake Stock Fundamental Analysis\nSoftware stocks typically trade as a multiple of forward-looking revenue growth. Software-as-a-service, or SaaS, companies, such asSalesforce.com(CRM), typically provide the highest revenue growth. Salesforce is a key marketing partner of SNOW stock.\nSnowflake also partners with consulting firms such as Deloitte and information technology firms such as privately held Informatica.\nSnowflake is not an SaaS company, however. Instead, it uses a consumption-based business model based on how much data its customers crunch and store.\nSnowflake's revenue growth stands out. First-quartersales jumped 110%to $228.9 million. But there's less transparency and predictability than with subscription-based, recurring-revenue SaaS business models, analysts say.\n\"SNOW has a consumption model, whereby customers contract for a certain amount of compute and storage capacity,\" Mizuho Securities analyst Gregg Moskowitz said in a note. \"The company only records revenue, however, as that capacity is used, so there can be a lag of several months or more before revenue recognition begins.\"\nSnowflake is nearing an annual revenue run-rate of $1 billion. That's a big milestone for software growth companies. But SNOW stock is unprofitable on the two most common accounting standards.\nMany software companies are unprofitable using GAAP earnings, or generally accepted accounting principles, which includes stock-based compensation. But they're profitable on a non-GAAP or \"adjusted\" earnings basis.\nSNOW Stock Operates In The Red\nIn the first quarter, Snowflake reported a GAAP operating loss of $205.6 million and a GAAP per-share loss of 70 cents. Snowflake stock subsequently fell. It recorded an adjusted operating loss of $35.8 million.\nSnowflake doesn't break out adjusted earnings. Analysts estimate it lost 11 cents on an adjusted basis in the first quarter.\nSnowflake operates in the red amid sizable investments, analysts say. For fiscal 2022, for example, Snowflake has told analysts it plans to hire 1,200 net new employees, which would represent 48% growth in head count.\nStill, investments are paying off in revenue growth. Snowflake had 4,532 customers as of April 30, up 67% from the year-earlier period. That includes 187 of the Fortune 500. In the April quarter, Snowflake added a record 27 customers with more than $1 million per year in product revenue, giving it 104 such customers overall.\nGoldman Sachs analyst Kash Rangan is bullish on Snowflake's potential to dominate in cloud-based data analytics and management.\n\"We believe Snowflake will continue to replace incumbent warehousing solutions owing to their scalable and elastic cloud native data platform while also capitalizing on net new workloads and use cases as digital transformation drives greater digitization within the enterprise, and business intelligence and analytics remains a top priority for spending,\" he said in a note.\nSNOW Stock Technical Analysis\nSnowflake stock went public on Sept. 16 at 120 a share. At the time, software growth stocks were hot as investors sought recurring revenue amid the coronavirus emergency.\nSNOW stock popped as high as 319 on the first day of trading and closed 111.6% above the IPO price at 253.93. Shares pulled back as analysts debated Snowflake's valuation.\nSnowflake stock forged acup-with-handle baseover the next two months. The new base created an entry point of 301. SNOW stock blew past the buy point, hitting an all-time high of 429 on Dec. 8.\nSnowflake stock swooned in late 2020 amid questions over its valuation even as the IBD Computer-Software Enterprise group stayed resilient. The Computer-Software Enterprise group did not break down until mid-February amid a market rotation to value.\nSnowflake stock hit a low of 184.71 on May 13.\nCanaccord Genuity analyst David Hynes said in a note that one question for investors is whether SNOW stock will trade in concert with software growth stocks. Software growth stocks have sold off onworries over inflation and rising interest rates.\nIs Snowflake Stock A Buy Right Now?\nSnowflake stock still trades at a substantial premium as a multiple of forward-looking revenue growth. SNOW stock holds anIBD Composite Ratingof 37 out of a best possible 99, according toIBD Stock Checkup.\nIBD's Composite Rating combines five separate proprietary ratings into one easy-to-use rating. The best growth stocks have a Composite Rating of 90 or better.\nOne plus is that Snowflake stock owns an Accumulation/Distribution Rating of B, according toIBD MarketSmithanalysis. That rating analyzes price and volume changes in a stock over the past 13 weeks of trading.\nThe rating, on an A+ to E scale, measures institutional buying and selling in a stock. A+ signifies heavy institutional buying; E means heavy selling. Think of the C grade as neutral.\nSNOW stock has yet toform a basewith a proper entry point. Snowflake stock has clawed above its 50-day moving average. If it holds above the 50-day line that could kick-start the right side of a deep base.\nAs of Aug. 2, Snowflake stock is not a buy.","news_type":1},"isVote":1,"tweetType":1,"viewCount":76,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":804107384,"gmtCreate":1627943514348,"gmtModify":1633755163579,"author":{"id":"3573940420673790","authorId":"3573940420673790","name":"Zyl13","avatar":"https://static.tigerbbs.com/abc0f03108ec1f9a9c459181df989db8","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573940420673790","idStr":"3573940420673790"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/804107384","repostId":"1172320411","repostType":4,"isVote":1,"tweetType":1,"viewCount":33,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":804104478,"gmtCreate":1627943481194,"gmtModify":1631886209318,"author":{"id":"3573940420673790","authorId":"3573940420673790","name":"Zyl13","avatar":"https://static.tigerbbs.com/abc0f03108ec1f9a9c459181df989db8","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573940420673790","idStr":"3573940420673790"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/MCD\">$McDonald's(MCD)$</a>Mekdonald","listText":"<a href=\"https://laohu8.com/S/MCD\">$McDonald's(MCD)$</a>Mekdonald","text":"$McDonald's(MCD)$Mekdonald","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/804104478","isVote":1,"tweetType":1,"viewCount":38,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":109674601,"gmtCreate":1619696372703,"gmtModify":1634210663766,"author":{"id":"3573940420673790","authorId":"3573940420673790","name":"Zyl13","avatar":"https://static.tigerbbs.com/abc0f03108ec1f9a9c459181df989db8","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573940420673790","idStr":"3573940420673790"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/109674601","repostId":"1120053963","repostType":4,"repost":{"id":"1120053963","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1619694728,"share":"https://www.laohu8.com/m/news/1120053963?lang=&edition=full","pubTime":"2021-04-29 19:12","market":"us","language":"en","title":"McDonald's Reports First Quarter 2021 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=1120053963","media":"Tiger Newspress","summary":"- 2021 global comparable sales and revenues for the quarter surpassed first quarter 2019 levels, dri","content":"<p>- 2021 global comparable sales and revenues for the quarter surpassed first quarter 2019 levels, driven by the U.S.</p>\n<p>- Global comparable sales increased 7.5% in the first quarter, with growth across all segments</p>\n<p>- Diluted earnings per share of $2.05 increased 39%; excluding strategic gains, diluted earnings per share of $1.92 increased 31%</p>\n<p>McDonald's Corporation today announced results for the first quarter ended March&nbsp;31, 2021.</p>\n<p>\"Our first quarter 2021 global comparable sales and revenues surpassed first quarter 2019 levels, even as resurgences and operating restrictions persist in many parts of the world. I continue to be inspired by the resilience of our crew members, franchisees, suppliers, and company employees as we lead with our values and stay true to our purpose of feeding and fostering communities,\" said McDonald's President and Chief Executive OfficerChris Kempczinski. \"Our teams around the world are focused on executing our Accelerating the Arches strategy at the highest level - we're maximizing our marketing in a culturally relevant way, committed to the great tasting customer favorites on our core menu and doubling-down on digital, delivery and drive thru to create a faster and easier customer experience.\"</p>\n<p>First quarter financial performance:</p>\n<ul>\n <li>Global comparable sales increased 7.5%, reflecting positive comparable sales across all segments: 13.6% in the U.S.; 0.6% in the International Operated segment; and 6.4% in the International Developmental Licensed segment.</li>\n <li>Consolidated revenues increased 9% (5% in constant currencies).</li>\n <li>Systemwide sales increased 12% (8% in constant currencies).</li>\n <li>Consolidated operating income increased 35% (30% in constant currencies) and included$135 millionof strategic gains primarily related to the sale of McDonald'sJapanstock. Excluding these gains, operating income increased 27% (22% in constant currencies).</li>\n <li>Diluted earnings per share of$2.05increased 39% (35% in constant currencies). Excluding$0.13per share of strategic gains, diluted earnings per share was$1.92for the quarter, an increase of 31% (27% in constant currencies).</li>\n</ul>\n<p>COMPARABLE SALES</p>\n<p><img src=\"https://static.tigerbbs.com/b29686bc7559d3b6501fe3e993552ef0\" tg-width=\"808\" tg-height=\"272\"></p>\n<ul>\n <li><b>Comparable Sales:</b>Quarterly comparable sales results were positive across all segments as we began to lap the significant impact of COVID-19 on our global results beginning inMarch 2020. Guest counts remained negative for all segments.</li>\n <ul>\n  <li><b>U.S.:</b>Comparable sales results benefited from average check growth with double digit positive comparable sales across all dayparts. The Company's strong national menu and marketing offerings, as well as growth in delivery and digital platforms, contributed to the comparable sales growth.</li>\n  <li><b>International Operated Markets:</b>Results reflected strong positive comparable sales in the U.K.,AustraliaandCanada, partly offset by significantly negative comparable sales inFranceandGermany. Comparable sales in many markets continued to be impacted by varying levels of government imposed COVID-19 restrictions on restaurant operations.</li>\n  <li><b>International Developmental Licensed Markets:</b>Monthly comparable sales results improved sequentially throughout the quarter. The strong quarterly comparable sales were primarily driven byChinaandJapan.</li>\n </ul>\n</ul>\n<p>KEY FINANCIAL METRICS - CONSOLIDATED</p>\n<p>Dollars in millions, except per share data</p>\n<p><img src=\"https://static.tigerbbs.com/a7bd034ca637b55103900edf98fe76c4\" tg-width=\"909\" tg-height=\"333\"></p>\n<p>Results for the quarter reflected stronger operating performance in the U.S. due to higher sales-driven restaurant margins.</p>\n<p>Results for the quarter included$135 millionof pre-tax strategic gains, or$0.13per share, primarily related to the sale of McDonald'sJapanstock, which reduced the Company's ownership by an additional 3%.</p>\n<p>Foreign currency translation had a positive impact of$0.06on diluted earnings per share for the quarter.</p>\n<p>EARNINGS PER SHARE-DILUTED RECONCILIATION</p>\n<p><img src=\"https://static.tigerbbs.com/0e55f7dddfed1169d20085686d68ed5a\" tg-width=\"831\" tg-height=\"288\"></p>\n<p>Excluding the strategic gains, for the quarter net income increased 30% (26% in constant currencies) and diluted earnings per share increased 31% (27% in constant currencies).</p>\n<p>RESTAURANT UPDATE</p>\n<p>The Company has continued to follow the guidance of expert health authorities to ensure the appropriate precautionary steps are taken to protect the health and safety of our people and our customers.</p>\n<p>As a result of COVID-19 resurgences, throughout the quarter there have been numerous instances of government restrictions on restaurant operating hours, limited dine-in capacity and, in some cases, mandated dining room closures particularly in the International Operated Markets. These restrictions are impacting most of the Company's markets acrossEurope, particularly those with fewer drive thru restaurant locations. The Company expects some restrictions in various markets so long as the COVID-19 pandemic continues.</p>\n<p><b>THE FOLLOWING DEFINITIONS APPLY TO THESE TERMS AS USED THROUGHOUT THIS RELEASE</b></p>\n<p>Constant currency results exclude the effects of foreign currency translation and are calculated by translating current year results at prior year average exchange rates. Management reviews and analyzes business results excluding the effect of foreign currency translation, as well as impairment and other strategic charges and gains, and bases incentive compensation plans on these results, because the Company believes this better represents underlying business trends.</p>\n<p>Comparable sales are compared to the same period in the prior year and represent sales at all restaurants, whether operated by the Company or by franchisees, in operation at least thirteen months including those temporarily closed. Some of the reasons restaurants may be temporarily closed include reimaging or remodeling, rebuilding, road construction and natural disasters (including restaurants temporarily closed due to COVID-19). Comparable sales exclude the impact of currency translation and the sales of any market considered hyper-inflationary (generally identified as those markets whose cumulative inflation rate over a three-year period exceeds 100%), which management believes more accurately reflects the underlying business trends. Comparable sales are driven by changes in guest counts and average check, which is affected by changes in pricing and product mix.</p>\n<p>Comparable guest counts represent the number of transactions at all restaurants, whether operated by the Company or by franchisees, in operation at least thirteen months including those temporarily closed.</p>\n<p>Systemwide sales include sales at all restaurants, whether operated by the Company or by franchisees. While franchised sales are not recorded as revenues by the Company, management believes the information is important in understanding the Company's financial performance, because these sales are the basis on which the Company calculates and records franchised revenues and are indicative of the financial health of the franchisee base. The Company's revenues consist of sales by Company-operated restaurants and fees from franchised restaurants operated by conventional franchisees, developmental licensees and affiliates. Changes in Systemwide sales are primarily driven by comparable sales and net restaurant unit expansion.</p>\n<p>Free cash flow, defined as cash provided by operations less capital expenditures, and free cash flow conversion rate, defined as free cash flow divided by net income, are measures reviewed by management in order to evaluate the Company's ability to convert net profits into cash resources, after reinvesting in the core business, that can be used to pursue opportunities to enhance shareholder value.</p>\n<p><b>RELATED COMMUNICATIONS</b></p>\n<p>This press release should be read in conjunction with Exhibit<u>99.2</u>&nbsp;in the Company's Form 8-K filing for supplemental information related to the Company's results for the quarter ended March&nbsp;31, 2021.</p>\n<p>McDonald's Corporation will broadcast its investor earnings conference call live over the Internet at7:30 a.m. (Central Time)on April&nbsp;29, 2021. A link to the live webcast will be available at<u>www.investor.mcdonalds.com</u>. There will also be an archived webcast available for a limited time thereafter.</p>\n<p><b>UPCOMING COMMUNICATIONS</b></p>\n<p>For important news and information regarding McDonald's, including the timing of future investor conferences and earnings calls, visit the Investor Relations section of the Company's Internet home page at<u>www.investor.mcdonalds.com</u>. McDonald's uses this website as a primary channel for disclosing key information to its investors, some of which may contain material and previously non-public information.</p>\n<p><b>ABOUT McDONALD'S</b></p>\n<p>McDonald's is the world's leading global foodservice retailer with over 39,000 locations in over 100 countries. Approximately 93% of McDonald's restaurants worldwide are owned and operated by independent local business owners.</p>\n<p><b>FORWARD-LOOKING STATEMENTS</b></p>\n<p>This release contains certain forward-looking statements, which reflect management's expectations regarding future events and operating performance and speak only as of the date hereof. These forward-looking statements involve a number of risks and uncertainties. Factors that could cause actual results to differ materially from our expectations are detailed in the Company's filings with the Securities and Exchange Commission, including the risk factors discussed in Exhibit<u>99.2</u>&nbsp;in the Company's Form 8-K filing on April&nbsp;29, 2021. The Company undertakes no obligation to update such forward-looking statements, except as may otherwise be required by law.</p>\n<p><b>McDONALD'S CORPORATIONCONDENSED CONSOLIDATED STATEMENT OF INCOME (UNAUDITED)</b></p>\n<p><img src=\"https://static.tigerbbs.com/bdcf3fe0c7538ec45397769b91cd96e0\" tg-width=\"806\" tg-height=\"792\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>McDonald's Reports First Quarter 2021 Results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMcDonald's Reports First Quarter 2021 Results\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-04-29 19:12</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>- 2021 global comparable sales and revenues for the quarter surpassed first quarter 2019 levels, driven by the U.S.</p>\n<p>- Global comparable sales increased 7.5% in the first quarter, with growth across all segments</p>\n<p>- Diluted earnings per share of $2.05 increased 39%; excluding strategic gains, diluted earnings per share of $1.92 increased 31%</p>\n<p>McDonald's Corporation today announced results for the first quarter ended March&nbsp;31, 2021.</p>\n<p>\"Our first quarter 2021 global comparable sales and revenues surpassed first quarter 2019 levels, even as resurgences and operating restrictions persist in many parts of the world. I continue to be inspired by the resilience of our crew members, franchisees, suppliers, and company employees as we lead with our values and stay true to our purpose of feeding and fostering communities,\" said McDonald's President and Chief Executive OfficerChris Kempczinski. \"Our teams around the world are focused on executing our Accelerating the Arches strategy at the highest level - we're maximizing our marketing in a culturally relevant way, committed to the great tasting customer favorites on our core menu and doubling-down on digital, delivery and drive thru to create a faster and easier customer experience.\"</p>\n<p>First quarter financial performance:</p>\n<ul>\n <li>Global comparable sales increased 7.5%, reflecting positive comparable sales across all segments: 13.6% in the U.S.; 0.6% in the International Operated segment; and 6.4% in the International Developmental Licensed segment.</li>\n <li>Consolidated revenues increased 9% (5% in constant currencies).</li>\n <li>Systemwide sales increased 12% (8% in constant currencies).</li>\n <li>Consolidated operating income increased 35% (30% in constant currencies) and included$135 millionof strategic gains primarily related to the sale of McDonald'sJapanstock. Excluding these gains, operating income increased 27% (22% in constant currencies).</li>\n <li>Diluted earnings per share of$2.05increased 39% (35% in constant currencies). Excluding$0.13per share of strategic gains, diluted earnings per share was$1.92for the quarter, an increase of 31% (27% in constant currencies).</li>\n</ul>\n<p>COMPARABLE SALES</p>\n<p><img src=\"https://static.tigerbbs.com/b29686bc7559d3b6501fe3e993552ef0\" tg-width=\"808\" tg-height=\"272\"></p>\n<ul>\n <li><b>Comparable Sales:</b>Quarterly comparable sales results were positive across all segments as we began to lap the significant impact of COVID-19 on our global results beginning inMarch 2020. Guest counts remained negative for all segments.</li>\n <ul>\n  <li><b>U.S.:</b>Comparable sales results benefited from average check growth with double digit positive comparable sales across all dayparts. The Company's strong national menu and marketing offerings, as well as growth in delivery and digital platforms, contributed to the comparable sales growth.</li>\n  <li><b>International Operated Markets:</b>Results reflected strong positive comparable sales in the U.K.,AustraliaandCanada, partly offset by significantly negative comparable sales inFranceandGermany. Comparable sales in many markets continued to be impacted by varying levels of government imposed COVID-19 restrictions on restaurant operations.</li>\n  <li><b>International Developmental Licensed Markets:</b>Monthly comparable sales results improved sequentially throughout the quarter. The strong quarterly comparable sales were primarily driven byChinaandJapan.</li>\n </ul>\n</ul>\n<p>KEY FINANCIAL METRICS - CONSOLIDATED</p>\n<p>Dollars in millions, except per share data</p>\n<p><img src=\"https://static.tigerbbs.com/a7bd034ca637b55103900edf98fe76c4\" tg-width=\"909\" tg-height=\"333\"></p>\n<p>Results for the quarter reflected stronger operating performance in the U.S. due to higher sales-driven restaurant margins.</p>\n<p>Results for the quarter included$135 millionof pre-tax strategic gains, or$0.13per share, primarily related to the sale of McDonald'sJapanstock, which reduced the Company's ownership by an additional 3%.</p>\n<p>Foreign currency translation had a positive impact of$0.06on diluted earnings per share for the quarter.</p>\n<p>EARNINGS PER SHARE-DILUTED RECONCILIATION</p>\n<p><img src=\"https://static.tigerbbs.com/0e55f7dddfed1169d20085686d68ed5a\" tg-width=\"831\" tg-height=\"288\"></p>\n<p>Excluding the strategic gains, for the quarter net income increased 30% (26% in constant currencies) and diluted earnings per share increased 31% (27% in constant currencies).</p>\n<p>RESTAURANT UPDATE</p>\n<p>The Company has continued to follow the guidance of expert health authorities to ensure the appropriate precautionary steps are taken to protect the health and safety of our people and our customers.</p>\n<p>As a result of COVID-19 resurgences, throughout the quarter there have been numerous instances of government restrictions on restaurant operating hours, limited dine-in capacity and, in some cases, mandated dining room closures particularly in the International Operated Markets. These restrictions are impacting most of the Company's markets acrossEurope, particularly those with fewer drive thru restaurant locations. The Company expects some restrictions in various markets so long as the COVID-19 pandemic continues.</p>\n<p><b>THE FOLLOWING DEFINITIONS APPLY TO THESE TERMS AS USED THROUGHOUT THIS RELEASE</b></p>\n<p>Constant currency results exclude the effects of foreign currency translation and are calculated by translating current year results at prior year average exchange rates. Management reviews and analyzes business results excluding the effect of foreign currency translation, as well as impairment and other strategic charges and gains, and bases incentive compensation plans on these results, because the Company believes this better represents underlying business trends.</p>\n<p>Comparable sales are compared to the same period in the prior year and represent sales at all restaurants, whether operated by the Company or by franchisees, in operation at least thirteen months including those temporarily closed. Some of the reasons restaurants may be temporarily closed include reimaging or remodeling, rebuilding, road construction and natural disasters (including restaurants temporarily closed due to COVID-19). Comparable sales exclude the impact of currency translation and the sales of any market considered hyper-inflationary (generally identified as those markets whose cumulative inflation rate over a three-year period exceeds 100%), which management believes more accurately reflects the underlying business trends. Comparable sales are driven by changes in guest counts and average check, which is affected by changes in pricing and product mix.</p>\n<p>Comparable guest counts represent the number of transactions at all restaurants, whether operated by the Company or by franchisees, in operation at least thirteen months including those temporarily closed.</p>\n<p>Systemwide sales include sales at all restaurants, whether operated by the Company or by franchisees. While franchised sales are not recorded as revenues by the Company, management believes the information is important in understanding the Company's financial performance, because these sales are the basis on which the Company calculates and records franchised revenues and are indicative of the financial health of the franchisee base. The Company's revenues consist of sales by Company-operated restaurants and fees from franchised restaurants operated by conventional franchisees, developmental licensees and affiliates. Changes in Systemwide sales are primarily driven by comparable sales and net restaurant unit expansion.</p>\n<p>Free cash flow, defined as cash provided by operations less capital expenditures, and free cash flow conversion rate, defined as free cash flow divided by net income, are measures reviewed by management in order to evaluate the Company's ability to convert net profits into cash resources, after reinvesting in the core business, that can be used to pursue opportunities to enhance shareholder value.</p>\n<p><b>RELATED COMMUNICATIONS</b></p>\n<p>This press release should be read in conjunction with Exhibit<u>99.2</u>&nbsp;in the Company's Form 8-K filing for supplemental information related to the Company's results for the quarter ended March&nbsp;31, 2021.</p>\n<p>McDonald's Corporation will broadcast its investor earnings conference call live over the Internet at7:30 a.m. (Central Time)on April&nbsp;29, 2021. A link to the live webcast will be available at<u>www.investor.mcdonalds.com</u>. There will also be an archived webcast available for a limited time thereafter.</p>\n<p><b>UPCOMING COMMUNICATIONS</b></p>\n<p>For important news and information regarding McDonald's, including the timing of future investor conferences and earnings calls, visit the Investor Relations section of the Company's Internet home page at<u>www.investor.mcdonalds.com</u>. McDonald's uses this website as a primary channel for disclosing key information to its investors, some of which may contain material and previously non-public information.</p>\n<p><b>ABOUT McDONALD'S</b></p>\n<p>McDonald's is the world's leading global foodservice retailer with over 39,000 locations in over 100 countries. Approximately 93% of McDonald's restaurants worldwide are owned and operated by independent local business owners.</p>\n<p><b>FORWARD-LOOKING STATEMENTS</b></p>\n<p>This release contains certain forward-looking statements, which reflect management's expectations regarding future events and operating performance and speak only as of the date hereof. These forward-looking statements involve a number of risks and uncertainties. Factors that could cause actual results to differ materially from our expectations are detailed in the Company's filings with the Securities and Exchange Commission, including the risk factors discussed in Exhibit<u>99.2</u>&nbsp;in the Company's Form 8-K filing on April&nbsp;29, 2021. The Company undertakes no obligation to update such forward-looking statements, except as may otherwise be required by law.</p>\n<p><b>McDONALD'S CORPORATIONCONDENSED CONSOLIDATED STATEMENT OF INCOME (UNAUDITED)</b></p>\n<p><img src=\"https://static.tigerbbs.com/bdcf3fe0c7538ec45397769b91cd96e0\" tg-width=\"806\" tg-height=\"792\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MCD":"麦当劳"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1120053963","content_text":"- 2021 global comparable sales and revenues for the quarter surpassed first quarter 2019 levels, driven by the U.S.\n- Global comparable sales increased 7.5% in the first quarter, with growth across all segments\n- Diluted earnings per share of $2.05 increased 39%; excluding strategic gains, diluted earnings per share of $1.92 increased 31%\nMcDonald's Corporation today announced results for the first quarter ended March 31, 2021.\n\"Our first quarter 2021 global comparable sales and revenues surpassed first quarter 2019 levels, even as resurgences and operating restrictions persist in many parts of the world. I continue to be inspired by the resilience of our crew members, franchisees, suppliers, and company employees as we lead with our values and stay true to our purpose of feeding and fostering communities,\" said McDonald's President and Chief Executive OfficerChris Kempczinski. \"Our teams around the world are focused on executing our Accelerating the Arches strategy at the highest level - we're maximizing our marketing in a culturally relevant way, committed to the great tasting customer favorites on our core menu and doubling-down on digital, delivery and drive thru to create a faster and easier customer experience.\"\nFirst quarter financial performance:\n\nGlobal comparable sales increased 7.5%, reflecting positive comparable sales across all segments: 13.6% in the U.S.; 0.6% in the International Operated segment; and 6.4% in the International Developmental Licensed segment.\nConsolidated revenues increased 9% (5% in constant currencies).\nSystemwide sales increased 12% (8% in constant currencies).\nConsolidated operating income increased 35% (30% in constant currencies) and included$135 millionof strategic gains primarily related to the sale of McDonald'sJapanstock. Excluding these gains, operating income increased 27% (22% in constant currencies).\nDiluted earnings per share of$2.05increased 39% (35% in constant currencies). Excluding$0.13per share of strategic gains, diluted earnings per share was$1.92for the quarter, an increase of 31% (27% in constant currencies).\n\nCOMPARABLE SALES\n\n\nComparable Sales:Quarterly comparable sales results were positive across all segments as we began to lap the significant impact of COVID-19 on our global results beginning inMarch 2020. Guest counts remained negative for all segments.\n\nU.S.:Comparable sales results benefited from average check growth with double digit positive comparable sales across all dayparts. The Company's strong national menu and marketing offerings, as well as growth in delivery and digital platforms, contributed to the comparable sales growth.\nInternational Operated Markets:Results reflected strong positive comparable sales in the U.K.,AustraliaandCanada, partly offset by significantly negative comparable sales inFranceandGermany. Comparable sales in many markets continued to be impacted by varying levels of government imposed COVID-19 restrictions on restaurant operations.\nInternational Developmental Licensed Markets:Monthly comparable sales results improved sequentially throughout the quarter. The strong quarterly comparable sales were primarily driven byChinaandJapan.\n\n\nKEY FINANCIAL METRICS - CONSOLIDATED\nDollars in millions, except per share data\n\nResults for the quarter reflected stronger operating performance in the U.S. due to higher sales-driven restaurant margins.\nResults for the quarter included$135 millionof pre-tax strategic gains, or$0.13per share, primarily related to the sale of McDonald'sJapanstock, which reduced the Company's ownership by an additional 3%.\nForeign currency translation had a positive impact of$0.06on diluted earnings per share for the quarter.\nEARNINGS PER SHARE-DILUTED RECONCILIATION\n\nExcluding the strategic gains, for the quarter net income increased 30% (26% in constant currencies) and diluted earnings per share increased 31% (27% in constant currencies).\nRESTAURANT UPDATE\nThe Company has continued to follow the guidance of expert health authorities to ensure the appropriate precautionary steps are taken to protect the health and safety of our people and our customers.\nAs a result of COVID-19 resurgences, throughout the quarter there have been numerous instances of government restrictions on restaurant operating hours, limited dine-in capacity and, in some cases, mandated dining room closures particularly in the International Operated Markets. These restrictions are impacting most of the Company's markets acrossEurope, particularly those with fewer drive thru restaurant locations. The Company expects some restrictions in various markets so long as the COVID-19 pandemic continues.\nTHE FOLLOWING DEFINITIONS APPLY TO THESE TERMS AS USED THROUGHOUT THIS RELEASE\nConstant currency results exclude the effects of foreign currency translation and are calculated by translating current year results at prior year average exchange rates. Management reviews and analyzes business results excluding the effect of foreign currency translation, as well as impairment and other strategic charges and gains, and bases incentive compensation plans on these results, because the Company believes this better represents underlying business trends.\nComparable sales are compared to the same period in the prior year and represent sales at all restaurants, whether operated by the Company or by franchisees, in operation at least thirteen months including those temporarily closed. Some of the reasons restaurants may be temporarily closed include reimaging or remodeling, rebuilding, road construction and natural disasters (including restaurants temporarily closed due to COVID-19). Comparable sales exclude the impact of currency translation and the sales of any market considered hyper-inflationary (generally identified as those markets whose cumulative inflation rate over a three-year period exceeds 100%), which management believes more accurately reflects the underlying business trends. Comparable sales are driven by changes in guest counts and average check, which is affected by changes in pricing and product mix.\nComparable guest counts represent the number of transactions at all restaurants, whether operated by the Company or by franchisees, in operation at least thirteen months including those temporarily closed.\nSystemwide sales include sales at all restaurants, whether operated by the Company or by franchisees. While franchised sales are not recorded as revenues by the Company, management believes the information is important in understanding the Company's financial performance, because these sales are the basis on which the Company calculates and records franchised revenues and are indicative of the financial health of the franchisee base. The Company's revenues consist of sales by Company-operated restaurants and fees from franchised restaurants operated by conventional franchisees, developmental licensees and affiliates. Changes in Systemwide sales are primarily driven by comparable sales and net restaurant unit expansion.\nFree cash flow, defined as cash provided by operations less capital expenditures, and free cash flow conversion rate, defined as free cash flow divided by net income, are measures reviewed by management in order to evaluate the Company's ability to convert net profits into cash resources, after reinvesting in the core business, that can be used to pursue opportunities to enhance shareholder value.\nRELATED COMMUNICATIONS\nThis press release should be read in conjunction with Exhibit99.2 in the Company's Form 8-K filing for supplemental information related to the Company's results for the quarter ended March 31, 2021.\nMcDonald's Corporation will broadcast its investor earnings conference call live over the Internet at7:30 a.m. (Central Time)on April 29, 2021. A link to the live webcast will be available atwww.investor.mcdonalds.com. There will also be an archived webcast available for a limited time thereafter.\nUPCOMING COMMUNICATIONS\nFor important news and information regarding McDonald's, including the timing of future investor conferences and earnings calls, visit the Investor Relations section of the Company's Internet home page atwww.investor.mcdonalds.com. McDonald's uses this website as a primary channel for disclosing key information to its investors, some of which may contain material and previously non-public information.\nABOUT McDONALD'S\nMcDonald's is the world's leading global foodservice retailer with over 39,000 locations in over 100 countries. Approximately 93% of McDonald's restaurants worldwide are owned and operated by independent local business owners.\nFORWARD-LOOKING STATEMENTS\nThis release contains certain forward-looking statements, which reflect management's expectations regarding future events and operating performance and speak only as of the date hereof. These forward-looking statements involve a number of risks and uncertainties. Factors that could cause actual results to differ materially from our expectations are detailed in the Company's filings with the Securities and Exchange Commission, including the risk factors discussed in Exhibit99.2 in the Company's Form 8-K filing on April 29, 2021. The Company undertakes no obligation to update such forward-looking statements, except as may otherwise be required by law.\nMcDONALD'S CORPORATIONCONDENSED CONSOLIDATED STATEMENT OF INCOME (UNAUDITED)","news_type":1},"isVote":1,"tweetType":1,"viewCount":2,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":371312111,"gmtCreate":1618910586333,"gmtModify":1634289975694,"author":{"id":"3573940420673790","authorId":"3573940420673790","name":"Zyl13","avatar":"https://static.tigerbbs.com/abc0f03108ec1f9a9c459181df989db8","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573940420673790","idStr":"3573940420673790"},"themes":[],"htmlText":"Buy","listText":"Buy","text":"Buy","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/371312111","repostId":"1196760355","repostType":2,"repost":{"id":"1196760355","pubTimestamp":1618902002,"share":"https://www.laohu8.com/m/news/1196760355?lang=&edition=full","pubTime":"2021-04-20 15:00","market":"us","language":"en","title":"Apple Earnings Preview: Smashing Quarter For The iPhone","url":"https://stock-news.laohu8.com/highlight/detail?id=1196760355","media":"TheStreet","summary":"The Apple Maven’s pre-earnings coverage continues. Below is a discussion of how the iPhone, the larg","content":"<p>The Apple Maven’s pre-earnings coverage continues. Below is a discussion of how the iPhone, the largest of Apple’s segment, will likely outperform in fiscal second quarter.</p><p>The Apple Maven moves on with its coverage of the current quarterly earnings reporting season. Here are a few of the preview articles published so far:</p><ul><li>Mark your calendars for April 28, after the closing bell. The Apple Maven will review Apple earnings report and conference call via live blog, starting at 4 p.m. EST;</li><li>Wall Street analyst estimates are through the roof: a year-over-year increase in revenues and earnings per share of 32% and 53%, respectively;</li><li>The Mac is shaping up to be&nbsp;the most successful segment in the quarter. I see Apple’s PC sales rising by an astounding 50% or more over easy 2020 comps;</li><li>The iPad will&nbsp;face an uphill battle: tablet sales across the industry are expected to fall double digits this quarter. I believe that Apple will do better than average, however.</li><li>In the last several years, Apple stock&nbsp;gained three times morein the two weeks following earnings day than during other, non-earnings related weeks.</li></ul><p>As I continue to dive deeper into Apple’s fiscal second quarter numbers by segment, I turn my attention to the iPhone today.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/4a969d65f8683b4e0266088aefd59b13\" tg-width=\"970\" tg-height=\"585\" referrerpolicy=\"no-referrer\"><span>Figure 1: Apple's iPhone lineup.</span></p><p><b>iPhone: easy comps, solid lineup</b></p><p>The iPhone, not unlike much of the rest of the Cupertino company, will face easy comps this time – the comparable period in a COVID-19 pandemic-stricken 2020 saw revenues land flat, the worst top-line performance since early 2019. This is a good start for fiscal second quarter results.</p><p>Beyond comps, at least one research company&nbsp;expects&nbsp;Apple and other China-based device makers to stand out in the three-month period. Total smartphone shipments are projected to grow by an impressive 50%, with Apple claiming an unusual top vendor status over the past half year.</p><p>The graph below shows revenue growth for the iPhone over the past nine quarters. The upward trend is clear, and seems to be at least partly explained by the success of the most recent device launches:</p><ul><li>The iPhone XS and XR fell short of expectations in 2019 (red dot number 1), after the previous year’s iPhone X seems to have accelerated the upgrade cycle;</li><li>The iPhone 11 marked a recovery in 2020 smartphone sales (red dot number 2), but the rebound was quickly squashed by the COVID-19 crisis;</li><li>The second generation of the iPhone SE was&nbsp;a successful midcycle launch&nbsp;(red dot number 3) that helped to jump-start revenues during the pandemic year, even if momentarily;</li><li>The iPhone 12 captured much of the pent-up demand in the first fiscal year of 2021 (red dot number 4), returning Apple to what seems to be a path of longer-lasting recovery.</li></ul><p><b>The Apple Maven’s take</b></p><p>Apple seems to have a great lineup of iPhones, from the well-received 11 to the budget-oriented SE to the higher-end 5G models launched late last year.</p><p>In fiscal second quarter, the robust smartphone portfolio will meet a recovering consumer in the US, many of whom have recently received the third wave of fiscal stimulus from the government. It is hard to imagine the iPhone not performing well in the post-holiday quarter, especially against easy comps.</p><p>Here are a few questions that remain to be answered:</p><ol><li>Will the higher-end models (i.e. 12 Pro and Pro Max) perform substantially better than the cheaper version (i.e. mini),as some suggest? If so, will ASP (average selling prices) and margins increase beyond expectations?</li><li>Will the global component shortage negatively impact sales in the quarter or revenue expectations for the remainder of 2021?</li></ol>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apple Earnings Preview: Smashing Quarter For The iPhone</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApple Earnings Preview: Smashing Quarter For The iPhone\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-20 15:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.thestreet.com/apple/iphone/apple-earnings-preview-smashing-quarter-for-the-iphone><strong>TheStreet</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The Apple Maven’s pre-earnings coverage continues. Below is a discussion of how the iPhone, the largest of Apple’s segment, will likely outperform in fiscal second quarter.The Apple Maven moves on ...</p>\n\n<a href=\"https://www.thestreet.com/apple/iphone/apple-earnings-preview-smashing-quarter-for-the-iphone\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"source_url":"https://www.thestreet.com/apple/iphone/apple-earnings-preview-smashing-quarter-for-the-iphone","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1196760355","content_text":"The Apple Maven’s pre-earnings coverage continues. Below is a discussion of how the iPhone, the largest of Apple’s segment, will likely outperform in fiscal second quarter.The Apple Maven moves on with its coverage of the current quarterly earnings reporting season. Here are a few of the preview articles published so far:Mark your calendars for April 28, after the closing bell. The Apple Maven will review Apple earnings report and conference call via live blog, starting at 4 p.m. EST;Wall Street analyst estimates are through the roof: a year-over-year increase in revenues and earnings per share of 32% and 53%, respectively;The Mac is shaping up to be the most successful segment in the quarter. I see Apple’s PC sales rising by an astounding 50% or more over easy 2020 comps;The iPad will face an uphill battle: tablet sales across the industry are expected to fall double digits this quarter. I believe that Apple will do better than average, however.In the last several years, Apple stock gained three times morein the two weeks following earnings day than during other, non-earnings related weeks.As I continue to dive deeper into Apple’s fiscal second quarter numbers by segment, I turn my attention to the iPhone today.Figure 1: Apple's iPhone lineup.iPhone: easy comps, solid lineupThe iPhone, not unlike much of the rest of the Cupertino company, will face easy comps this time – the comparable period in a COVID-19 pandemic-stricken 2020 saw revenues land flat, the worst top-line performance since early 2019. This is a good start for fiscal second quarter results.Beyond comps, at least one research company expects Apple and other China-based device makers to stand out in the three-month period. Total smartphone shipments are projected to grow by an impressive 50%, with Apple claiming an unusual top vendor status over the past half year.The graph below shows revenue growth for the iPhone over the past nine quarters. The upward trend is clear, and seems to be at least partly explained by the success of the most recent device launches:The iPhone XS and XR fell short of expectations in 2019 (red dot number 1), after the previous year’s iPhone X seems to have accelerated the upgrade cycle;The iPhone 11 marked a recovery in 2020 smartphone sales (red dot number 2), but the rebound was quickly squashed by the COVID-19 crisis;The second generation of the iPhone SE was a successful midcycle launch (red dot number 3) that helped to jump-start revenues during the pandemic year, even if momentarily;The iPhone 12 captured much of the pent-up demand in the first fiscal year of 2021 (red dot number 4), returning Apple to what seems to be a path of longer-lasting recovery.The Apple Maven’s takeApple seems to have a great lineup of iPhones, from the well-received 11 to the budget-oriented SE to the higher-end 5G models launched late last year.In fiscal second quarter, the robust smartphone portfolio will meet a recovering consumer in the US, many of whom have recently received the third wave of fiscal stimulus from the government. It is hard to imagine the iPhone not performing well in the post-holiday quarter, especially against easy comps.Here are a few questions that remain to be answered:Will the higher-end models (i.e. 12 Pro and Pro Max) perform substantially better than the cheaper version (i.e. mini),as some suggest? If so, will ASP (average selling prices) and margins increase beyond expectations?Will the global component shortage negatively impact sales in the quarter or revenue expectations for the remainder of 2021?","news_type":1},"isVote":1,"tweetType":1,"viewCount":22,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":373163898,"gmtCreate":1618832314114,"gmtModify":1634290559472,"author":{"id":"3573940420673790","authorId":"3573940420673790","name":"Zyl13","avatar":"https://static.tigerbbs.com/abc0f03108ec1f9a9c459181df989db8","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573940420673790","idStr":"3573940420673790"},"themes":[],"htmlText":"Buy","listText":"Buy","text":"Buy","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/373163898","repostId":"2128315893","repostType":2,"repost":{"id":"2128315893","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1618828860,"share":"https://www.laohu8.com/m/news/2128315893?lang=&edition=full","pubTime":"2021-04-19 18:41","market":"us","language":"en","title":"Tesla stock falls 1.7% premarket, after surging 19.6% over the previous 3 sessions","url":"https://stock-news.laohu8.com/highlight/detail?id=2128315893","media":"Dow Jones","summary":"MW Tesla stock falls 1.7% premarket, after surging 19.6% over the previous 3 sessions.","content":"<p>MW Tesla stock falls 1.7% premarket, after surging 19.6% over the previous 3 sessions.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tesla stock falls 1.7% premarket, after surging 19.6% over the previous 3 sessions</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTesla stock falls 1.7% premarket, after surging 19.6% over the previous 3 sessions\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-04-19 18:41</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>MW Tesla stock falls 1.7% premarket, after surging 19.6% over the previous 3 sessions.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2128315893","content_text":"MW Tesla stock falls 1.7% premarket, after surging 19.6% over the previous 3 sessions.","news_type":1},"isVote":1,"tweetType":1,"viewCount":27,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":389539130,"gmtCreate":1612786092220,"gmtModify":1703764969728,"author":{"id":"3573940420673790","authorId":"3573940420673790","name":"Zyl13","avatar":"https://static.tigerbbs.com/abc0f03108ec1f9a9c459181df989db8","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573940420673790","idStr":"3573940420673790"},"themes":[],"htmlText":"Wow interesting&nbsp;","listText":"Wow interesting&nbsp;","text":"Wow interesting","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/389539130","repostId":"1126813487","repostType":4,"repost":{"id":"1126813487","pubTimestamp":1612776380,"share":"https://www.laohu8.com/m/news/1126813487?lang=&edition=full","pubTime":"2021-02-08 17:26","market":"us","language":"en","title":"Moderna Gets Added to Southeast Asia’s Vaccine Arsenal","url":"https://stock-news.laohu8.com/highlight/detail?id=1126813487","media":"Bloomberg","summary":"Moderna Inc. won approval from Singapore for its Covid vaccine and signed a deal to sell doses to th","content":"<p>Moderna Inc. won approval from Singapore for its Covid vaccine and signed a deal to sell doses to the Philippines, becoming the fourth supplier to get regulatory clearance in Southeast Asia.</p>\n<p>Shots by&nbsp;AstraZeneca Plc,Pfizer Inc.-BioNTech SEandSinovac Biotech Ltd.have also been approved by at least one country in the region as inoculations roll out. China and India are giving somefreevaccines to countries like the Philippines, Myanmar and Cambodia.</p>\n<p>Indonesia, Southeast Asia’s biggest and most populous economy,startedits coronavirus vaccination program on Jan. 13, with President Joko Widodo taking thefirst Sinovac jab. More than 784,000 people have received their first dose.</p>\n<p>Wealthier but smaller Singapore -- the first in Southeast Asia to start an official Covid-19 vaccination program -- began inoculatinghealthcareworkers with the Pfizer shot on Dec. 30 and has given the first shot to more than 175,000 people since then. Its prime minister got his first dose on Jan. 8 and has also received his second shot.</p>\n<p>Strategies are evolving across the region as different supply deals are sealed. In the Philippines, President Rodrigo Duterte has said he will take a Russian or Chinese vaccine, but his government’s first approval was for the Pfizer shot.</p>\n<p>Indonesia, which is battling the worst outbreak in Southeast Asia, ended 2020 by switching up who’s on its priority list for shots -- focusing on the elderly first instead of the young as previously announced. It was the earliest in the region to receive a vaccine shipment with a Sinovac supply in December.</p>\n<p>Some countries are also involved in vaccine development and manufacturing, a testament to the variety of strategies employed by Southeast Asian nations. Here’s how the region of more than 650 million people is dealing with differing fiscal, demographic and distribution challenges in their vaccination efforts.</p>\n<p>INDONESIA</p>\n<p>STRATEGY:</p>\n<p>Indonesia seeks to vaccinate 181.5 million people -- about two-thirds of the population -- by March 2022 and President Widodo has called on the cabinet to complete the program by end-2021.</p>\n<p>The nation expects its vaccination program to cost more than 73 trillion rupiah ($5.2 billion). It plans to be able to vaccinate 16 million people a month; the initial phase of inoculations will target more than 1.5 million health workers by the end of February.</p>\n<p>The country will offerfree vaccinesto people. With about 13,000 community health centers and 9,000 hospitals across the country, the government said it will be able to complete its targeted vaccination to achieve mass immunity.</p>\n<ul>\n <li>The world’s fourth most populous nation is banking on both Western and Chinese vaccines, ordering 125.5 million doses from Sinovac, 50 million fromAstraZenecaand another 50 million fromNovavax Inc., while developing 57.6 million of its own Merah Putih</li>\n <li>It is set to get as many as 23.1 million AstraZeneca doses from the GAVI alliance, after requesting 108 million free doses from the global vaccine facility</li>\n <li>Talks are also on with Pfizer for 50 million doses and loaned cold storage facilities for the vaccine</li>\n</ul>\n<p>TIMELINE:</p>\n<p>January, 2021: Sinovac</p>\n<p>(More than 784,000 people have received their first dose.)</p>\n<ul>\n <li>President Widodo got his first dose of the Sinovac shot on Jan. 13 along with public and army representatives, which kicked off Indonesia’s inoculation program</li>\n <li>More than 784,000 people have received their first dose as of Feb. 7, with over 139,000 of them completing their second shot</li>\n <li>China’s Sinovac Biotech shipped 3 million doses of vaccines to the country in December; the local food and drug regulator approved them for emergency use in January, and has since also given the nod for its use among theelderly</li>\n <li>Even before the regulator’s approval, the government started distributing the vaccines to its 34 provinces spread across the world’s largest archipelago</li>\n <li>Sinovac has shipped raw material for 55 million doses to be manufactured by Indonesia’s PT Bio Farma so far. The state firm aims to produce 24 million doses a month</li>\n <li>Bio Farma plans to also produce shots for other countries through the Coalition for Epidemic Preparedness Innovations as early as the fourth quarter, according to Indonesia’s state-owned enterprises ministry. Bio Farma will produce 100 million doses a year for CEPI.</li>\n</ul>\n<p>March, 2021: AstraZeneca</p>\n<ul>\n <li>Indonesia willreceivean initial allocation of between 13.7 million and 23.1 million shots of the AstraZeneca vaccine in the first half through the global Covax initiative</li>\n <li>The vaccines will arrive in stages, with 25%-35% by March and the remainder in the second quarter, according to the government. The shots can be used once the WHO approves the AstraZeneca inoculation for emergency use</li>\n <li>Under a separate deal with the company directly, Indonesia will also get the AstraZeneca vaccines delivered in stages starting from as early as April through the first quarter of 2022. The deal also includes the option for the country to purchase an additional 50 million doses.</li>\n</ul>\n<p>MALAYSIA</p>\n<p>STRATEGY:</p>\n<p>Malaysia is spending $504 million to buy enough shots to cover 26.5 million people, or about 80% of its population. It will start vaccinations from February, according to Prime Minister Muhyiddin Yassin. The government aims to get as many people inoculated within a year of getting the first batch of vaccines in February, Science Minister Khairy Jamaluddin said mid-January.</p>\n<p>The first phase of vaccinations, which will begin by end of February and last until April, will focus on inoculating 500,000 frontline workers, followed by the elderly and high-risk groups between April and August. The third leg will run from May through February 2022 for thoseaged18 and above, the prime minister has said.</p>\n<p>The country will have a “slight extra”stockpileof vaccines as only those 18 years old and above will be inoculated. The excess vaccines will be administered to migrant workers, expatriates, and non-Malaysian residents, the cost of which must be borne by their employers.</p>\n<p>Pfizer vaccines will probably be administered to those in urban areas due to the need for ultra-cold storage, while AstraZeneca vaccines will be deployed to rural areas.</p>\n<ul>\n <li>Malaysia hassecured12.8 million doses of the AstraZeneca vaccine through the Covax facility and directly, enough to inoculate 20% of the country’s population, according to the government</li>\n <li>The country has secured 25 million doses of the Pfizer-BioNTech vaccine, enough to cover 39% of the population</li>\n <li>It has also signed agreements for 12 million doses of China’s Sinovac andup to6.4 million doses of Russia’s Sputnik V vaccine</li>\n <li>Solution Group Bhd.signeda deal to supply the Malaysian government with 3.5 million doses of the Recombinant Ad5-nCoV coronavirus vaccine jointly developed by China’sCanSino Biologics Inc.and Beijing Institute of Biotechnology under the Academy of Military Medical Sciences. The purchase is subject to Solution obtaining product registration and market authorization of the vaccine in the country by April</li>\n <li>The government has also been in talks with Moderna and Johnson &amp; Johnson, according to officials</li>\n <li>Malaysia was due to conduct its first vaccine trial involving 3,000 volunteers in late January. It would be a phase-III trial on a vaccine candidate developed by the Institute of Medical Biology Chinese Academy of Medical Sciences</li>\n <li>Malaysia signed an agreement with China inOctoberto be given priority access to Covid-19 vaccines that China develops.</li>\n</ul>\n<p>TIMELINE:</p>\n<p>February, 2021: Pfizer</p>\n<ul>\n <li>The government secured 12.8 million doses from Pfizer-BioNTech SEin a deal signed in late 2020. The country in January agreed to buy an additional 12.2 million doses</li>\n <li>The first batch is due to arrive on Feb. 26</li>\n <li>The agreement with Pfizer is contingent on the vaccine being approved by the U.S. FDA and Malaysia’s regulator. Malaysia’s National Pharmaceutical Regulatory Agency has granted conditional approval for the vaccine, subject to further information from Pfizer, according to a local media report.</li>\n</ul>\n<p>March/April, 2021: Sinovac</p>\n<ul>\n <li>China’s Sinovac signed an agreement to supply 14 million doses to Malaysia, which may be ready for distribution by the end of March</li>\n <li>As part of this deal,Pharmaniaga Bhd.will supply a total of 12 million doses developed by China’s Sinovac Life Sciences Co. starting in April, the health ministry said in January</li>\n</ul>\n<p>1Q 2021: Sputnik V</p>\n<ul>\n <li>Duopharma Co. (M) will supplyup to6.4 million doses of Russia’s Sputnik V vaccines produced by Gamaleya Research Institute toward the end of March</li>\n</ul>\n<p>2Q 2021: AstraZeneca</p>\n<ul>\n <li>Malaysia hassecured6.4 million doses of the AstraZeneca vaccine through the Covax facility, and another 6.4 million directly</li>\n <li>The first batch is expected in the second quarter of 2021</li>\n</ul>\n<p>MYANMAR</p>\n<p>STRATEGY:</p>\n<p>Myanmar began inoculating its nearly 55 million population at theend ofJanuary. Before the military coup in early February, Aung San Suu Kyi’s administration had said frontline health workers and key government officials would be prioritized in the first phase of vaccinations, to be followed by vulnerable groups such as those older than 65 years.</p>\n<p>Myanmar kicked off vaccination for the general public on Feb. 5, less than a week after the coup. Interim President Myint Swe and officials from all ministries with the rank of director or above were also inoculated, along with the elderly in townships with the highest infection rates, according to the health and sports ministry. Suu Kyi, who is under detention at her residence, was also vaccinated on Feb. 6, according to her party officials.</p>\n<p>Myanmar has vowed to inoculate 38.4 million people older than 18 by the end of this year.</p>\n<p>The previous government had also been cooperating with GAVI, the vaccine alliance, to get shots for 20% of its population through the Covax facility. The Southeast Asian nation was also planning to allow the private sector to import World Health Organization-approved vaccines later this year.</p>\n<ul>\n <li>Other than the AstraZeneca deal it has signed, Myanmar also expected vaccines from Chinese developers to arrive in early 2021, with some doses from the Covax facility expected before April 7.</li>\n</ul>\n<p>TIMELINE:</p>\n<p>January, 2021: AstraZeneca</p>\n<p>(At least 103,142 health workers and volunteers have received shots)</p>\n<ul>\n <li>Myanmarordered30 million doses of the AstraZeneca vaccine produced under license bySerum Institute of Indiato vaccinate 15 million people. The country expects the first batch of this order to arrive in the second week of February</li>\n <li>The country expects an additional 27 million doses from the Covax facility from March</li>\n <li>It nevertheless began vaccinations at the end of January, with a separate 1.5 million doses that were donated by India having arrived Jan. 22</li>\n <li>The nation inoculated 103,142 health workers and volunteers as of Feb. 2, official data show.</li>\n</ul>\n<p>PHILIPPINES</p>\n<p>STRATEGY:</p>\n<p></p>\n<p>The Philippines plans to buy 148 million vaccine doses to inoculateup to70 million people this year, or more than half of its population. But it is negotiating for 178 million doses, enough to inoculate 92 million people, to take into account possible delays in deliveries, according to the finance secretary. The government seeks to vaccinate its entire population of more than 100 million by 2023.</p>\n<p>The nation is eyeing 82.5 billion pesos ($1.7 billion) in vaccinepurchasesthat it plans to fund with financing from multilateral agencies, state-owned banks and companies and bilateral sources, vaccine czar Carlito Galvez said.</p>\n<p>A number of mayors in Metropolitan Manila have separately drafted plans to provide shots to their constituents while waiting for guidelines on how local government units can purchase the vaccines.</p>\n<p>Priority for vaccinations will be given to medical frontliners and workers in industries deemed critical, including low-income groups and those identified as at risk.</p>\n<ul>\n <li>The government has signed deals for 30 million doses of the Covovax vaccine from the Serum Institute of India, and for 17 million doses from AstraZeneca</li>\n <li>It is also in talks with Pfizer, Johnson &amp; Johnson, Sinovac Biotech and Russia’s Gamaleya, according to Galvez</li>\n <li>The Philippines has signed apreliminaryagreement with Moderna following negotiations for as many as 20 million vaccine doses. A final supply deal with Moderna will likely be finished in February</li>\n <li>The nation is also expecting to receive fewer doses from the World Health Organization-backed Covax Facility, Galvez said</li>\n <li>China will donate 500,000 coronavirus vaccine doses to the Philippines</li>\n <li>Pfizer and AstraZeneca have been approved for emergency use by the local FDA, while Gamaleya and Sinovac have applied for the same authorization</li>\n <li>India-basedBharat Biotech International Ltd.has applied for emergency use authorization in the Philippines for its coronavirus vaccine, ABS-CBN News reported, citing the Food and Drug Administration head.</li>\n</ul>\n<p>TIMELINE:</p>\n<p>1Q 2021: Sinovac, Sputnik V</p>\n<ul>\n <li>Vaccinations could start as early as the first quarter of 2021 using Sinovac and Russia’s Sputnik V shots, according to Galvez</li>\n <li>Sinovac, Sputnik V are yet to receive the local FDA approval.</li>\n</ul>\n<p>1Q 2021: Pfizer, AstraZeneca</p>\n<ul>\n <li>At least 5.6 million coronavirus vaccine doses produced by Pfizer-BioNTech and AstraZeneca are expected to arrive in the country within the first quarter through the Covax facility</li>\n <li>The country will also receive as early as May 2.6 million doses of AstraZeneca vaccines purchased by local companies which pooled about800 million pesosto buy 3 million shots.</li>\n</ul>\n<p>SINGAPORE</p>\n<p>STRATEGY:</p>\n<p>The city-state has set aside roughly S$1 billion ($750 million) for vaccines, tapping the likes ofArcturus Therapeutics Holdings Inc.,Moderna, Pfizer and Sinovac for supplies. It estimates it should haveenoughfor its around 5.5 million-strong population by the third quarter of 2021.</p>\n<p>The city-state is prioritizinghealthcareworkers, the elderly and those in jobs or settings where risk of a super-spreading event is high -- such as the construction, marine and process sector, including migrant workers. For the elderly, it began with seniorsaged70 and above.</p>\n<p>Singapore aims to vaccinate the entire adult population, though this will be voluntary. Vaccines will be free for all Singaporeans and long-term residents. It is setting up vaccination centers across the island.</p>\n<p>TIMELINE:</p>\n<p>December, 2020: Pfizer</p>\n<p>(More than 175,000 people given first dose)</p>\n<ul>\n <li>Singapore started vaccinations on Dec. 30, 2020</li>\n <li>Prime Minister Lee Hsien Loong got a first dose of the vaccine on Jan. 8, making him the first member of cabinet to get the coronavirus vaccine shot</li>\n <li>The government said more than 175,000 people have received their first dose of the Covid-19 vaccine as of Feb. 2. Roughly 6,000 have received their second vaccine dose</li>\n <li>The city-state received its first shipment of the Pfizer-BioNTech vaccine on Dec. 21</li>\n <li>Those who have received shots include staff working inhealthcare, frontline and essential services, as well as staff and senior citizens in nursing homes. Some employees at the National Centre for Infectious Diseases have also received their second dose.</li>\n <li>Pilot vaccinations for senior citizensstartedJan. 27.</li>\n</ul>\n<p>March, 2021: Moderna</p>\n<ul>\n <li>Singapore granted interim authorization in February for Moderna’s Covid-19 vaccine to be used in the city-state. Moderna is the second vaccine to be authorized in Singapore</li>\n <li>Singapore’s Ministry of Health said that the country will roll out the Moderna vaccine for individualsaged18 years and above when shipments of the vaccine arrive</li>\n <li>If there are no disruptions to the schedule, the first shipment should arrive around March.</li>\n</ul>\n<p>Early 2021: Arcturus</p>\n<ul>\n <li>Arcturus and Singapore’s Economic Development Board have entered into a supply agreement for the right to buy the ARCT-021 vaccine</li>\n <li>Arcturus may ship the first batch of the Covid-19 vaccine it’s developing with local scientists early 2021</li>\n <li>Results so far show that the vaccine could be effective as a single dose, the Straits Times reported, citing a professor who co-developed the vaccine with Arcturus.</li>\n</ul>\n<p>THAILAND</p>\n<p>STRATEGY:</p>\n<p>Thailand wants to inoculate about 50% of its population by the end of this year.</p>\n<p>It has previously said it will allow private companies and hospitals to import and sell Covid-19 vaccinations as long as those shots have been approved by the nation’s Food and Drug Administration.</p>\n<p>Thailand’s health regulatorendorsedAstraZeneca’s vaccine for emergency use, the health minister said on Jan. 21. It’s the first to win approval in Thailand, which also has ordered shots developed by China’s Sinovac Biotech. Johnson &amp; Johnson has begun the process of seeking domestic approval for its vaccine.</p>\n<p>The Southeast Asian nation plans to distribute shots free of cost, while the imports by private firms would allow those who can afford to pay for inoculations along with non-Thais an alternative pathway to get shots. It won’t procure vaccines through the WHO-backed Covax program for now because theconditionsare too strict.</p>\n<ul>\n <li>The government has so far approved plans to purchase a total of 63 million doses, and the National Vaccine Institute is in talks with several manufacturers for additional supplies for delivery as early as the first quarter. These include 2 million doses from Sinovac and 61 million doses from AstraZeneca</li>\n <li>Not wanting to rely solely on inoculations from abroad, Thailand is also developing its own anti-coronavirus shot</li>\n</ul>\n<p>TIMELINE:</p>\n<p>February, 2021: Sinovac</p>\n<ul>\n <li>The country has said it plans to roll out 200,000 doses of Sinovac vaccines in February, 800,000 in March, and 1 million in April</li>\n</ul>\n<p>February, 2021: AstraZeneca</p>\n<ul>\n <li>Thailand has an advance agreement with AstraZeneca to secure Covid-19 vaccines, which are expected to be distributed by mid-2021, the prime minister has said</li>\n <li>The government expects 50,000 doses to arrive in February</li>\n <li>The government has ordered 61 million shots. The regulatory nod already given will also open the door for imports by private Thai companies for administering the doses to people who can afford to pay</li>\n <li>The country said early January it plans to roll out locally-produced AstraZeneca vaccines in May</li>\n <li>Under agreement with AstraZeneca, Siam Bioscience will produce vaccines at its facilities, and Thailand will receive technology transfer</li>\n <li>Thailand’s prime minister has said the country will supply coronavirus vaccines at “reasonable prices” to Myanmar, Laos, Cambodia and Vietnam when it begins production.</li>\n</ul>\n<p>VIETNAM</p>\n<p>STRATEGY:</p>\n<p>Vietnam is working on developing vaccines and will collaborate with suppliers when doses are available, according to a spokeswoman at the foreign affairs ministry.</p>\n<ul>\n <li>It signed a deal with AstraZeneca to acquire about 30 million doses of the Covid-19 vaccine, Deputy Health Minister Truong Quoc Cuong said during a government briefing in January</li>\n <li>It has also been negotiating to buy vaccines from Pfizer and companies from Russia and China, Cuong said</li>\n <li>Vietnam has four companies and institutes working on developing vaccines.Nanogen Pharmaceutical Biotechnologybegan its human vaccine trials Dec. 17. The Institute of Vaccines and Medical Biologicals started human trials Jan. 21, according to the health ministry.</li>\n</ul>\n<p>TIMELINE:</p>\n<p>1Q 2021: AstraZeneca</p>\n<ul>\n <li>Under the deal with AstraZeneca for about 30 million doses, Vietnam expects to receive vaccines each quarter this year, the deputy health minister said Jan. 4</li>\n <li>In addition, Vietnam expects to receive between 4.9 million to 8.25 million AstraZeneca vaccine doses through the WHO-backed Covax program during the first and second quarters, according to a government posting citing Covax.</li>\n</ul>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna Gets Added to Southeast Asia’s Vaccine Arsenal</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna Gets Added to Southeast Asia’s Vaccine Arsenal\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-02-08 17:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=http://bloomberg.com/news/articles/2021-02-08/moderna-gets-added-to-arsenal-southeast-asia-vaccine-tracker?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Moderna Inc. won approval from Singapore for its Covid vaccine and signed a deal to sell doses to the Philippines, becoming the fourth supplier to get regulatory clearance in Southeast Asia.\nShots by ...</p>\n\n<a href=\"http://bloomberg.com/news/articles/2021-02-08/moderna-gets-added-to-arsenal-southeast-asia-vaccine-tracker?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"http://bloomberg.com/news/articles/2021-02-08/moderna-gets-added-to-arsenal-southeast-asia-vaccine-tracker?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1126813487","content_text":"Moderna Inc. won approval from Singapore for its Covid vaccine and signed a deal to sell doses to the Philippines, becoming the fourth supplier to get regulatory clearance in Southeast Asia.\nShots by AstraZeneca Plc,Pfizer Inc.-BioNTech SEandSinovac Biotech Ltd.have also been approved by at least one country in the region as inoculations roll out. China and India are giving somefreevaccines to countries like the Philippines, Myanmar and Cambodia.\nIndonesia, Southeast Asia’s biggest and most populous economy,startedits coronavirus vaccination program on Jan. 13, with President Joko Widodo taking thefirst Sinovac jab. More than 784,000 people have received their first dose.\nWealthier but smaller Singapore -- the first in Southeast Asia to start an official Covid-19 vaccination program -- began inoculatinghealthcareworkers with the Pfizer shot on Dec. 30 and has given the first shot to more than 175,000 people since then. Its prime minister got his first dose on Jan. 8 and has also received his second shot.\nStrategies are evolving across the region as different supply deals are sealed. In the Philippines, President Rodrigo Duterte has said he will take a Russian or Chinese vaccine, but his government’s first approval was for the Pfizer shot.\nIndonesia, which is battling the worst outbreak in Southeast Asia, ended 2020 by switching up who’s on its priority list for shots -- focusing on the elderly first instead of the young as previously announced. It was the earliest in the region to receive a vaccine shipment with a Sinovac supply in December.\nSome countries are also involved in vaccine development and manufacturing, a testament to the variety of strategies employed by Southeast Asian nations. Here’s how the region of more than 650 million people is dealing with differing fiscal, demographic and distribution challenges in their vaccination efforts.\nINDONESIA\nSTRATEGY:\nIndonesia seeks to vaccinate 181.5 million people -- about two-thirds of the population -- by March 2022 and President Widodo has called on the cabinet to complete the program by end-2021.\nThe nation expects its vaccination program to cost more than 73 trillion rupiah ($5.2 billion). It plans to be able to vaccinate 16 million people a month; the initial phase of inoculations will target more than 1.5 million health workers by the end of February.\nThe country will offerfree vaccinesto people. With about 13,000 community health centers and 9,000 hospitals across the country, the government said it will be able to complete its targeted vaccination to achieve mass immunity.\n\nThe world’s fourth most populous nation is banking on both Western and Chinese vaccines, ordering 125.5 million doses from Sinovac, 50 million fromAstraZenecaand another 50 million fromNovavax Inc., while developing 57.6 million of its own Merah Putih\nIt is set to get as many as 23.1 million AstraZeneca doses from the GAVI alliance, after requesting 108 million free doses from the global vaccine facility\nTalks are also on with Pfizer for 50 million doses and loaned cold storage facilities for the vaccine\n\nTIMELINE:\nJanuary, 2021: Sinovac\n(More than 784,000 people have received their first dose.)\n\nPresident Widodo got his first dose of the Sinovac shot on Jan. 13 along with public and army representatives, which kicked off Indonesia’s inoculation program\nMore than 784,000 people have received their first dose as of Feb. 7, with over 139,000 of them completing their second shot\nChina’s Sinovac Biotech shipped 3 million doses of vaccines to the country in December; the local food and drug regulator approved them for emergency use in January, and has since also given the nod for its use among theelderly\nEven before the regulator’s approval, the government started distributing the vaccines to its 34 provinces spread across the world’s largest archipelago\nSinovac has shipped raw material for 55 million doses to be manufactured by Indonesia’s PT Bio Farma so far. The state firm aims to produce 24 million doses a month\nBio Farma plans to also produce shots for other countries through the Coalition for Epidemic Preparedness Innovations as early as the fourth quarter, according to Indonesia’s state-owned enterprises ministry. Bio Farma will produce 100 million doses a year for CEPI.\n\nMarch, 2021: AstraZeneca\n\nIndonesia willreceivean initial allocation of between 13.7 million and 23.1 million shots of the AstraZeneca vaccine in the first half through the global Covax initiative\nThe vaccines will arrive in stages, with 25%-35% by March and the remainder in the second quarter, according to the government. The shots can be used once the WHO approves the AstraZeneca inoculation for emergency use\nUnder a separate deal with the company directly, Indonesia will also get the AstraZeneca vaccines delivered in stages starting from as early as April through the first quarter of 2022. The deal also includes the option for the country to purchase an additional 50 million doses.\n\nMALAYSIA\nSTRATEGY:\nMalaysia is spending $504 million to buy enough shots to cover 26.5 million people, or about 80% of its population. It will start vaccinations from February, according to Prime Minister Muhyiddin Yassin. The government aims to get as many people inoculated within a year of getting the first batch of vaccines in February, Science Minister Khairy Jamaluddin said mid-January.\nThe first phase of vaccinations, which will begin by end of February and last until April, will focus on inoculating 500,000 frontline workers, followed by the elderly and high-risk groups between April and August. The third leg will run from May through February 2022 for thoseaged18 and above, the prime minister has said.\nThe country will have a “slight extra”stockpileof vaccines as only those 18 years old and above will be inoculated. The excess vaccines will be administered to migrant workers, expatriates, and non-Malaysian residents, the cost of which must be borne by their employers.\nPfizer vaccines will probably be administered to those in urban areas due to the need for ultra-cold storage, while AstraZeneca vaccines will be deployed to rural areas.\n\nMalaysia hassecured12.8 million doses of the AstraZeneca vaccine through the Covax facility and directly, enough to inoculate 20% of the country’s population, according to the government\nThe country has secured 25 million doses of the Pfizer-BioNTech vaccine, enough to cover 39% of the population\nIt has also signed agreements for 12 million doses of China’s Sinovac andup to6.4 million doses of Russia’s Sputnik V vaccine\nSolution Group Bhd.signeda deal to supply the Malaysian government with 3.5 million doses of the Recombinant Ad5-nCoV coronavirus vaccine jointly developed by China’sCanSino Biologics Inc.and Beijing Institute of Biotechnology under the Academy of Military Medical Sciences. The purchase is subject to Solution obtaining product registration and market authorization of the vaccine in the country by April\nThe government has also been in talks with Moderna and Johnson & Johnson, according to officials\nMalaysia was due to conduct its first vaccine trial involving 3,000 volunteers in late January. It would be a phase-III trial on a vaccine candidate developed by the Institute of Medical Biology Chinese Academy of Medical Sciences\nMalaysia signed an agreement with China inOctoberto be given priority access to Covid-19 vaccines that China develops.\n\nTIMELINE:\nFebruary, 2021: Pfizer\n\nThe government secured 12.8 million doses from Pfizer-BioNTech SEin a deal signed in late 2020. The country in January agreed to buy an additional 12.2 million doses\nThe first batch is due to arrive on Feb. 26\nThe agreement with Pfizer is contingent on the vaccine being approved by the U.S. FDA and Malaysia’s regulator. Malaysia’s National Pharmaceutical Regulatory Agency has granted conditional approval for the vaccine, subject to further information from Pfizer, according to a local media report.\n\nMarch/April, 2021: Sinovac\n\nChina’s Sinovac signed an agreement to supply 14 million doses to Malaysia, which may be ready for distribution by the end of March\nAs part of this deal,Pharmaniaga Bhd.will supply a total of 12 million doses developed by China’s Sinovac Life Sciences Co. starting in April, the health ministry said in January\n\n1Q 2021: Sputnik V\n\nDuopharma Co. (M) will supplyup to6.4 million doses of Russia’s Sputnik V vaccines produced by Gamaleya Research Institute toward the end of March\n\n2Q 2021: AstraZeneca\n\nMalaysia hassecured6.4 million doses of the AstraZeneca vaccine through the Covax facility, and another 6.4 million directly\nThe first batch is expected in the second quarter of 2021\n\nMYANMAR\nSTRATEGY:\nMyanmar began inoculating its nearly 55 million population at theend ofJanuary. Before the military coup in early February, Aung San Suu Kyi’s administration had said frontline health workers and key government officials would be prioritized in the first phase of vaccinations, to be followed by vulnerable groups such as those older than 65 years.\nMyanmar kicked off vaccination for the general public on Feb. 5, less than a week after the coup. Interim President Myint Swe and officials from all ministries with the rank of director or above were also inoculated, along with the elderly in townships with the highest infection rates, according to the health and sports ministry. Suu Kyi, who is under detention at her residence, was also vaccinated on Feb. 6, according to her party officials.\nMyanmar has vowed to inoculate 38.4 million people older than 18 by the end of this year.\nThe previous government had also been cooperating with GAVI, the vaccine alliance, to get shots for 20% of its population through the Covax facility. The Southeast Asian nation was also planning to allow the private sector to import World Health Organization-approved vaccines later this year.\n\nOther than the AstraZeneca deal it has signed, Myanmar also expected vaccines from Chinese developers to arrive in early 2021, with some doses from the Covax facility expected before April 7.\n\nTIMELINE:\nJanuary, 2021: AstraZeneca\n(At least 103,142 health workers and volunteers have received shots)\n\nMyanmarordered30 million doses of the AstraZeneca vaccine produced under license bySerum Institute of Indiato vaccinate 15 million people. The country expects the first batch of this order to arrive in the second week of February\nThe country expects an additional 27 million doses from the Covax facility from March\nIt nevertheless began vaccinations at the end of January, with a separate 1.5 million doses that were donated by India having arrived Jan. 22\nThe nation inoculated 103,142 health workers and volunteers as of Feb. 2, official data show.\n\nPHILIPPINES\nSTRATEGY:\n\nThe Philippines plans to buy 148 million vaccine doses to inoculateup to70 million people this year, or more than half of its population. But it is negotiating for 178 million doses, enough to inoculate 92 million people, to take into account possible delays in deliveries, according to the finance secretary. The government seeks to vaccinate its entire population of more than 100 million by 2023.\nThe nation is eyeing 82.5 billion pesos ($1.7 billion) in vaccinepurchasesthat it plans to fund with financing from multilateral agencies, state-owned banks and companies and bilateral sources, vaccine czar Carlito Galvez said.\nA number of mayors in Metropolitan Manila have separately drafted plans to provide shots to their constituents while waiting for guidelines on how local government units can purchase the vaccines.\nPriority for vaccinations will be given to medical frontliners and workers in industries deemed critical, including low-income groups and those identified as at risk.\n\nThe government has signed deals for 30 million doses of the Covovax vaccine from the Serum Institute of India, and for 17 million doses from AstraZeneca\nIt is also in talks with Pfizer, Johnson & Johnson, Sinovac Biotech and Russia’s Gamaleya, according to Galvez\nThe Philippines has signed apreliminaryagreement with Moderna following negotiations for as many as 20 million vaccine doses. A final supply deal with Moderna will likely be finished in February\nThe nation is also expecting to receive fewer doses from the World Health Organization-backed Covax Facility, Galvez said\nChina will donate 500,000 coronavirus vaccine doses to the Philippines\nPfizer and AstraZeneca have been approved for emergency use by the local FDA, while Gamaleya and Sinovac have applied for the same authorization\nIndia-basedBharat Biotech International Ltd.has applied for emergency use authorization in the Philippines for its coronavirus vaccine, ABS-CBN News reported, citing the Food and Drug Administration head.\n\nTIMELINE:\n1Q 2021: Sinovac, Sputnik V\n\nVaccinations could start as early as the first quarter of 2021 using Sinovac and Russia’s Sputnik V shots, according to Galvez\nSinovac, Sputnik V are yet to receive the local FDA approval.\n\n1Q 2021: Pfizer, AstraZeneca\n\nAt least 5.6 million coronavirus vaccine doses produced by Pfizer-BioNTech and AstraZeneca are expected to arrive in the country within the first quarter through the Covax facility\nThe country will also receive as early as May 2.6 million doses of AstraZeneca vaccines purchased by local companies which pooled about800 million pesosto buy 3 million shots.\n\nSINGAPORE\nSTRATEGY:\nThe city-state has set aside roughly S$1 billion ($750 million) for vaccines, tapping the likes ofArcturus Therapeutics Holdings Inc.,Moderna, Pfizer and Sinovac for supplies. It estimates it should haveenoughfor its around 5.5 million-strong population by the third quarter of 2021.\nThe city-state is prioritizinghealthcareworkers, the elderly and those in jobs or settings where risk of a super-spreading event is high -- such as the construction, marine and process sector, including migrant workers. For the elderly, it began with seniorsaged70 and above.\nSingapore aims to vaccinate the entire adult population, though this will be voluntary. Vaccines will be free for all Singaporeans and long-term residents. It is setting up vaccination centers across the island.\nTIMELINE:\nDecember, 2020: Pfizer\n(More than 175,000 people given first dose)\n\nSingapore started vaccinations on Dec. 30, 2020\nPrime Minister Lee Hsien Loong got a first dose of the vaccine on Jan. 8, making him the first member of cabinet to get the coronavirus vaccine shot\nThe government said more than 175,000 people have received their first dose of the Covid-19 vaccine as of Feb. 2. Roughly 6,000 have received their second vaccine dose\nThe city-state received its first shipment of the Pfizer-BioNTech vaccine on Dec. 21\nThose who have received shots include staff working inhealthcare, frontline and essential services, as well as staff and senior citizens in nursing homes. Some employees at the National Centre for Infectious Diseases have also received their second dose.\nPilot vaccinations for senior citizensstartedJan. 27.\n\nMarch, 2021: Moderna\n\nSingapore granted interim authorization in February for Moderna’s Covid-19 vaccine to be used in the city-state. Moderna is the second vaccine to be authorized in Singapore\nSingapore’s Ministry of Health said that the country will roll out the Moderna vaccine for individualsaged18 years and above when shipments of the vaccine arrive\nIf there are no disruptions to the schedule, the first shipment should arrive around March.\n\nEarly 2021: Arcturus\n\nArcturus and Singapore’s Economic Development Board have entered into a supply agreement for the right to buy the ARCT-021 vaccine\nArcturus may ship the first batch of the Covid-19 vaccine it’s developing with local scientists early 2021\nResults so far show that the vaccine could be effective as a single dose, the Straits Times reported, citing a professor who co-developed the vaccine with Arcturus.\n\nTHAILAND\nSTRATEGY:\nThailand wants to inoculate about 50% of its population by the end of this year.\nIt has previously said it will allow private companies and hospitals to import and sell Covid-19 vaccinations as long as those shots have been approved by the nation’s Food and Drug Administration.\nThailand’s health regulatorendorsedAstraZeneca’s vaccine for emergency use, the health minister said on Jan. 21. It’s the first to win approval in Thailand, which also has ordered shots developed by China’s Sinovac Biotech. Johnson & Johnson has begun the process of seeking domestic approval for its vaccine.\nThe Southeast Asian nation plans to distribute shots free of cost, while the imports by private firms would allow those who can afford to pay for inoculations along with non-Thais an alternative pathway to get shots. It won’t procure vaccines through the WHO-backed Covax program for now because theconditionsare too strict.\n\nThe government has so far approved plans to purchase a total of 63 million doses, and the National Vaccine Institute is in talks with several manufacturers for additional supplies for delivery as early as the first quarter. These include 2 million doses from Sinovac and 61 million doses from AstraZeneca\nNot wanting to rely solely on inoculations from abroad, Thailand is also developing its own anti-coronavirus shot\n\nTIMELINE:\nFebruary, 2021: Sinovac\n\nThe country has said it plans to roll out 200,000 doses of Sinovac vaccines in February, 800,000 in March, and 1 million in April\n\nFebruary, 2021: AstraZeneca\n\nThailand has an advance agreement with AstraZeneca to secure Covid-19 vaccines, which are expected to be distributed by mid-2021, the prime minister has said\nThe government expects 50,000 doses to arrive in February\nThe government has ordered 61 million shots. The regulatory nod already given will also open the door for imports by private Thai companies for administering the doses to people who can afford to pay\nThe country said early January it plans to roll out locally-produced AstraZeneca vaccines in May\nUnder agreement with AstraZeneca, Siam Bioscience will produce vaccines at its facilities, and Thailand will receive technology transfer\nThailand’s prime minister has said the country will supply coronavirus vaccines at “reasonable prices” to Myanmar, Laos, Cambodia and Vietnam when it begins production.\n\nVIETNAM\nSTRATEGY:\nVietnam is working on developing vaccines and will collaborate with suppliers when doses are available, according to a spokeswoman at the foreign affairs ministry.\n\nIt signed a deal with AstraZeneca to acquire about 30 million doses of the Covid-19 vaccine, Deputy Health Minister Truong Quoc Cuong said during a government briefing in January\nIt has also been negotiating to buy vaccines from Pfizer and companies from Russia and China, Cuong said\nVietnam has four companies and institutes working on developing vaccines.Nanogen Pharmaceutical Biotechnologybegan its human vaccine trials Dec. 17. The Institute of Vaccines and Medical Biologicals started human trials Jan. 21, according to the health ministry.\n\nTIMELINE:\n1Q 2021: AstraZeneca\n\nUnder the deal with AstraZeneca for about 30 million doses, Vietnam expects to receive vaccines each quarter this year, the deputy health minister said Jan. 4\nIn addition, Vietnam expects to receive between 4.9 million to 8.25 million AstraZeneca vaccine doses through the WHO-backed Covax program during the first and second quarters, according to a government posting citing Covax.","news_type":1},"isVote":1,"tweetType":1,"viewCount":41,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":389530601,"gmtCreate":1612786034203,"gmtModify":1703764968867,"author":{"id":"3573940420673790","authorId":"3573940420673790","name":"Zyl13","avatar":"https://static.tigerbbs.com/abc0f03108ec1f9a9c459181df989db8","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573940420673790","idStr":"3573940420673790"},"themes":[],"htmlText":"Hahaahah","listText":"Hahaahah","text":"Hahaahah","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/389530601","repostId":"1163750848","repostType":4,"isVote":1,"tweetType":1,"viewCount":34,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":389086567,"gmtCreate":1612622197159,"gmtModify":1703764036103,"author":{"id":"3573940420673790","authorId":"3573940420673790","name":"Zyl13","avatar":"https://static.tigerbbs.com/abc0f03108ec1f9a9c459181df989db8","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573940420673790","idStr":"3573940420673790"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/389086567","repostId":"2109726787","repostType":4,"isVote":1,"tweetType":1,"viewCount":16,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":389086334,"gmtCreate":1612622109928,"gmtModify":1703764034896,"author":{"id":"3573940420673790","authorId":"3573940420673790","name":"Zyl13","avatar":"https://static.tigerbbs.com/abc0f03108ec1f9a9c459181df989db8","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573940420673790","idStr":"3573940420673790"},"themes":[],"htmlText":"&nbsp;Wow","listText":"&nbsp;Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/389086334","repostId":"2109727286","repostType":4,"isVote":1,"tweetType":1,"viewCount":54,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":317166544,"gmtCreate":1612429426088,"gmtModify":1703761708603,"author":{"id":"3573940420673790","authorId":"3573940420673790","name":"Zyl13","avatar":"https://static.tigerbbs.com/abc0f03108ec1f9a9c459181df989db8","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573940420673790","idStr":"3573940420673790"},"themes":[],"htmlText":"To the moon!! diamonds hands&nbsp;","listText":"To the moon!! diamonds hands&nbsp;","text":"To the moon!! diamonds hands","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/317166544","repostId":"2108713067","repostType":4,"isVote":1,"tweetType":1,"viewCount":32,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":317169959,"gmtCreate":1612429054671,"gmtModify":1703761701484,"author":{"id":"3573940420673790","authorId":"3573940420673790","name":"Zyl13","avatar":"https://static.tigerbbs.com/abc0f03108ec1f9a9c459181df989db8","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573940420673790","idStr":"3573940420673790"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/317169959","repostId":"2108713067","repostType":4,"isVote":1,"tweetType":1,"viewCount":9,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":836556302,"gmtCreate":1629509510206,"gmtModify":1633684370886,"author":{"id":"3573940420673790","authorId":"3573940420673790","name":"Zyl13","avatar":"https://static.tigerbbs.com/abc0f03108ec1f9a9c459181df989db8","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573940420673790","authorIdStr":"3573940420673790"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/836556302","repostId":"2161743232","repostType":4,"isVote":1,"tweetType":1,"viewCount":59,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":898132894,"gmtCreate":1628477147418,"gmtModify":1633746870785,"author":{"id":"3573940420673790","authorId":"3573940420673790","name":"Zyl13","avatar":"https://static.tigerbbs.com/abc0f03108ec1f9a9c459181df989db8","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573940420673790","authorIdStr":"3573940420673790"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/898132894","repostId":"1190850891","repostType":4,"repost":{"id":"1190850891","pubTimestamp":1628474246,"share":"https://www.laohu8.com/m/news/1190850891?lang=&edition=full","pubTime":"2021-08-09 09:57","market":"us","language":"en","title":"Slowly but surely, bipartisan infrastructure bill passes another hurdle","url":"https://stock-news.laohu8.com/highlight/detail?id=1190850891","media":"Market Watch","summary":"Vote to end debate approved, 68-29; final passage could be pushed to Tuesday.\nWASHINGTON — Senators ","content":"<p><i>Vote to end debate approved, 68-29; final passage could be pushed to Tuesday.</i></p>\n<p>WASHINGTON — Senators hoisted the $1 trillion bipartisan infrastructure package over another hurdle late Sunday, a coalition of Democrats and Republicans pushing it closer to passage despite a few holdouts trying to derail one of President Joe Biden’s top priorities.</p>\n<p>The rare bipartisan momentum was holding steady, a reflection of the bill’s popularity and the eagerness of senators to show voters back home they can deliver. One of the biggest investments of its kind in years, the package promises to unleash billions of dollars to upgrade roads, bridges, broadband internet, water pipes and other public works systems undergirding the nation.</p>\n<p>Senators easily overcame another 60-vote hurdle on a vote of 68-29. Final passage could drag into early Tuesday as a single GOP senator, Tennessee’s Bill Hagerty, refused to relent on the mandatory debate time.</p>\n<p>Majority Leader Chuck Schumer, D-N.Y., stressed to colleagues that they could proceed the “easy way or the hard way,” as the Senate slogged through its second consecutive weekend session.</p>\n<p>“We’ll keep proceeding until we get this bill done,” Schumer said.</p>\n<p>The Infrastructure Investment and Jobs Act would provide what Biden has called a “historic investment” in public works programs, the first part of the president’s his rebuilding agenda. As many as 20 Republicans are expected to join Democrats in the evenly split Senate for what would be a robust final tally. If approved, it would go to the House.</p>\n<p>“We’re on the cusp of seeing that move through the Senate,” Transportation Secretary Pete Buttigieg said on “Fox News Sunday,” citing “a remarkable coalition” that includes business, labor and lawmakers from both parties. “I think we’re about to get this done.”</p>\n<p>Once voting wraps up, senators immediately will turn to the budget outline for&nbsp;a $3.5 trillion package&nbsp;of child care, elder care and other programs that is a much more partisan undertaking and expected to draw only Democratic support.</p>\n<p>Despite the momentum, action ground to a halt over the weekend when Hagerty, an ally of Donald Trump, forced the Senate to run out the clock on debate time, refusing to consent to speeding up the process.</p>\n<p>Hagerty, who had been Trump’s ambassador to Japan, was leading the effort to take as much time as needed to debate and amend the bipartisan bill, in part because he wants to slow the march toward Biden’s next big bill, which plans $3.5 trillion for child care, an expansion of Medicare for seniors and other so-called soft infrastructure needs.</p>\n<p>Trump called Hagerty on Sunday morning, said a person familiar with the call who requested anonymity to discuss it. Hagerty said later Sunday in a speech on the Senate floor that he was trying to prevent a “socialist debt bomb” of new government spending.</p>\n<p>The former president has been publicly critical of the bipartisan bill and criticizing Biden and the senators from both parties who support it, though it’s unclear whether Trump’s broadsides will have much sway with Republican senators. He celebrated Hagerty’s stand in a statement Sunday.</p>\n<p>Senate Republican leader Mitch McConnell, R-Ky., has so far allowed the bill to progress, despite the name-calling and criticism coming his way from Trump. “This is a compromise,” McConnell said.</p>\n<p>As the weekend standoff dragged on, Republicans who helped negotiate the compromise spoke up Sunday commending the former president for having sparked infrastructure talks when he was in the White House even if those bills never panned out.</p>\n<p>Sen. Rob Portman of Ohio, the lead Republican negotiator, said it’s time overdue to improve the nation’s public works systems.</p>\n<p>“The American people deserve to have good roads and bridges and infrastructure to drive on, travel on,” he said.</p>\n<p>Another negotiator, Sen. Mitt Romney, R-Utah, acknowledged that no compromise is perfect, but doing nothing when there was a bill before them was not an option.</p>\n<p>“Every president in the modern era has proposed an infrastructure package,” he said. “This was an effort to say let’s break the logjam.”</p>\n<p>Biden, who was spending the weekend in Delaware, said the bipartisan package offers an investment on par with the building of the transcontinental railroad or interstate highway system.</p>\n<p>Senators have spent the past week processing nearly two dozen amendments to the 2,700-page package, but so far none has substantially changed its framework.</p>\n<p>More amendments have been offered as senators seek to revise a section on cryptocurrency, a long-shot effort by defense hawks to add $50 billion for defense-related infrastructure and a bipartisan amendment to repurpose a portion of the untapped COVID-19 relief aid that had been sent to the states. But it’s unclear if they will be considered for votes.</p>\n<p>Senators have found much to like in the bill, even though it does not fully satisfy liberals, who view it as too small, or conservatives, who find it too large. It would provide federal money for projects many states and cities could not afford on their own.</p>\n<p>An analysis of the bill from the Congressional Budget Office drew concerns, particularly from Republicans. It&nbsp;concluded that the legislation would increase deficits by about $256 billion&nbsp;over the next decade.</p>\n<p>But the bill’s backers argued that the budget office was unable to take into account certain revenue streams — including from future economic growth. Additional analysis released Saturday by the budget office suggested infrastructure spending overall could boost productivity and lower the ultimate costs.</p>\n<p>Paying for the package has been a pressure point throughout the months of negotiations after Democrats objected to an increase in the gas tax paid at the pump and Republicans resisted a plan to bolster the IRS to go after tax scofflaws.</p>\n<p>Unlike Biden’s bigger $3.5 trillion package, which would be paid for by higher tax rates for corporations and the wealthy, the bipartisan package is funded by repurposing other money, including untapped COVID-19 aid, and other spending cuts and revenue streams.</p>\n<p>The House is in recess and is expected to consider both Biden infrastructure packages when it returns in September.</p>","source":"lsy1616996754749","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Slowly but surely, bipartisan infrastructure bill passes another hurdle </title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSlowly but surely, bipartisan infrastructure bill passes another hurdle \n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-09 09:57 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.marketwatch.com/story/slow-progress-but-progress-nonetheless-on-bipartisan-infrastructure-bill-01628453793><strong>Market Watch</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Vote to end debate approved, 68-29; final passage could be pushed to Tuesday.\nWASHINGTON — Senators hoisted the $1 trillion bipartisan infrastructure package over another hurdle late Sunday, a ...</p>\n\n<a href=\"https://www.marketwatch.com/story/slow-progress-but-progress-nonetheless-on-bipartisan-infrastructure-bill-01628453793\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index",".DJI":"道琼斯"},"source_url":"https://www.marketwatch.com/story/slow-progress-but-progress-nonetheless-on-bipartisan-infrastructure-bill-01628453793","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1190850891","content_text":"Vote to end debate approved, 68-29; final passage could be pushed to Tuesday.\nWASHINGTON — Senators hoisted the $1 trillion bipartisan infrastructure package over another hurdle late Sunday, a coalition of Democrats and Republicans pushing it closer to passage despite a few holdouts trying to derail one of President Joe Biden’s top priorities.\nThe rare bipartisan momentum was holding steady, a reflection of the bill’s popularity and the eagerness of senators to show voters back home they can deliver. One of the biggest investments of its kind in years, the package promises to unleash billions of dollars to upgrade roads, bridges, broadband internet, water pipes and other public works systems undergirding the nation.\nSenators easily overcame another 60-vote hurdle on a vote of 68-29. Final passage could drag into early Tuesday as a single GOP senator, Tennessee’s Bill Hagerty, refused to relent on the mandatory debate time.\nMajority Leader Chuck Schumer, D-N.Y., stressed to colleagues that they could proceed the “easy way or the hard way,” as the Senate slogged through its second consecutive weekend session.\n“We’ll keep proceeding until we get this bill done,” Schumer said.\nThe Infrastructure Investment and Jobs Act would provide what Biden has called a “historic investment” in public works programs, the first part of the president’s his rebuilding agenda. As many as 20 Republicans are expected to join Democrats in the evenly split Senate for what would be a robust final tally. If approved, it would go to the House.\n“We’re on the cusp of seeing that move through the Senate,” Transportation Secretary Pete Buttigieg said on “Fox News Sunday,” citing “a remarkable coalition” that includes business, labor and lawmakers from both parties. “I think we’re about to get this done.”\nOnce voting wraps up, senators immediately will turn to the budget outline for a $3.5 trillion package of child care, elder care and other programs that is a much more partisan undertaking and expected to draw only Democratic support.\nDespite the momentum, action ground to a halt over the weekend when Hagerty, an ally of Donald Trump, forced the Senate to run out the clock on debate time, refusing to consent to speeding up the process.\nHagerty, who had been Trump’s ambassador to Japan, was leading the effort to take as much time as needed to debate and amend the bipartisan bill, in part because he wants to slow the march toward Biden’s next big bill, which plans $3.5 trillion for child care, an expansion of Medicare for seniors and other so-called soft infrastructure needs.\nTrump called Hagerty on Sunday morning, said a person familiar with the call who requested anonymity to discuss it. Hagerty said later Sunday in a speech on the Senate floor that he was trying to prevent a “socialist debt bomb” of new government spending.\nThe former president has been publicly critical of the bipartisan bill and criticizing Biden and the senators from both parties who support it, though it’s unclear whether Trump’s broadsides will have much sway with Republican senators. He celebrated Hagerty’s stand in a statement Sunday.\nSenate Republican leader Mitch McConnell, R-Ky., has so far allowed the bill to progress, despite the name-calling and criticism coming his way from Trump. “This is a compromise,” McConnell said.\nAs the weekend standoff dragged on, Republicans who helped negotiate the compromise spoke up Sunday commending the former president for having sparked infrastructure talks when he was in the White House even if those bills never panned out.\nSen. Rob Portman of Ohio, the lead Republican negotiator, said it’s time overdue to improve the nation’s public works systems.\n“The American people deserve to have good roads and bridges and infrastructure to drive on, travel on,” he said.\nAnother negotiator, Sen. Mitt Romney, R-Utah, acknowledged that no compromise is perfect, but doing nothing when there was a bill before them was not an option.\n“Every president in the modern era has proposed an infrastructure package,” he said. “This was an effort to say let’s break the logjam.”\nBiden, who was spending the weekend in Delaware, said the bipartisan package offers an investment on par with the building of the transcontinental railroad or interstate highway system.\nSenators have spent the past week processing nearly two dozen amendments to the 2,700-page package, but so far none has substantially changed its framework.\nMore amendments have been offered as senators seek to revise a section on cryptocurrency, a long-shot effort by defense hawks to add $50 billion for defense-related infrastructure and a bipartisan amendment to repurpose a portion of the untapped COVID-19 relief aid that had been sent to the states. But it’s unclear if they will be considered for votes.\nSenators have found much to like in the bill, even though it does not fully satisfy liberals, who view it as too small, or conservatives, who find it too large. It would provide federal money for projects many states and cities could not afford on their own.\nAn analysis of the bill from the Congressional Budget Office drew concerns, particularly from Republicans. It concluded that the legislation would increase deficits by about $256 billion over the next decade.\nBut the bill’s backers argued that the budget office was unable to take into account certain revenue streams — including from future economic growth. Additional analysis released Saturday by the budget office suggested infrastructure spending overall could boost productivity and lower the ultimate costs.\nPaying for the package has been a pressure point throughout the months of negotiations after Democrats objected to an increase in the gas tax paid at the pump and Republicans resisted a plan to bolster the IRS to go after tax scofflaws.\nUnlike Biden’s bigger $3.5 trillion package, which would be paid for by higher tax rates for corporations and the wealthy, the bipartisan package is funded by repurposing other money, including untapped COVID-19 aid, and other spending cuts and revenue streams.\nThe House is in recess and is expected to consider both Biden infrastructure packages when it returns in September.","news_type":1},"isVote":1,"tweetType":1,"viewCount":34,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":832114359,"gmtCreate":1629598071471,"gmtModify":1633683874416,"author":{"id":"3573940420673790","authorId":"3573940420673790","name":"Zyl13","avatar":"https://static.tigerbbs.com/abc0f03108ec1f9a9c459181df989db8","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573940420673790","authorIdStr":"3573940420673790"},"themes":[],"htmlText":"Up","listText":"Up","text":"Up","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/832114359","repostId":"2161149745","repostType":4,"repost":{"id":"2161149745","pubTimestamp":1629498960,"share":"https://www.laohu8.com/m/news/2161149745?lang=&edition=full","pubTime":"2021-08-21 06:36","market":"us","language":"en","title":"Bitcoin rises 5 percent to $49,106","url":"https://stock-news.laohu8.com/highlight/detail?id=2161149745","media":"StreetInsider","summary":"(Reuters) - Bitcoin rose 5.01 % to $49,106.4 at 22:04 GMT on Friday, adding $2,342.1 to its previous","content":"<p><img src=\"https://static.tigerbbs.com/e0b53399a7d28656bb2d3f7824cf0bea\" tg-width=\"200\" tg-height=\"135\" referrerpolicy=\"no-referrer\"></p>\n<p>(Reuters) - Bitcoin rose 5.01 % to $49,106.4 at 22:04 GMT on Friday, adding $2,342.1 to its previous close.</p>\n<p>Bitcoin, the world's biggest and best-known cryptocurrency, is up 77.4% from the year's low of $27,734 on Jan. 4.</p>\n<p>Ether, the coin linked to the ethereum blockchain network, rose 3.03% to $3,281.82 on Friday, adding $96.64 to its previous close.</p>\n<p>(Reporting by Radhika Anilkumar in Bengaluru; Editing by Sonya Hepinstall)</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Bitcoin rises 5 percent to $49,106</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBitcoin rises 5 percent to $49,106\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-21 06:36 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=18847810><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Reuters) - Bitcoin rose 5.01 % to $49,106.4 at 22:04 GMT on Friday, adding $2,342.1 to its previous close.\nBitcoin, the world's biggest and best-known cryptocurrency, is up 77.4% from the year's low ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18847810\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GBTC":"Grayscale Bitcoin Trust","COIN":"Coinbase Global, Inc."},"source_url":"https://www.streetinsider.com/dr/news.php?id=18847810","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2161149745","content_text":"(Reuters) - Bitcoin rose 5.01 % to $49,106.4 at 22:04 GMT on Friday, adding $2,342.1 to its previous close.\nBitcoin, the world's biggest and best-known cryptocurrency, is up 77.4% from the year's low of $27,734 on Jan. 4.\nEther, the coin linked to the ethereum blockchain network, rose 3.03% to $3,281.82 on Friday, adding $96.64 to its previous close.\n(Reporting by Radhika Anilkumar in Bengaluru; Editing by Sonya Hepinstall)","news_type":1},"isVote":1,"tweetType":1,"viewCount":100,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":804107384,"gmtCreate":1627943514348,"gmtModify":1633755163579,"author":{"id":"3573940420673790","authorId":"3573940420673790","name":"Zyl13","avatar":"https://static.tigerbbs.com/abc0f03108ec1f9a9c459181df989db8","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573940420673790","authorIdStr":"3573940420673790"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/804107384","repostId":"1172320411","repostType":4,"isVote":1,"tweetType":1,"viewCount":33,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":810077946,"gmtCreate":1629937226185,"gmtModify":1633681361868,"author":{"id":"3573940420673790","authorId":"3573940420673790","name":"Zyl13","avatar":"https://static.tigerbbs.com/abc0f03108ec1f9a9c459181df989db8","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573940420673790","authorIdStr":"3573940420673790"},"themes":[],"htmlText":"Up","listText":"Up","text":"Up","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/810077946","repostId":"2162507820","repostType":4,"repost":{"id":"2162507820","pubTimestamp":1629934288,"share":"https://www.laohu8.com/m/news/2162507820?lang=&edition=full","pubTime":"2021-08-26 07:31","market":"us","language":"en","title":"Snowflake Beats Revenue Estimates and Gives Upbeat Forecast","url":"https://stock-news.laohu8.com/highlight/detail?id=2162507820","media":"Bloomberg","summary":"(Bloomberg) -- Snowflake Inc., the software company with 2020’s biggest U.S. initial public offering","content":"<p>(Bloomberg) -- <a href=\"https://laohu8.com/S/SNOW\">Snowflake</a> Inc., the software company with 2020’s biggest U.S. initial public offering, delivered better-than-expected results and a rosy forecast for the current quarter.</p>\n<p>Product sales, which make up more than 90% of Snowflake’s revenue, will be $280 million to $285 million this quarter, the company said on Wednesday. Analysts have projected $271.4 million on average. Revenue also topped projections in the second quarter, and Snowflake posted a narrower loss than predicted.</p>\n<p>Snowflake, which makes software for warehousing data in the cloud, is benefiting from companies modernizing their corporate applications and networks. Customers also are seeking ways to manage and analyze ever-increasing volumes of information from multiple locations. And Snowflake is facing less of a threat from a rival Amazon Web Services product called Redshift, according to <a href=\"https://laohu8.com/S/UGBLF\">UBS AG</a>.</p>\n<p>Snowflake makes software that pulls in, stores and analyzes information from multiple systems. Its customers include BlackRock Inc. and McKesson Corp. Product revenue climbed to $254.6 million last quarter, compared with an average analyst estimate of $240.1 million. Snowflake reported a loss of 64 cents a share, narrower than the 70 cents projected.</p>\n<p>At its analyst day in June, Snowflake said it is aiming for $10 billion in sales by fiscal 2029. Analysts expect annual sales to top $1 billion in the current fiscal year, 2022.</p>\n<p>Snowflake listed on the New York Stock Exchange in September in the largest IPO ever for a software maker. The stock has more than doubled since then. It climbed as much as 5.3% to $298.75 in late trading Wednesday, before paring the gains.</p>\n<p>The onetime Silicon Valley company said in May that it no longer has a corporate headquarters because its workforce is distributed. It currently lists Bozeman, Montana -- where Chief Executive Officer Frank Slootman and Chief Financial Officer Mike Scarpelli live -- as its principal executive office.</p>\n<p>Snowflake&nbsp;shares&nbsp;rose&nbsp;nearly&nbsp;4%&nbsp;in&nbsp;after-hour&nbsp;trading.</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Snowflake Beats Revenue Estimates and Gives Upbeat Forecast</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSnowflake Beats Revenue Estimates and Gives Upbeat Forecast\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-26 07:31 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/snowflake-beats-revenue-estimates-gives-202528632.html><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Bloomberg) -- Snowflake Inc., the software company with 2020’s biggest U.S. initial public offering, delivered better-than-expected results and a rosy forecast for the current quarter.\nProduct sales,...</p>\n\n<a href=\"https://finance.yahoo.com/news/snowflake-beats-revenue-estimates-gives-202528632.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://finance.yahoo.com/news/snowflake-beats-revenue-estimates-gives-202528632.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2162507820","content_text":"(Bloomberg) -- Snowflake Inc., the software company with 2020’s biggest U.S. initial public offering, delivered better-than-expected results and a rosy forecast for the current quarter.\nProduct sales, which make up more than 90% of Snowflake’s revenue, will be $280 million to $285 million this quarter, the company said on Wednesday. Analysts have projected $271.4 million on average. Revenue also topped projections in the second quarter, and Snowflake posted a narrower loss than predicted.\nSnowflake, which makes software for warehousing data in the cloud, is benefiting from companies modernizing their corporate applications and networks. Customers also are seeking ways to manage and analyze ever-increasing volumes of information from multiple locations. And Snowflake is facing less of a threat from a rival Amazon Web Services product called Redshift, according to UBS AG.\nSnowflake makes software that pulls in, stores and analyzes information from multiple systems. Its customers include BlackRock Inc. and McKesson Corp. Product revenue climbed to $254.6 million last quarter, compared with an average analyst estimate of $240.1 million. Snowflake reported a loss of 64 cents a share, narrower than the 70 cents projected.\nAt its analyst day in June, Snowflake said it is aiming for $10 billion in sales by fiscal 2029. Analysts expect annual sales to top $1 billion in the current fiscal year, 2022.\nSnowflake listed on the New York Stock Exchange in September in the largest IPO ever for a software maker. The stock has more than doubled since then. It climbed as much as 5.3% to $298.75 in late trading Wednesday, before paring the gains.\nThe onetime Silicon Valley company said in May that it no longer has a corporate headquarters because its workforce is distributed. It currently lists Bozeman, Montana -- where Chief Executive Officer Frank Slootman and Chief Financial Officer Mike Scarpelli live -- as its principal executive office.\nSnowflake shares rose nearly 4% in after-hour trading.","news_type":1},"isVote":1,"tweetType":1,"viewCount":153,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":891694914,"gmtCreate":1628384842538,"gmtModify":1633751363298,"author":{"id":"3573940420673790","authorId":"3573940420673790","name":"Zyl13","avatar":"https://static.tigerbbs.com/abc0f03108ec1f9a9c459181df989db8","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573940420673790","authorIdStr":"3573940420673790"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/891694914","repostId":"1157428986","repostType":4,"repost":{"id":"1157428986","pubTimestamp":1628296262,"share":"https://www.laohu8.com/m/news/1157428986?lang=&edition=full","pubTime":"2021-08-07 08:31","market":"us","language":"en","title":"US IPO Week Ahead: 2 banks test the waters amid annual summer slowdown","url":"https://stock-news.laohu8.com/highlight/detail?id=1157428986","media":"renaissancecap...","summary":"The IPO market is getting a breather as the August lull continues to set in, with just two banks sch","content":"<p>The IPO market is getting a breather as the August lull continues to set in, with just two banks scheduled for the week ahead.</p>\n<p>Utah-based digital bank&nbsp;<b>FinWise Bancorp</b>(FINW) plans to raise $58 million at a $183 million market cap. FinWise Bank makes loans to and takes deposits from consumers and small businesses across the US. As of 3/31/21, FinWise Bancorp had total assets of $330 million, total loans of $245 million, total deposits of $189 million, and total shareholders’ equity of $52 million.</p>\n<p>Alabama bank&nbsp;<b>Southern States Bancshares</b>(SSBK) plans to raise $40 million at a $174 million market cap. Southern States Bank is a full service community bank, serving businesses and individuals through 15 branches across Alabama and Georgia. As of 3/31/21, Southern States had total assets of $1.5 billion, total loans of $1.1 billion, total deposits of $1.3 billion, and total shareholders’ equity of $145 million.</p>\n<p><img src=\"https://static.tigerbbs.com/8919c8c9b4257f3c84869f14fa89bcab\" tg-width=\"1414\" tg-height=\"356\" width=\"100%\" height=\"auto\"></p>","source":"lsy1619493174116","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US IPO Week Ahead: 2 banks test the waters amid annual summer slowdown</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS IPO Week Ahead: 2 banks test the waters amid annual summer slowdown\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-07 08:31 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.renaissancecapital.com/IPO-Center/News/85076/US-IPO-Week-Ahead-2-banks-test-the-waters-amid-annual-summer-slowdown><strong>renaissancecap...</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The IPO market is getting a breather as the August lull continues to set in, with just two banks scheduled for the week ahead.\nUtah-based digital bank FinWise Bancorp(FINW) plans to raise $58 million ...</p>\n\n<a href=\"https://www.renaissancecapital.com/IPO-Center/News/85076/US-IPO-Week-Ahead-2-banks-test-the-waters-amid-annual-summer-slowdown\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"FINW":"Finwise Bancorp","SSBK":"Southern States Bancshares, Inc."},"source_url":"https://www.renaissancecapital.com/IPO-Center/News/85076/US-IPO-Week-Ahead-2-banks-test-the-waters-amid-annual-summer-slowdown","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1157428986","content_text":"The IPO market is getting a breather as the August lull continues to set in, with just two banks scheduled for the week ahead.\nUtah-based digital bank FinWise Bancorp(FINW) plans to raise $58 million at a $183 million market cap. FinWise Bank makes loans to and takes deposits from consumers and small businesses across the US. As of 3/31/21, FinWise Bancorp had total assets of $330 million, total loans of $245 million, total deposits of $189 million, and total shareholders’ equity of $52 million.\nAlabama bank Southern States Bancshares(SSBK) plans to raise $40 million at a $174 million market cap. Southern States Bank is a full service community bank, serving businesses and individuals through 15 branches across Alabama and Georgia. As of 3/31/21, Southern States had total assets of $1.5 billion, total loans of $1.1 billion, total deposits of $1.3 billion, and total shareholders’ equity of $145 million.","news_type":1},"isVote":1,"tweetType":1,"viewCount":99,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":804199007,"gmtCreate":1627943670509,"gmtModify":1633755161722,"author":{"id":"3573940420673790","authorId":"3573940420673790","name":"Zyl13","avatar":"https://static.tigerbbs.com/abc0f03108ec1f9a9c459181df989db8","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573940420673790","authorIdStr":"3573940420673790"},"themes":[],"htmlText":"Buy because it’s going to the moon&nbsp;","listText":"Buy because it’s going to the moon&nbsp;","text":"Buy because it’s going to the moon","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/804199007","repostId":"1107596279","repostType":4,"isVote":1,"tweetType":1,"viewCount":54,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":890573927,"gmtCreate":1628125939969,"gmtModify":1633753359597,"author":{"id":"3573940420673790","authorId":"3573940420673790","name":"Zyl13","avatar":"https://static.tigerbbs.com/abc0f03108ec1f9a9c459181df989db8","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573940420673790","authorIdStr":"3573940420673790"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/890573927","repostId":"2157488863","repostType":4,"repost":{"id":"2157488863","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1628125479,"share":"https://www.laohu8.com/m/news/2157488863?lang=&edition=full","pubTime":"2021-08-05 09:04","market":"hk","language":"en","title":"AMD stock scores sixth straight record high as more data shows gains against Intel","url":"https://stock-news.laohu8.com/highlight/detail?id=2157488863","media":"Dow Jones","summary":"Shares have rallied 35% since earnings report showed chip maker succeeding against larger rival, and","content":"<p>Shares have rallied 35% since earnings report showed chip maker succeeding against larger rival, and new data shows market share wins in data center, microprocessors.</p>\n<p>Advanced Micro Devices Inc. shares closed at a sixth consecutive record high on Wednesday following continued indications that the chip maker is taking market share away from larger rival <a href=\"https://laohu8.com/S/INTC\">Intel</a>.</p>\n<p><a href=\"https://laohu8.com/S/AMD\">AMD</a> shares closed up 5.5% at a record $118.77 Wednesday, after carving out a new all-time intraday high of $122.49. Shares closed at a then-record $112.56 on Tuesday . The sixth straight day of record high closing prices coincides with a sixth straight day of gains of 2% or more. The last time AMD shares experienced such a streak was June 2, when the stock rose for seven days in a row, according to Dow Jones data.</p>\n<p>Coincidentally, AMD's streak began on July 28 shares, which closed down 0.3% Wednesday, have gained 1% since July 28.</p>\n<p>Additionally, the PHLX Semiconductor Index closed at its fourth record high in a row at 3,436.90, having finished at 3,396.66 on Tuesday. Chip stocks have been popular amid a global shortage of semiconductors that has pushed prices up.</p>\n<p>Citi Research analyst Christopher Danley, who has neutral ratings on both AMD and Intel, wrote in a Wednesday note that data from Mercury Research showed that while total microprocessor shipments had declined 3.1% quarter-over-quarter, AMD's total share of the market increased to 16.9% in the second quarter from 16.1% in the first quarter. Meanwhile, Intel's share fell to 83.1% in the second quarter from 83.9% in the first quarter.</p>\n<p>The data also showed gains for AMD in the important data-center category. The Mercury data showed AMD with 8.9% share in servers, up from 5.5% in the year-ago second quarter and 8.2% in this year's first quarter. That's compared with Intel's 91.1% share, down from 94.5% in the year-ago second quarter and 91.8% in the first quarter.</p>\n<p>Additionally, a Wednesday report from tech news site wccftech.com noted that AMD CPUs are still outselling Intel according to data compiled from MindFactory, Germany's largest tech retailer.</p>\n<p>On Tuesday, AMD announced its line of Radeon Pro W6000X series of GPUs Mac Pro can tack on up to another $10,000 to the workstation's sticker price.</p>\n<p>Another tailwind for AMD shares could be coming from a Bloomberg report $40 billion acquisition of Arm from Japan's SoftBank Group Corp. citing national security reasons, a development that could benefit AMD.</p>\n<p>-Wallace Witkowski</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AMD stock scores sixth straight record high as more data shows gains against Intel</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAMD stock scores sixth straight record high as more data shows gains against Intel\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-08-05 09:04</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shares have rallied 35% since earnings report showed chip maker succeeding against larger rival, and new data shows market share wins in data center, microprocessors.</p>\n<p>Advanced Micro Devices Inc. shares closed at a sixth consecutive record high on Wednesday following continued indications that the chip maker is taking market share away from larger rival <a href=\"https://laohu8.com/S/INTC\">Intel</a>.</p>\n<p><a href=\"https://laohu8.com/S/AMD\">AMD</a> shares closed up 5.5% at a record $118.77 Wednesday, after carving out a new all-time intraday high of $122.49. Shares closed at a then-record $112.56 on Tuesday . The sixth straight day of record high closing prices coincides with a sixth straight day of gains of 2% or more. The last time AMD shares experienced such a streak was June 2, when the stock rose for seven days in a row, according to Dow Jones data.</p>\n<p>Coincidentally, AMD's streak began on July 28 shares, which closed down 0.3% Wednesday, have gained 1% since July 28.</p>\n<p>Additionally, the PHLX Semiconductor Index closed at its fourth record high in a row at 3,436.90, having finished at 3,396.66 on Tuesday. Chip stocks have been popular amid a global shortage of semiconductors that has pushed prices up.</p>\n<p>Citi Research analyst Christopher Danley, who has neutral ratings on both AMD and Intel, wrote in a Wednesday note that data from Mercury Research showed that while total microprocessor shipments had declined 3.1% quarter-over-quarter, AMD's total share of the market increased to 16.9% in the second quarter from 16.1% in the first quarter. Meanwhile, Intel's share fell to 83.1% in the second quarter from 83.9% in the first quarter.</p>\n<p>The data also showed gains for AMD in the important data-center category. The Mercury data showed AMD with 8.9% share in servers, up from 5.5% in the year-ago second quarter and 8.2% in this year's first quarter. That's compared with Intel's 91.1% share, down from 94.5% in the year-ago second quarter and 91.8% in the first quarter.</p>\n<p>Additionally, a Wednesday report from tech news site wccftech.com noted that AMD CPUs are still outselling Intel according to data compiled from MindFactory, Germany's largest tech retailer.</p>\n<p>On Tuesday, AMD announced its line of Radeon Pro W6000X series of GPUs Mac Pro can tack on up to another $10,000 to the workstation's sticker price.</p>\n<p>Another tailwind for AMD shares could be coming from a Bloomberg report $40 billion acquisition of Arm from Japan's SoftBank Group Corp. citing national security reasons, a development that could benefit AMD.</p>\n<p>-Wallace Witkowski</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"INTC":"英特尔","AMD":"美国超微公司"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2157488863","content_text":"Shares have rallied 35% since earnings report showed chip maker succeeding against larger rival, and new data shows market share wins in data center, microprocessors.\nAdvanced Micro Devices Inc. shares closed at a sixth consecutive record high on Wednesday following continued indications that the chip maker is taking market share away from larger rival Intel.\nAMD shares closed up 5.5% at a record $118.77 Wednesday, after carving out a new all-time intraday high of $122.49. Shares closed at a then-record $112.56 on Tuesday . The sixth straight day of record high closing prices coincides with a sixth straight day of gains of 2% or more. The last time AMD shares experienced such a streak was June 2, when the stock rose for seven days in a row, according to Dow Jones data.\nCoincidentally, AMD's streak began on July 28 shares, which closed down 0.3% Wednesday, have gained 1% since July 28.\nAdditionally, the PHLX Semiconductor Index closed at its fourth record high in a row at 3,436.90, having finished at 3,396.66 on Tuesday. Chip stocks have been popular amid a global shortage of semiconductors that has pushed prices up.\nCiti Research analyst Christopher Danley, who has neutral ratings on both AMD and Intel, wrote in a Wednesday note that data from Mercury Research showed that while total microprocessor shipments had declined 3.1% quarter-over-quarter, AMD's total share of the market increased to 16.9% in the second quarter from 16.1% in the first quarter. Meanwhile, Intel's share fell to 83.1% in the second quarter from 83.9% in the first quarter.\nThe data also showed gains for AMD in the important data-center category. The Mercury data showed AMD with 8.9% share in servers, up from 5.5% in the year-ago second quarter and 8.2% in this year's first quarter. That's compared with Intel's 91.1% share, down from 94.5% in the year-ago second quarter and 91.8% in the first quarter.\nAdditionally, a Wednesday report from tech news site wccftech.com noted that AMD CPUs are still outselling Intel according to data compiled from MindFactory, Germany's largest tech retailer.\nOn Tuesday, AMD announced its line of Radeon Pro W6000X series of GPUs Mac Pro can tack on up to another $10,000 to the workstation's sticker price.\nAnother tailwind for AMD shares could be coming from a Bloomberg report $40 billion acquisition of Arm from Japan's SoftBank Group Corp. citing national security reasons, a development that could benefit AMD.\n-Wallace Witkowski","news_type":1},"isVote":1,"tweetType":1,"viewCount":43,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":804190336,"gmtCreate":1627943592725,"gmtModify":1633755162517,"author":{"id":"3573940420673790","authorId":"3573940420673790","name":"Zyl13","avatar":"https://static.tigerbbs.com/abc0f03108ec1f9a9c459181df989db8","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573940420673790","authorIdStr":"3573940420673790"},"themes":[],"htmlText":"&nbsp;Wow","listText":"&nbsp;Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/804190336","repostId":"1131839624","repostType":4,"isVote":1,"tweetType":1,"viewCount":76,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":109674601,"gmtCreate":1619696372703,"gmtModify":1634210663766,"author":{"id":"3573940420673790","authorId":"3573940420673790","name":"Zyl13","avatar":"https://static.tigerbbs.com/abc0f03108ec1f9a9c459181df989db8","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573940420673790","authorIdStr":"3573940420673790"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/109674601","repostId":"1120053963","repostType":4,"repost":{"id":"1120053963","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1619694728,"share":"https://www.laohu8.com/m/news/1120053963?lang=&edition=full","pubTime":"2021-04-29 19:12","market":"us","language":"en","title":"McDonald's Reports First Quarter 2021 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=1120053963","media":"Tiger Newspress","summary":"- 2021 global comparable sales and revenues for the quarter surpassed first quarter 2019 levels, dri","content":"<p>- 2021 global comparable sales and revenues for the quarter surpassed first quarter 2019 levels, driven by the U.S.</p>\n<p>- Global comparable sales increased 7.5% in the first quarter, with growth across all segments</p>\n<p>- Diluted earnings per share of $2.05 increased 39%; excluding strategic gains, diluted earnings per share of $1.92 increased 31%</p>\n<p>McDonald's Corporation today announced results for the first quarter ended March&nbsp;31, 2021.</p>\n<p>\"Our first quarter 2021 global comparable sales and revenues surpassed first quarter 2019 levels, even as resurgences and operating restrictions persist in many parts of the world. I continue to be inspired by the resilience of our crew members, franchisees, suppliers, and company employees as we lead with our values and stay true to our purpose of feeding and fostering communities,\" said McDonald's President and Chief Executive OfficerChris Kempczinski. \"Our teams around the world are focused on executing our Accelerating the Arches strategy at the highest level - we're maximizing our marketing in a culturally relevant way, committed to the great tasting customer favorites on our core menu and doubling-down on digital, delivery and drive thru to create a faster and easier customer experience.\"</p>\n<p>First quarter financial performance:</p>\n<ul>\n <li>Global comparable sales increased 7.5%, reflecting positive comparable sales across all segments: 13.6% in the U.S.; 0.6% in the International Operated segment; and 6.4% in the International Developmental Licensed segment.</li>\n <li>Consolidated revenues increased 9% (5% in constant currencies).</li>\n <li>Systemwide sales increased 12% (8% in constant currencies).</li>\n <li>Consolidated operating income increased 35% (30% in constant currencies) and included$135 millionof strategic gains primarily related to the sale of McDonald'sJapanstock. Excluding these gains, operating income increased 27% (22% in constant currencies).</li>\n <li>Diluted earnings per share of$2.05increased 39% (35% in constant currencies). Excluding$0.13per share of strategic gains, diluted earnings per share was$1.92for the quarter, an increase of 31% (27% in constant currencies).</li>\n</ul>\n<p>COMPARABLE SALES</p>\n<p><img src=\"https://static.tigerbbs.com/b29686bc7559d3b6501fe3e993552ef0\" tg-width=\"808\" tg-height=\"272\"></p>\n<ul>\n <li><b>Comparable Sales:</b>Quarterly comparable sales results were positive across all segments as we began to lap the significant impact of COVID-19 on our global results beginning inMarch 2020. Guest counts remained negative for all segments.</li>\n <ul>\n  <li><b>U.S.:</b>Comparable sales results benefited from average check growth with double digit positive comparable sales across all dayparts. The Company's strong national menu and marketing offerings, as well as growth in delivery and digital platforms, contributed to the comparable sales growth.</li>\n  <li><b>International Operated Markets:</b>Results reflected strong positive comparable sales in the U.K.,AustraliaandCanada, partly offset by significantly negative comparable sales inFranceandGermany. Comparable sales in many markets continued to be impacted by varying levels of government imposed COVID-19 restrictions on restaurant operations.</li>\n  <li><b>International Developmental Licensed Markets:</b>Monthly comparable sales results improved sequentially throughout the quarter. The strong quarterly comparable sales were primarily driven byChinaandJapan.</li>\n </ul>\n</ul>\n<p>KEY FINANCIAL METRICS - CONSOLIDATED</p>\n<p>Dollars in millions, except per share data</p>\n<p><img src=\"https://static.tigerbbs.com/a7bd034ca637b55103900edf98fe76c4\" tg-width=\"909\" tg-height=\"333\"></p>\n<p>Results for the quarter reflected stronger operating performance in the U.S. due to higher sales-driven restaurant margins.</p>\n<p>Results for the quarter included$135 millionof pre-tax strategic gains, or$0.13per share, primarily related to the sale of McDonald'sJapanstock, which reduced the Company's ownership by an additional 3%.</p>\n<p>Foreign currency translation had a positive impact of$0.06on diluted earnings per share for the quarter.</p>\n<p>EARNINGS PER SHARE-DILUTED RECONCILIATION</p>\n<p><img src=\"https://static.tigerbbs.com/0e55f7dddfed1169d20085686d68ed5a\" tg-width=\"831\" tg-height=\"288\"></p>\n<p>Excluding the strategic gains, for the quarter net income increased 30% (26% in constant currencies) and diluted earnings per share increased 31% (27% in constant currencies).</p>\n<p>RESTAURANT UPDATE</p>\n<p>The Company has continued to follow the guidance of expert health authorities to ensure the appropriate precautionary steps are taken to protect the health and safety of our people and our customers.</p>\n<p>As a result of COVID-19 resurgences, throughout the quarter there have been numerous instances of government restrictions on restaurant operating hours, limited dine-in capacity and, in some cases, mandated dining room closures particularly in the International Operated Markets. These restrictions are impacting most of the Company's markets acrossEurope, particularly those with fewer drive thru restaurant locations. The Company expects some restrictions in various markets so long as the COVID-19 pandemic continues.</p>\n<p><b>THE FOLLOWING DEFINITIONS APPLY TO THESE TERMS AS USED THROUGHOUT THIS RELEASE</b></p>\n<p>Constant currency results exclude the effects of foreign currency translation and are calculated by translating current year results at prior year average exchange rates. Management reviews and analyzes business results excluding the effect of foreign currency translation, as well as impairment and other strategic charges and gains, and bases incentive compensation plans on these results, because the Company believes this better represents underlying business trends.</p>\n<p>Comparable sales are compared to the same period in the prior year and represent sales at all restaurants, whether operated by the Company or by franchisees, in operation at least thirteen months including those temporarily closed. Some of the reasons restaurants may be temporarily closed include reimaging or remodeling, rebuilding, road construction and natural disasters (including restaurants temporarily closed due to COVID-19). Comparable sales exclude the impact of currency translation and the sales of any market considered hyper-inflationary (generally identified as those markets whose cumulative inflation rate over a three-year period exceeds 100%), which management believes more accurately reflects the underlying business trends. Comparable sales are driven by changes in guest counts and average check, which is affected by changes in pricing and product mix.</p>\n<p>Comparable guest counts represent the number of transactions at all restaurants, whether operated by the Company or by franchisees, in operation at least thirteen months including those temporarily closed.</p>\n<p>Systemwide sales include sales at all restaurants, whether operated by the Company or by franchisees. While franchised sales are not recorded as revenues by the Company, management believes the information is important in understanding the Company's financial performance, because these sales are the basis on which the Company calculates and records franchised revenues and are indicative of the financial health of the franchisee base. The Company's revenues consist of sales by Company-operated restaurants and fees from franchised restaurants operated by conventional franchisees, developmental licensees and affiliates. Changes in Systemwide sales are primarily driven by comparable sales and net restaurant unit expansion.</p>\n<p>Free cash flow, defined as cash provided by operations less capital expenditures, and free cash flow conversion rate, defined as free cash flow divided by net income, are measures reviewed by management in order to evaluate the Company's ability to convert net profits into cash resources, after reinvesting in the core business, that can be used to pursue opportunities to enhance shareholder value.</p>\n<p><b>RELATED COMMUNICATIONS</b></p>\n<p>This press release should be read in conjunction with Exhibit<u>99.2</u>&nbsp;in the Company's Form 8-K filing for supplemental information related to the Company's results for the quarter ended March&nbsp;31, 2021.</p>\n<p>McDonald's Corporation will broadcast its investor earnings conference call live over the Internet at7:30 a.m. (Central Time)on April&nbsp;29, 2021. A link to the live webcast will be available at<u>www.investor.mcdonalds.com</u>. There will also be an archived webcast available for a limited time thereafter.</p>\n<p><b>UPCOMING COMMUNICATIONS</b></p>\n<p>For important news and information regarding McDonald's, including the timing of future investor conferences and earnings calls, visit the Investor Relations section of the Company's Internet home page at<u>www.investor.mcdonalds.com</u>. McDonald's uses this website as a primary channel for disclosing key information to its investors, some of which may contain material and previously non-public information.</p>\n<p><b>ABOUT McDONALD'S</b></p>\n<p>McDonald's is the world's leading global foodservice retailer with over 39,000 locations in over 100 countries. Approximately 93% of McDonald's restaurants worldwide are owned and operated by independent local business owners.</p>\n<p><b>FORWARD-LOOKING STATEMENTS</b></p>\n<p>This release contains certain forward-looking statements, which reflect management's expectations regarding future events and operating performance and speak only as of the date hereof. These forward-looking statements involve a number of risks and uncertainties. Factors that could cause actual results to differ materially from our expectations are detailed in the Company's filings with the Securities and Exchange Commission, including the risk factors discussed in Exhibit<u>99.2</u>&nbsp;in the Company's Form 8-K filing on April&nbsp;29, 2021. The Company undertakes no obligation to update such forward-looking statements, except as may otherwise be required by law.</p>\n<p><b>McDONALD'S CORPORATIONCONDENSED CONSOLIDATED STATEMENT OF INCOME (UNAUDITED)</b></p>\n<p><img src=\"https://static.tigerbbs.com/bdcf3fe0c7538ec45397769b91cd96e0\" tg-width=\"806\" tg-height=\"792\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>McDonald's Reports First Quarter 2021 Results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMcDonald's Reports First Quarter 2021 Results\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-04-29 19:12</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>- 2021 global comparable sales and revenues for the quarter surpassed first quarter 2019 levels, driven by the U.S.</p>\n<p>- Global comparable sales increased 7.5% in the first quarter, with growth across all segments</p>\n<p>- Diluted earnings per share of $2.05 increased 39%; excluding strategic gains, diluted earnings per share of $1.92 increased 31%</p>\n<p>McDonald's Corporation today announced results for the first quarter ended March&nbsp;31, 2021.</p>\n<p>\"Our first quarter 2021 global comparable sales and revenues surpassed first quarter 2019 levels, even as resurgences and operating restrictions persist in many parts of the world. I continue to be inspired by the resilience of our crew members, franchisees, suppliers, and company employees as we lead with our values and stay true to our purpose of feeding and fostering communities,\" said McDonald's President and Chief Executive OfficerChris Kempczinski. \"Our teams around the world are focused on executing our Accelerating the Arches strategy at the highest level - we're maximizing our marketing in a culturally relevant way, committed to the great tasting customer favorites on our core menu and doubling-down on digital, delivery and drive thru to create a faster and easier customer experience.\"</p>\n<p>First quarter financial performance:</p>\n<ul>\n <li>Global comparable sales increased 7.5%, reflecting positive comparable sales across all segments: 13.6% in the U.S.; 0.6% in the International Operated segment; and 6.4% in the International Developmental Licensed segment.</li>\n <li>Consolidated revenues increased 9% (5% in constant currencies).</li>\n <li>Systemwide sales increased 12% (8% in constant currencies).</li>\n <li>Consolidated operating income increased 35% (30% in constant currencies) and included$135 millionof strategic gains primarily related to the sale of McDonald'sJapanstock. Excluding these gains, operating income increased 27% (22% in constant currencies).</li>\n <li>Diluted earnings per share of$2.05increased 39% (35% in constant currencies). Excluding$0.13per share of strategic gains, diluted earnings per share was$1.92for the quarter, an increase of 31% (27% in constant currencies).</li>\n</ul>\n<p>COMPARABLE SALES</p>\n<p><img src=\"https://static.tigerbbs.com/b29686bc7559d3b6501fe3e993552ef0\" tg-width=\"808\" tg-height=\"272\"></p>\n<ul>\n <li><b>Comparable Sales:</b>Quarterly comparable sales results were positive across all segments as we began to lap the significant impact of COVID-19 on our global results beginning inMarch 2020. Guest counts remained negative for all segments.</li>\n <ul>\n  <li><b>U.S.:</b>Comparable sales results benefited from average check growth with double digit positive comparable sales across all dayparts. The Company's strong national menu and marketing offerings, as well as growth in delivery and digital platforms, contributed to the comparable sales growth.</li>\n  <li><b>International Operated Markets:</b>Results reflected strong positive comparable sales in the U.K.,AustraliaandCanada, partly offset by significantly negative comparable sales inFranceandGermany. Comparable sales in many markets continued to be impacted by varying levels of government imposed COVID-19 restrictions on restaurant operations.</li>\n  <li><b>International Developmental Licensed Markets:</b>Monthly comparable sales results improved sequentially throughout the quarter. The strong quarterly comparable sales were primarily driven byChinaandJapan.</li>\n </ul>\n</ul>\n<p>KEY FINANCIAL METRICS - CONSOLIDATED</p>\n<p>Dollars in millions, except per share data</p>\n<p><img src=\"https://static.tigerbbs.com/a7bd034ca637b55103900edf98fe76c4\" tg-width=\"909\" tg-height=\"333\"></p>\n<p>Results for the quarter reflected stronger operating performance in the U.S. due to higher sales-driven restaurant margins.</p>\n<p>Results for the quarter included$135 millionof pre-tax strategic gains, or$0.13per share, primarily related to the sale of McDonald'sJapanstock, which reduced the Company's ownership by an additional 3%.</p>\n<p>Foreign currency translation had a positive impact of$0.06on diluted earnings per share for the quarter.</p>\n<p>EARNINGS PER SHARE-DILUTED RECONCILIATION</p>\n<p><img src=\"https://static.tigerbbs.com/0e55f7dddfed1169d20085686d68ed5a\" tg-width=\"831\" tg-height=\"288\"></p>\n<p>Excluding the strategic gains, for the quarter net income increased 30% (26% in constant currencies) and diluted earnings per share increased 31% (27% in constant currencies).</p>\n<p>RESTAURANT UPDATE</p>\n<p>The Company has continued to follow the guidance of expert health authorities to ensure the appropriate precautionary steps are taken to protect the health and safety of our people and our customers.</p>\n<p>As a result of COVID-19 resurgences, throughout the quarter there have been numerous instances of government restrictions on restaurant operating hours, limited dine-in capacity and, in some cases, mandated dining room closures particularly in the International Operated Markets. These restrictions are impacting most of the Company's markets acrossEurope, particularly those with fewer drive thru restaurant locations. The Company expects some restrictions in various markets so long as the COVID-19 pandemic continues.</p>\n<p><b>THE FOLLOWING DEFINITIONS APPLY TO THESE TERMS AS USED THROUGHOUT THIS RELEASE</b></p>\n<p>Constant currency results exclude the effects of foreign currency translation and are calculated by translating current year results at prior year average exchange rates. Management reviews and analyzes business results excluding the effect of foreign currency translation, as well as impairment and other strategic charges and gains, and bases incentive compensation plans on these results, because the Company believes this better represents underlying business trends.</p>\n<p>Comparable sales are compared to the same period in the prior year and represent sales at all restaurants, whether operated by the Company or by franchisees, in operation at least thirteen months including those temporarily closed. Some of the reasons restaurants may be temporarily closed include reimaging or remodeling, rebuilding, road construction and natural disasters (including restaurants temporarily closed due to COVID-19). Comparable sales exclude the impact of currency translation and the sales of any market considered hyper-inflationary (generally identified as those markets whose cumulative inflation rate over a three-year period exceeds 100%), which management believes more accurately reflects the underlying business trends. Comparable sales are driven by changes in guest counts and average check, which is affected by changes in pricing and product mix.</p>\n<p>Comparable guest counts represent the number of transactions at all restaurants, whether operated by the Company or by franchisees, in operation at least thirteen months including those temporarily closed.</p>\n<p>Systemwide sales include sales at all restaurants, whether operated by the Company or by franchisees. While franchised sales are not recorded as revenues by the Company, management believes the information is important in understanding the Company's financial performance, because these sales are the basis on which the Company calculates and records franchised revenues and are indicative of the financial health of the franchisee base. The Company's revenues consist of sales by Company-operated restaurants and fees from franchised restaurants operated by conventional franchisees, developmental licensees and affiliates. Changes in Systemwide sales are primarily driven by comparable sales and net restaurant unit expansion.</p>\n<p>Free cash flow, defined as cash provided by operations less capital expenditures, and free cash flow conversion rate, defined as free cash flow divided by net income, are measures reviewed by management in order to evaluate the Company's ability to convert net profits into cash resources, after reinvesting in the core business, that can be used to pursue opportunities to enhance shareholder value.</p>\n<p><b>RELATED COMMUNICATIONS</b></p>\n<p>This press release should be read in conjunction with Exhibit<u>99.2</u>&nbsp;in the Company's Form 8-K filing for supplemental information related to the Company's results for the quarter ended March&nbsp;31, 2021.</p>\n<p>McDonald's Corporation will broadcast its investor earnings conference call live over the Internet at7:30 a.m. (Central Time)on April&nbsp;29, 2021. A link to the live webcast will be available at<u>www.investor.mcdonalds.com</u>. There will also be an archived webcast available for a limited time thereafter.</p>\n<p><b>UPCOMING COMMUNICATIONS</b></p>\n<p>For important news and information regarding McDonald's, including the timing of future investor conferences and earnings calls, visit the Investor Relations section of the Company's Internet home page at<u>www.investor.mcdonalds.com</u>. McDonald's uses this website as a primary channel for disclosing key information to its investors, some of which may contain material and previously non-public information.</p>\n<p><b>ABOUT McDONALD'S</b></p>\n<p>McDonald's is the world's leading global foodservice retailer with over 39,000 locations in over 100 countries. Approximately 93% of McDonald's restaurants worldwide are owned and operated by independent local business owners.</p>\n<p><b>FORWARD-LOOKING STATEMENTS</b></p>\n<p>This release contains certain forward-looking statements, which reflect management's expectations regarding future events and operating performance and speak only as of the date hereof. These forward-looking statements involve a number of risks and uncertainties. Factors that could cause actual results to differ materially from our expectations are detailed in the Company's filings with the Securities and Exchange Commission, including the risk factors discussed in Exhibit<u>99.2</u>&nbsp;in the Company's Form 8-K filing on April&nbsp;29, 2021. The Company undertakes no obligation to update such forward-looking statements, except as may otherwise be required by law.</p>\n<p><b>McDONALD'S CORPORATIONCONDENSED CONSOLIDATED STATEMENT OF INCOME (UNAUDITED)</b></p>\n<p><img src=\"https://static.tigerbbs.com/bdcf3fe0c7538ec45397769b91cd96e0\" tg-width=\"806\" tg-height=\"792\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MCD":"麦当劳"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1120053963","content_text":"- 2021 global comparable sales and revenues for the quarter surpassed first quarter 2019 levels, driven by the U.S.\n- Global comparable sales increased 7.5% in the first quarter, with growth across all segments\n- Diluted earnings per share of $2.05 increased 39%; excluding strategic gains, diluted earnings per share of $1.92 increased 31%\nMcDonald's Corporation today announced results for the first quarter ended March 31, 2021.\n\"Our first quarter 2021 global comparable sales and revenues surpassed first quarter 2019 levels, even as resurgences and operating restrictions persist in many parts of the world. I continue to be inspired by the resilience of our crew members, franchisees, suppliers, and company employees as we lead with our values and stay true to our purpose of feeding and fostering communities,\" said McDonald's President and Chief Executive OfficerChris Kempczinski. \"Our teams around the world are focused on executing our Accelerating the Arches strategy at the highest level - we're maximizing our marketing in a culturally relevant way, committed to the great tasting customer favorites on our core menu and doubling-down on digital, delivery and drive thru to create a faster and easier customer experience.\"\nFirst quarter financial performance:\n\nGlobal comparable sales increased 7.5%, reflecting positive comparable sales across all segments: 13.6% in the U.S.; 0.6% in the International Operated segment; and 6.4% in the International Developmental Licensed segment.\nConsolidated revenues increased 9% (5% in constant currencies).\nSystemwide sales increased 12% (8% in constant currencies).\nConsolidated operating income increased 35% (30% in constant currencies) and included$135 millionof strategic gains primarily related to the sale of McDonald'sJapanstock. Excluding these gains, operating income increased 27% (22% in constant currencies).\nDiluted earnings per share of$2.05increased 39% (35% in constant currencies). Excluding$0.13per share of strategic gains, diluted earnings per share was$1.92for the quarter, an increase of 31% (27% in constant currencies).\n\nCOMPARABLE SALES\n\n\nComparable Sales:Quarterly comparable sales results were positive across all segments as we began to lap the significant impact of COVID-19 on our global results beginning inMarch 2020. Guest counts remained negative for all segments.\n\nU.S.:Comparable sales results benefited from average check growth with double digit positive comparable sales across all dayparts. The Company's strong national menu and marketing offerings, as well as growth in delivery and digital platforms, contributed to the comparable sales growth.\nInternational Operated Markets:Results reflected strong positive comparable sales in the U.K.,AustraliaandCanada, partly offset by significantly negative comparable sales inFranceandGermany. Comparable sales in many markets continued to be impacted by varying levels of government imposed COVID-19 restrictions on restaurant operations.\nInternational Developmental Licensed Markets:Monthly comparable sales results improved sequentially throughout the quarter. The strong quarterly comparable sales were primarily driven byChinaandJapan.\n\n\nKEY FINANCIAL METRICS - CONSOLIDATED\nDollars in millions, except per share data\n\nResults for the quarter reflected stronger operating performance in the U.S. due to higher sales-driven restaurant margins.\nResults for the quarter included$135 millionof pre-tax strategic gains, or$0.13per share, primarily related to the sale of McDonald'sJapanstock, which reduced the Company's ownership by an additional 3%.\nForeign currency translation had a positive impact of$0.06on diluted earnings per share for the quarter.\nEARNINGS PER SHARE-DILUTED RECONCILIATION\n\nExcluding the strategic gains, for the quarter net income increased 30% (26% in constant currencies) and diluted earnings per share increased 31% (27% in constant currencies).\nRESTAURANT UPDATE\nThe Company has continued to follow the guidance of expert health authorities to ensure the appropriate precautionary steps are taken to protect the health and safety of our people and our customers.\nAs a result of COVID-19 resurgences, throughout the quarter there have been numerous instances of government restrictions on restaurant operating hours, limited dine-in capacity and, in some cases, mandated dining room closures particularly in the International Operated Markets. These restrictions are impacting most of the Company's markets acrossEurope, particularly those with fewer drive thru restaurant locations. The Company expects some restrictions in various markets so long as the COVID-19 pandemic continues.\nTHE FOLLOWING DEFINITIONS APPLY TO THESE TERMS AS USED THROUGHOUT THIS RELEASE\nConstant currency results exclude the effects of foreign currency translation and are calculated by translating current year results at prior year average exchange rates. Management reviews and analyzes business results excluding the effect of foreign currency translation, as well as impairment and other strategic charges and gains, and bases incentive compensation plans on these results, because the Company believes this better represents underlying business trends.\nComparable sales are compared to the same period in the prior year and represent sales at all restaurants, whether operated by the Company or by franchisees, in operation at least thirteen months including those temporarily closed. Some of the reasons restaurants may be temporarily closed include reimaging or remodeling, rebuilding, road construction and natural disasters (including restaurants temporarily closed due to COVID-19). Comparable sales exclude the impact of currency translation and the sales of any market considered hyper-inflationary (generally identified as those markets whose cumulative inflation rate over a three-year period exceeds 100%), which management believes more accurately reflects the underlying business trends. Comparable sales are driven by changes in guest counts and average check, which is affected by changes in pricing and product mix.\nComparable guest counts represent the number of transactions at all restaurants, whether operated by the Company or by franchisees, in operation at least thirteen months including those temporarily closed.\nSystemwide sales include sales at all restaurants, whether operated by the Company or by franchisees. While franchised sales are not recorded as revenues by the Company, management believes the information is important in understanding the Company's financial performance, because these sales are the basis on which the Company calculates and records franchised revenues and are indicative of the financial health of the franchisee base. The Company's revenues consist of sales by Company-operated restaurants and fees from franchised restaurants operated by conventional franchisees, developmental licensees and affiliates. Changes in Systemwide sales are primarily driven by comparable sales and net restaurant unit expansion.\nFree cash flow, defined as cash provided by operations less capital expenditures, and free cash flow conversion rate, defined as free cash flow divided by net income, are measures reviewed by management in order to evaluate the Company's ability to convert net profits into cash resources, after reinvesting in the core business, that can be used to pursue opportunities to enhance shareholder value.\nRELATED COMMUNICATIONS\nThis press release should be read in conjunction with Exhibit99.2 in the Company's Form 8-K filing for supplemental information related to the Company's results for the quarter ended March 31, 2021.\nMcDonald's Corporation will broadcast its investor earnings conference call live over the Internet at7:30 a.m. (Central Time)on April 29, 2021. A link to the live webcast will be available atwww.investor.mcdonalds.com. There will also be an archived webcast available for a limited time thereafter.\nUPCOMING COMMUNICATIONS\nFor important news and information regarding McDonald's, including the timing of future investor conferences and earnings calls, visit the Investor Relations section of the Company's Internet home page atwww.investor.mcdonalds.com. McDonald's uses this website as a primary channel for disclosing key information to its investors, some of which may contain material and previously non-public information.\nABOUT McDONALD'S\nMcDonald's is the world's leading global foodservice retailer with over 39,000 locations in over 100 countries. Approximately 93% of McDonald's restaurants worldwide are owned and operated by independent local business owners.\nFORWARD-LOOKING STATEMENTS\nThis release contains certain forward-looking statements, which reflect management's expectations regarding future events and operating performance and speak only as of the date hereof. These forward-looking statements involve a number of risks and uncertainties. Factors that could cause actual results to differ materially from our expectations are detailed in the Company's filings with the Securities and Exchange Commission, including the risk factors discussed in Exhibit99.2 in the Company's Form 8-K filing on April 29, 2021. The Company undertakes no obligation to update such forward-looking statements, except as may otherwise be required by law.\nMcDONALD'S CORPORATIONCONDENSED CONSOLIDATED STATEMENT OF INCOME (UNAUDITED)","news_type":1},"isVote":1,"tweetType":1,"viewCount":2,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":810900970,"gmtCreate":1629937255290,"gmtModify":1633681361020,"author":{"id":"3573940420673790","authorId":"3573940420673790","name":"Zyl13","avatar":"https://static.tigerbbs.com/abc0f03108ec1f9a9c459181df989db8","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573940420673790","authorIdStr":"3573940420673790"},"themes":[],"htmlText":"&nbsp;Nice","listText":"&nbsp;Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/810900970","repostId":"2162539710","repostType":4,"repost":{"id":"2162539710","pubTimestamp":1629934200,"share":"https://www.laohu8.com/m/news/2162539710?lang=&edition=full","pubTime":"2021-08-26 07:30","market":"us","language":"en","title":"Johnson & Johnson  Announces Data to Support Boosting its Single-Shot COVID-19 Vaccine","url":"https://stock-news.laohu8.com/highlight/detail?id=2162539710","media":"StreetInsider","summary":"Johnson & Johnson (NYSE: JNJ) (the Company) today announced data supporting the use of its COVID-19 ","content":"<p>Johnson &amp; Johnson (NYSE: JNJ) (the Company) today announced data supporting the use of its COVID-19 vaccine as a booster shot for people previously vaccinated with the single-shot Johnson &amp; Johnson vaccine.</p>\n<p>In July, the Company reported interim Phase 1/2a data published in the <i>New England Journal of Medicine</i> that demonstrated neutralizing antibody responses generated by the Johnson &amp; Johnson single-shot COVID-19 vaccine were strong and stable through eight months after immunization.</p>\n<p>In anticipation of the potential need for boosters, the Company conducted two Phase 1/2a studies in individuals previously vaccinated with its single-shot vaccine. New interim data from these studies demonstrate that a booster dose of the Johnson &amp; Johnson COVID-19 vaccine generated a rapid and robust increase in spike-binding antibodies, nine-fold higher than 28 days after the primary single-dose vaccination. Significant increases in binding antibody responses were observed in participants between ages 18 and 55, and in those 65 years and older who received a lower booster dose. The study summaries were submitted to <i>medRxiv</i> on August 24.</p>\n<p>\"We have established that a single shot of our COVID-19 vaccine generates strong and robust immune responses that are durable and persistent through eight months. With these new data, we also see that a booster dose of the Johnson &amp; Johnson COVID-19 vaccine further increases antibody responses among study participants who had previously received our vaccine,\" said Mathai Mammen, M.D., Ph.D., Global Head, Janssen Research &amp; Development, Johnson &amp; Johnson. \"We look forward to discussing with public health officials a potential strategy for our Johnson &amp; Johnson COVID-19 vaccine, boosting eight months or longer after the primary single-dose vaccination.\"</p>\n<p>The Company is engaging with the U.S. Food and Drug Administration (FDA), U.S. Centers for Disease Control and Prevention (CDC), European Medicines Agency (EMA) and other health authorities regarding boosting with the Johnson &amp; Johnson COVID-19 vaccine. Johnson &amp; Johnson continues to diligently generate and evaluate data from ongoing trials as well as emerging real-world evidence.</p>\n<p>The Phase 1/2a clinical trials (VAC31518COV1001 and VAC31518COV2001) have been funded in part with federal funds from the U.S. Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority (BARDA), under other transaction authority (\"OTA\") agreement No. HHSO100201700018C.</p>\n<p>For more information on the Company's multi-pronged approach to helping combat the pandemic, visit: www.jnj.com/covid-19.</p>\n<p><b>Authorized Use </b>The Janssen COVID-19 vaccine is authorized for use in the U.S. under an Emergency Use Authorization (EUA) for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 18 years of age and older.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Johnson & Johnson  Announces Data to Support Boosting its Single-Shot COVID-19 Vaccine</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJohnson & Johnson  Announces Data to Support Boosting its Single-Shot COVID-19 Vaccine\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-26 07:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=18860180><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Johnson & Johnson (NYSE: JNJ) (the Company) today announced data supporting the use of its COVID-19 vaccine as a booster shot for people previously vaccinated with the single-shot Johnson & Johnson ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18860180\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生"},"source_url":"https://www.streetinsider.com/dr/news.php?id=18860180","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2162539710","content_text":"Johnson & Johnson (NYSE: JNJ) (the Company) today announced data supporting the use of its COVID-19 vaccine as a booster shot for people previously vaccinated with the single-shot Johnson & Johnson vaccine.\nIn July, the Company reported interim Phase 1/2a data published in the New England Journal of Medicine that demonstrated neutralizing antibody responses generated by the Johnson & Johnson single-shot COVID-19 vaccine were strong and stable through eight months after immunization.\nIn anticipation of the potential need for boosters, the Company conducted two Phase 1/2a studies in individuals previously vaccinated with its single-shot vaccine. New interim data from these studies demonstrate that a booster dose of the Johnson & Johnson COVID-19 vaccine generated a rapid and robust increase in spike-binding antibodies, nine-fold higher than 28 days after the primary single-dose vaccination. Significant increases in binding antibody responses were observed in participants between ages 18 and 55, and in those 65 years and older who received a lower booster dose. The study summaries were submitted to medRxiv on August 24.\n\"We have established that a single shot of our COVID-19 vaccine generates strong and robust immune responses that are durable and persistent through eight months. With these new data, we also see that a booster dose of the Johnson & Johnson COVID-19 vaccine further increases antibody responses among study participants who had previously received our vaccine,\" said Mathai Mammen, M.D., Ph.D., Global Head, Janssen Research & Development, Johnson & Johnson. \"We look forward to discussing with public health officials a potential strategy for our Johnson & Johnson COVID-19 vaccine, boosting eight months or longer after the primary single-dose vaccination.\"\nThe Company is engaging with the U.S. Food and Drug Administration (FDA), U.S. Centers for Disease Control and Prevention (CDC), European Medicines Agency (EMA) and other health authorities regarding boosting with the Johnson & Johnson COVID-19 vaccine. Johnson & Johnson continues to diligently generate and evaluate data from ongoing trials as well as emerging real-world evidence.\nThe Phase 1/2a clinical trials (VAC31518COV1001 and VAC31518COV2001) have been funded in part with federal funds from the U.S. Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority (BARDA), under other transaction authority (\"OTA\") agreement No. HHSO100201700018C.\nFor more information on the Company's multi-pronged approach to helping combat the pandemic, visit: www.jnj.com/covid-19.\nAuthorized Use The Janssen COVID-19 vaccine is authorized for use in the U.S. under an Emergency Use Authorization (EUA) for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 18 years of age and older.","news_type":1},"isVote":1,"tweetType":1,"viewCount":56,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":317166544,"gmtCreate":1612429426088,"gmtModify":1703761708603,"author":{"id":"3573940420673790","authorId":"3573940420673790","name":"Zyl13","avatar":"https://static.tigerbbs.com/abc0f03108ec1f9a9c459181df989db8","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573940420673790","authorIdStr":"3573940420673790"},"themes":[],"htmlText":"To the moon!! diamonds hands&nbsp;","listText":"To the moon!! diamonds hands&nbsp;","text":"To the moon!! diamonds hands","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/317166544","repostId":"2108713067","repostType":4,"isVote":1,"tweetType":1,"viewCount":32,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":804104478,"gmtCreate":1627943481194,"gmtModify":1631886209318,"author":{"id":"3573940420673790","authorId":"3573940420673790","name":"Zyl13","avatar":"https://static.tigerbbs.com/abc0f03108ec1f9a9c459181df989db8","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573940420673790","authorIdStr":"3573940420673790"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/MCD\">$McDonald's(MCD)$</a>Mekdonald","listText":"<a href=\"https://laohu8.com/S/MCD\">$McDonald's(MCD)$</a>Mekdonald","text":"$McDonald's(MCD)$Mekdonald","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/804104478","isVote":1,"tweetType":1,"viewCount":38,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":371312111,"gmtCreate":1618910586333,"gmtModify":1634289975694,"author":{"id":"3573940420673790","authorId":"3573940420673790","name":"Zyl13","avatar":"https://static.tigerbbs.com/abc0f03108ec1f9a9c459181df989db8","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573940420673790","authorIdStr":"3573940420673790"},"themes":[],"htmlText":"Buy","listText":"Buy","text":"Buy","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/371312111","repostId":"1196760355","repostType":2,"repost":{"id":"1196760355","pubTimestamp":1618902002,"share":"https://www.laohu8.com/m/news/1196760355?lang=&edition=full","pubTime":"2021-04-20 15:00","market":"us","language":"en","title":"Apple Earnings Preview: Smashing Quarter For The iPhone","url":"https://stock-news.laohu8.com/highlight/detail?id=1196760355","media":"TheStreet","summary":"The Apple Maven’s pre-earnings coverage continues. Below is a discussion of how the iPhone, the larg","content":"<p>The Apple Maven’s pre-earnings coverage continues. Below is a discussion of how the iPhone, the largest of Apple’s segment, will likely outperform in fiscal second quarter.</p><p>The Apple Maven moves on with its coverage of the current quarterly earnings reporting season. Here are a few of the preview articles published so far:</p><ul><li>Mark your calendars for April 28, after the closing bell. The Apple Maven will review Apple earnings report and conference call via live blog, starting at 4 p.m. EST;</li><li>Wall Street analyst estimates are through the roof: a year-over-year increase in revenues and earnings per share of 32% and 53%, respectively;</li><li>The Mac is shaping up to be&nbsp;the most successful segment in the quarter. I see Apple’s PC sales rising by an astounding 50% or more over easy 2020 comps;</li><li>The iPad will&nbsp;face an uphill battle: tablet sales across the industry are expected to fall double digits this quarter. I believe that Apple will do better than average, however.</li><li>In the last several years, Apple stock&nbsp;gained three times morein the two weeks following earnings day than during other, non-earnings related weeks.</li></ul><p>As I continue to dive deeper into Apple’s fiscal second quarter numbers by segment, I turn my attention to the iPhone today.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/4a969d65f8683b4e0266088aefd59b13\" tg-width=\"970\" tg-height=\"585\" referrerpolicy=\"no-referrer\"><span>Figure 1: Apple's iPhone lineup.</span></p><p><b>iPhone: easy comps, solid lineup</b></p><p>The iPhone, not unlike much of the rest of the Cupertino company, will face easy comps this time – the comparable period in a COVID-19 pandemic-stricken 2020 saw revenues land flat, the worst top-line performance since early 2019. This is a good start for fiscal second quarter results.</p><p>Beyond comps, at least one research company&nbsp;expects&nbsp;Apple and other China-based device makers to stand out in the three-month period. Total smartphone shipments are projected to grow by an impressive 50%, with Apple claiming an unusual top vendor status over the past half year.</p><p>The graph below shows revenue growth for the iPhone over the past nine quarters. The upward trend is clear, and seems to be at least partly explained by the success of the most recent device launches:</p><ul><li>The iPhone XS and XR fell short of expectations in 2019 (red dot number 1), after the previous year’s iPhone X seems to have accelerated the upgrade cycle;</li><li>The iPhone 11 marked a recovery in 2020 smartphone sales (red dot number 2), but the rebound was quickly squashed by the COVID-19 crisis;</li><li>The second generation of the iPhone SE was&nbsp;a successful midcycle launch&nbsp;(red dot number 3) that helped to jump-start revenues during the pandemic year, even if momentarily;</li><li>The iPhone 12 captured much of the pent-up demand in the first fiscal year of 2021 (red dot number 4), returning Apple to what seems to be a path of longer-lasting recovery.</li></ul><p><b>The Apple Maven’s take</b></p><p>Apple seems to have a great lineup of iPhones, from the well-received 11 to the budget-oriented SE to the higher-end 5G models launched late last year.</p><p>In fiscal second quarter, the robust smartphone portfolio will meet a recovering consumer in the US, many of whom have recently received the third wave of fiscal stimulus from the government. It is hard to imagine the iPhone not performing well in the post-holiday quarter, especially against easy comps.</p><p>Here are a few questions that remain to be answered:</p><ol><li>Will the higher-end models (i.e. 12 Pro and Pro Max) perform substantially better than the cheaper version (i.e. mini),as some suggest? If so, will ASP (average selling prices) and margins increase beyond expectations?</li><li>Will the global component shortage negatively impact sales in the quarter or revenue expectations for the remainder of 2021?</li></ol>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apple Earnings Preview: Smashing Quarter For The iPhone</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApple Earnings Preview: Smashing Quarter For The iPhone\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-20 15:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.thestreet.com/apple/iphone/apple-earnings-preview-smashing-quarter-for-the-iphone><strong>TheStreet</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The Apple Maven’s pre-earnings coverage continues. Below is a discussion of how the iPhone, the largest of Apple’s segment, will likely outperform in fiscal second quarter.The Apple Maven moves on ...</p>\n\n<a href=\"https://www.thestreet.com/apple/iphone/apple-earnings-preview-smashing-quarter-for-the-iphone\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"source_url":"https://www.thestreet.com/apple/iphone/apple-earnings-preview-smashing-quarter-for-the-iphone","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1196760355","content_text":"The Apple Maven’s pre-earnings coverage continues. Below is a discussion of how the iPhone, the largest of Apple’s segment, will likely outperform in fiscal second quarter.The Apple Maven moves on with its coverage of the current quarterly earnings reporting season. Here are a few of the preview articles published so far:Mark your calendars for April 28, after the closing bell. The Apple Maven will review Apple earnings report and conference call via live blog, starting at 4 p.m. EST;Wall Street analyst estimates are through the roof: a year-over-year increase in revenues and earnings per share of 32% and 53%, respectively;The Mac is shaping up to be the most successful segment in the quarter. I see Apple’s PC sales rising by an astounding 50% or more over easy 2020 comps;The iPad will face an uphill battle: tablet sales across the industry are expected to fall double digits this quarter. I believe that Apple will do better than average, however.In the last several years, Apple stock gained three times morein the two weeks following earnings day than during other, non-earnings related weeks.As I continue to dive deeper into Apple’s fiscal second quarter numbers by segment, I turn my attention to the iPhone today.Figure 1: Apple's iPhone lineup.iPhone: easy comps, solid lineupThe iPhone, not unlike much of the rest of the Cupertino company, will face easy comps this time – the comparable period in a COVID-19 pandemic-stricken 2020 saw revenues land flat, the worst top-line performance since early 2019. This is a good start for fiscal second quarter results.Beyond comps, at least one research company expects Apple and other China-based device makers to stand out in the three-month period. Total smartphone shipments are projected to grow by an impressive 50%, with Apple claiming an unusual top vendor status over the past half year.The graph below shows revenue growth for the iPhone over the past nine quarters. The upward trend is clear, and seems to be at least partly explained by the success of the most recent device launches:The iPhone XS and XR fell short of expectations in 2019 (red dot number 1), after the previous year’s iPhone X seems to have accelerated the upgrade cycle;The iPhone 11 marked a recovery in 2020 smartphone sales (red dot number 2), but the rebound was quickly squashed by the COVID-19 crisis;The second generation of the iPhone SE was a successful midcycle launch (red dot number 3) that helped to jump-start revenues during the pandemic year, even if momentarily;The iPhone 12 captured much of the pent-up demand in the first fiscal year of 2021 (red dot number 4), returning Apple to what seems to be a path of longer-lasting recovery.The Apple Maven’s takeApple seems to have a great lineup of iPhones, from the well-received 11 to the budget-oriented SE to the higher-end 5G models launched late last year.In fiscal second quarter, the robust smartphone portfolio will meet a recovering consumer in the US, many of whom have recently received the third wave of fiscal stimulus from the government. It is hard to imagine the iPhone not performing well in the post-holiday quarter, especially against easy comps.Here are a few questions that remain to be answered:Will the higher-end models (i.e. 12 Pro and Pro Max) perform substantially better than the cheaper version (i.e. mini),as some suggest? If so, will ASP (average selling prices) and margins increase beyond expectations?Will the global component shortage negatively impact sales in the quarter or revenue expectations for the remainder of 2021?","news_type":1},"isVote":1,"tweetType":1,"viewCount":22,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":373163898,"gmtCreate":1618832314114,"gmtModify":1634290559472,"author":{"id":"3573940420673790","authorId":"3573940420673790","name":"Zyl13","avatar":"https://static.tigerbbs.com/abc0f03108ec1f9a9c459181df989db8","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573940420673790","authorIdStr":"3573940420673790"},"themes":[],"htmlText":"Buy","listText":"Buy","text":"Buy","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/373163898","repostId":"2128315893","repostType":2,"repost":{"id":"2128315893","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1618828860,"share":"https://www.laohu8.com/m/news/2128315893?lang=&edition=full","pubTime":"2021-04-19 18:41","market":"us","language":"en","title":"Tesla stock falls 1.7% premarket, after surging 19.6% over the previous 3 sessions","url":"https://stock-news.laohu8.com/highlight/detail?id=2128315893","media":"Dow Jones","summary":"MW Tesla stock falls 1.7% premarket, after surging 19.6% over the previous 3 sessions.","content":"<p>MW Tesla stock falls 1.7% premarket, after surging 19.6% over the previous 3 sessions.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tesla stock falls 1.7% premarket, after surging 19.6% over the previous 3 sessions</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTesla stock falls 1.7% premarket, after surging 19.6% over the previous 3 sessions\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-04-19 18:41</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>MW Tesla stock falls 1.7% premarket, after surging 19.6% over the previous 3 sessions.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2128315893","content_text":"MW Tesla stock falls 1.7% premarket, after surging 19.6% over the previous 3 sessions.","news_type":1},"isVote":1,"tweetType":1,"viewCount":27,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":389539130,"gmtCreate":1612786092220,"gmtModify":1703764969728,"author":{"id":"3573940420673790","authorId":"3573940420673790","name":"Zyl13","avatar":"https://static.tigerbbs.com/abc0f03108ec1f9a9c459181df989db8","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573940420673790","authorIdStr":"3573940420673790"},"themes":[],"htmlText":"Wow interesting&nbsp;","listText":"Wow interesting&nbsp;","text":"Wow interesting","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/389539130","repostId":"1126813487","repostType":4,"repost":{"id":"1126813487","pubTimestamp":1612776380,"share":"https://www.laohu8.com/m/news/1126813487?lang=&edition=full","pubTime":"2021-02-08 17:26","market":"us","language":"en","title":"Moderna Gets Added to Southeast Asia’s Vaccine Arsenal","url":"https://stock-news.laohu8.com/highlight/detail?id=1126813487","media":"Bloomberg","summary":"Moderna Inc. won approval from Singapore for its Covid vaccine and signed a deal to sell doses to th","content":"<p>Moderna Inc. won approval from Singapore for its Covid vaccine and signed a deal to sell doses to the Philippines, becoming the fourth supplier to get regulatory clearance in Southeast Asia.</p>\n<p>Shots by&nbsp;AstraZeneca Plc,Pfizer Inc.-BioNTech SEandSinovac Biotech Ltd.have also been approved by at least one country in the region as inoculations roll out. China and India are giving somefreevaccines to countries like the Philippines, Myanmar and Cambodia.</p>\n<p>Indonesia, Southeast Asia’s biggest and most populous economy,startedits coronavirus vaccination program on Jan. 13, with President Joko Widodo taking thefirst Sinovac jab. More than 784,000 people have received their first dose.</p>\n<p>Wealthier but smaller Singapore -- the first in Southeast Asia to start an official Covid-19 vaccination program -- began inoculatinghealthcareworkers with the Pfizer shot on Dec. 30 and has given the first shot to more than 175,000 people since then. Its prime minister got his first dose on Jan. 8 and has also received his second shot.</p>\n<p>Strategies are evolving across the region as different supply deals are sealed. In the Philippines, President Rodrigo Duterte has said he will take a Russian or Chinese vaccine, but his government’s first approval was for the Pfizer shot.</p>\n<p>Indonesia, which is battling the worst outbreak in Southeast Asia, ended 2020 by switching up who’s on its priority list for shots -- focusing on the elderly first instead of the young as previously announced. It was the earliest in the region to receive a vaccine shipment with a Sinovac supply in December.</p>\n<p>Some countries are also involved in vaccine development and manufacturing, a testament to the variety of strategies employed by Southeast Asian nations. Here’s how the region of more than 650 million people is dealing with differing fiscal, demographic and distribution challenges in their vaccination efforts.</p>\n<p>INDONESIA</p>\n<p>STRATEGY:</p>\n<p>Indonesia seeks to vaccinate 181.5 million people -- about two-thirds of the population -- by March 2022 and President Widodo has called on the cabinet to complete the program by end-2021.</p>\n<p>The nation expects its vaccination program to cost more than 73 trillion rupiah ($5.2 billion). It plans to be able to vaccinate 16 million people a month; the initial phase of inoculations will target more than 1.5 million health workers by the end of February.</p>\n<p>The country will offerfree vaccinesto people. With about 13,000 community health centers and 9,000 hospitals across the country, the government said it will be able to complete its targeted vaccination to achieve mass immunity.</p>\n<ul>\n <li>The world’s fourth most populous nation is banking on both Western and Chinese vaccines, ordering 125.5 million doses from Sinovac, 50 million fromAstraZenecaand another 50 million fromNovavax Inc., while developing 57.6 million of its own Merah Putih</li>\n <li>It is set to get as many as 23.1 million AstraZeneca doses from the GAVI alliance, after requesting 108 million free doses from the global vaccine facility</li>\n <li>Talks are also on with Pfizer for 50 million doses and loaned cold storage facilities for the vaccine</li>\n</ul>\n<p>TIMELINE:</p>\n<p>January, 2021: Sinovac</p>\n<p>(More than 784,000 people have received their first dose.)</p>\n<ul>\n <li>President Widodo got his first dose of the Sinovac shot on Jan. 13 along with public and army representatives, which kicked off Indonesia’s inoculation program</li>\n <li>More than 784,000 people have received their first dose as of Feb. 7, with over 139,000 of them completing their second shot</li>\n <li>China’s Sinovac Biotech shipped 3 million doses of vaccines to the country in December; the local food and drug regulator approved them for emergency use in January, and has since also given the nod for its use among theelderly</li>\n <li>Even before the regulator’s approval, the government started distributing the vaccines to its 34 provinces spread across the world’s largest archipelago</li>\n <li>Sinovac has shipped raw material for 55 million doses to be manufactured by Indonesia’s PT Bio Farma so far. The state firm aims to produce 24 million doses a month</li>\n <li>Bio Farma plans to also produce shots for other countries through the Coalition for Epidemic Preparedness Innovations as early as the fourth quarter, according to Indonesia’s state-owned enterprises ministry. Bio Farma will produce 100 million doses a year for CEPI.</li>\n</ul>\n<p>March, 2021: AstraZeneca</p>\n<ul>\n <li>Indonesia willreceivean initial allocation of between 13.7 million and 23.1 million shots of the AstraZeneca vaccine in the first half through the global Covax initiative</li>\n <li>The vaccines will arrive in stages, with 25%-35% by March and the remainder in the second quarter, according to the government. The shots can be used once the WHO approves the AstraZeneca inoculation for emergency use</li>\n <li>Under a separate deal with the company directly, Indonesia will also get the AstraZeneca vaccines delivered in stages starting from as early as April through the first quarter of 2022. The deal also includes the option for the country to purchase an additional 50 million doses.</li>\n</ul>\n<p>MALAYSIA</p>\n<p>STRATEGY:</p>\n<p>Malaysia is spending $504 million to buy enough shots to cover 26.5 million people, or about 80% of its population. It will start vaccinations from February, according to Prime Minister Muhyiddin Yassin. The government aims to get as many people inoculated within a year of getting the first batch of vaccines in February, Science Minister Khairy Jamaluddin said mid-January.</p>\n<p>The first phase of vaccinations, which will begin by end of February and last until April, will focus on inoculating 500,000 frontline workers, followed by the elderly and high-risk groups between April and August. The third leg will run from May through February 2022 for thoseaged18 and above, the prime minister has said.</p>\n<p>The country will have a “slight extra”stockpileof vaccines as only those 18 years old and above will be inoculated. The excess vaccines will be administered to migrant workers, expatriates, and non-Malaysian residents, the cost of which must be borne by their employers.</p>\n<p>Pfizer vaccines will probably be administered to those in urban areas due to the need for ultra-cold storage, while AstraZeneca vaccines will be deployed to rural areas.</p>\n<ul>\n <li>Malaysia hassecured12.8 million doses of the AstraZeneca vaccine through the Covax facility and directly, enough to inoculate 20% of the country’s population, according to the government</li>\n <li>The country has secured 25 million doses of the Pfizer-BioNTech vaccine, enough to cover 39% of the population</li>\n <li>It has also signed agreements for 12 million doses of China’s Sinovac andup to6.4 million doses of Russia’s Sputnik V vaccine</li>\n <li>Solution Group Bhd.signeda deal to supply the Malaysian government with 3.5 million doses of the Recombinant Ad5-nCoV coronavirus vaccine jointly developed by China’sCanSino Biologics Inc.and Beijing Institute of Biotechnology under the Academy of Military Medical Sciences. The purchase is subject to Solution obtaining product registration and market authorization of the vaccine in the country by April</li>\n <li>The government has also been in talks with Moderna and Johnson &amp; Johnson, according to officials</li>\n <li>Malaysia was due to conduct its first vaccine trial involving 3,000 volunteers in late January. It would be a phase-III trial on a vaccine candidate developed by the Institute of Medical Biology Chinese Academy of Medical Sciences</li>\n <li>Malaysia signed an agreement with China inOctoberto be given priority access to Covid-19 vaccines that China develops.</li>\n</ul>\n<p>TIMELINE:</p>\n<p>February, 2021: Pfizer</p>\n<ul>\n <li>The government secured 12.8 million doses from Pfizer-BioNTech SEin a deal signed in late 2020. The country in January agreed to buy an additional 12.2 million doses</li>\n <li>The first batch is due to arrive on Feb. 26</li>\n <li>The agreement with Pfizer is contingent on the vaccine being approved by the U.S. FDA and Malaysia’s regulator. Malaysia’s National Pharmaceutical Regulatory Agency has granted conditional approval for the vaccine, subject to further information from Pfizer, according to a local media report.</li>\n</ul>\n<p>March/April, 2021: Sinovac</p>\n<ul>\n <li>China’s Sinovac signed an agreement to supply 14 million doses to Malaysia, which may be ready for distribution by the end of March</li>\n <li>As part of this deal,Pharmaniaga Bhd.will supply a total of 12 million doses developed by China’s Sinovac Life Sciences Co. starting in April, the health ministry said in January</li>\n</ul>\n<p>1Q 2021: Sputnik V</p>\n<ul>\n <li>Duopharma Co. (M) will supplyup to6.4 million doses of Russia’s Sputnik V vaccines produced by Gamaleya Research Institute toward the end of March</li>\n</ul>\n<p>2Q 2021: AstraZeneca</p>\n<ul>\n <li>Malaysia hassecured6.4 million doses of the AstraZeneca vaccine through the Covax facility, and another 6.4 million directly</li>\n <li>The first batch is expected in the second quarter of 2021</li>\n</ul>\n<p>MYANMAR</p>\n<p>STRATEGY:</p>\n<p>Myanmar began inoculating its nearly 55 million population at theend ofJanuary. Before the military coup in early February, Aung San Suu Kyi’s administration had said frontline health workers and key government officials would be prioritized in the first phase of vaccinations, to be followed by vulnerable groups such as those older than 65 years.</p>\n<p>Myanmar kicked off vaccination for the general public on Feb. 5, less than a week after the coup. Interim President Myint Swe and officials from all ministries with the rank of director or above were also inoculated, along with the elderly in townships with the highest infection rates, according to the health and sports ministry. Suu Kyi, who is under detention at her residence, was also vaccinated on Feb. 6, according to her party officials.</p>\n<p>Myanmar has vowed to inoculate 38.4 million people older than 18 by the end of this year.</p>\n<p>The previous government had also been cooperating with GAVI, the vaccine alliance, to get shots for 20% of its population through the Covax facility. The Southeast Asian nation was also planning to allow the private sector to import World Health Organization-approved vaccines later this year.</p>\n<ul>\n <li>Other than the AstraZeneca deal it has signed, Myanmar also expected vaccines from Chinese developers to arrive in early 2021, with some doses from the Covax facility expected before April 7.</li>\n</ul>\n<p>TIMELINE:</p>\n<p>January, 2021: AstraZeneca</p>\n<p>(At least 103,142 health workers and volunteers have received shots)</p>\n<ul>\n <li>Myanmarordered30 million doses of the AstraZeneca vaccine produced under license bySerum Institute of Indiato vaccinate 15 million people. The country expects the first batch of this order to arrive in the second week of February</li>\n <li>The country expects an additional 27 million doses from the Covax facility from March</li>\n <li>It nevertheless began vaccinations at the end of January, with a separate 1.5 million doses that were donated by India having arrived Jan. 22</li>\n <li>The nation inoculated 103,142 health workers and volunteers as of Feb. 2, official data show.</li>\n</ul>\n<p>PHILIPPINES</p>\n<p>STRATEGY:</p>\n<p></p>\n<p>The Philippines plans to buy 148 million vaccine doses to inoculateup to70 million people this year, or more than half of its population. But it is negotiating for 178 million doses, enough to inoculate 92 million people, to take into account possible delays in deliveries, according to the finance secretary. The government seeks to vaccinate its entire population of more than 100 million by 2023.</p>\n<p>The nation is eyeing 82.5 billion pesos ($1.7 billion) in vaccinepurchasesthat it plans to fund with financing from multilateral agencies, state-owned banks and companies and bilateral sources, vaccine czar Carlito Galvez said.</p>\n<p>A number of mayors in Metropolitan Manila have separately drafted plans to provide shots to their constituents while waiting for guidelines on how local government units can purchase the vaccines.</p>\n<p>Priority for vaccinations will be given to medical frontliners and workers in industries deemed critical, including low-income groups and those identified as at risk.</p>\n<ul>\n <li>The government has signed deals for 30 million doses of the Covovax vaccine from the Serum Institute of India, and for 17 million doses from AstraZeneca</li>\n <li>It is also in talks with Pfizer, Johnson &amp; Johnson, Sinovac Biotech and Russia’s Gamaleya, according to Galvez</li>\n <li>The Philippines has signed apreliminaryagreement with Moderna following negotiations for as many as 20 million vaccine doses. A final supply deal with Moderna will likely be finished in February</li>\n <li>The nation is also expecting to receive fewer doses from the World Health Organization-backed Covax Facility, Galvez said</li>\n <li>China will donate 500,000 coronavirus vaccine doses to the Philippines</li>\n <li>Pfizer and AstraZeneca have been approved for emergency use by the local FDA, while Gamaleya and Sinovac have applied for the same authorization</li>\n <li>India-basedBharat Biotech International Ltd.has applied for emergency use authorization in the Philippines for its coronavirus vaccine, ABS-CBN News reported, citing the Food and Drug Administration head.</li>\n</ul>\n<p>TIMELINE:</p>\n<p>1Q 2021: Sinovac, Sputnik V</p>\n<ul>\n <li>Vaccinations could start as early as the first quarter of 2021 using Sinovac and Russia’s Sputnik V shots, according to Galvez</li>\n <li>Sinovac, Sputnik V are yet to receive the local FDA approval.</li>\n</ul>\n<p>1Q 2021: Pfizer, AstraZeneca</p>\n<ul>\n <li>At least 5.6 million coronavirus vaccine doses produced by Pfizer-BioNTech and AstraZeneca are expected to arrive in the country within the first quarter through the Covax facility</li>\n <li>The country will also receive as early as May 2.6 million doses of AstraZeneca vaccines purchased by local companies which pooled about800 million pesosto buy 3 million shots.</li>\n</ul>\n<p>SINGAPORE</p>\n<p>STRATEGY:</p>\n<p>The city-state has set aside roughly S$1 billion ($750 million) for vaccines, tapping the likes ofArcturus Therapeutics Holdings Inc.,Moderna, Pfizer and Sinovac for supplies. It estimates it should haveenoughfor its around 5.5 million-strong population by the third quarter of 2021.</p>\n<p>The city-state is prioritizinghealthcareworkers, the elderly and those in jobs or settings where risk of a super-spreading event is high -- such as the construction, marine and process sector, including migrant workers. For the elderly, it began with seniorsaged70 and above.</p>\n<p>Singapore aims to vaccinate the entire adult population, though this will be voluntary. Vaccines will be free for all Singaporeans and long-term residents. It is setting up vaccination centers across the island.</p>\n<p>TIMELINE:</p>\n<p>December, 2020: Pfizer</p>\n<p>(More than 175,000 people given first dose)</p>\n<ul>\n <li>Singapore started vaccinations on Dec. 30, 2020</li>\n <li>Prime Minister Lee Hsien Loong got a first dose of the vaccine on Jan. 8, making him the first member of cabinet to get the coronavirus vaccine shot</li>\n <li>The government said more than 175,000 people have received their first dose of the Covid-19 vaccine as of Feb. 2. Roughly 6,000 have received their second vaccine dose</li>\n <li>The city-state received its first shipment of the Pfizer-BioNTech vaccine on Dec. 21</li>\n <li>Those who have received shots include staff working inhealthcare, frontline and essential services, as well as staff and senior citizens in nursing homes. Some employees at the National Centre for Infectious Diseases have also received their second dose.</li>\n <li>Pilot vaccinations for senior citizensstartedJan. 27.</li>\n</ul>\n<p>March, 2021: Moderna</p>\n<ul>\n <li>Singapore granted interim authorization in February for Moderna’s Covid-19 vaccine to be used in the city-state. Moderna is the second vaccine to be authorized in Singapore</li>\n <li>Singapore’s Ministry of Health said that the country will roll out the Moderna vaccine for individualsaged18 years and above when shipments of the vaccine arrive</li>\n <li>If there are no disruptions to the schedule, the first shipment should arrive around March.</li>\n</ul>\n<p>Early 2021: Arcturus</p>\n<ul>\n <li>Arcturus and Singapore’s Economic Development Board have entered into a supply agreement for the right to buy the ARCT-021 vaccine</li>\n <li>Arcturus may ship the first batch of the Covid-19 vaccine it’s developing with local scientists early 2021</li>\n <li>Results so far show that the vaccine could be effective as a single dose, the Straits Times reported, citing a professor who co-developed the vaccine with Arcturus.</li>\n</ul>\n<p>THAILAND</p>\n<p>STRATEGY:</p>\n<p>Thailand wants to inoculate about 50% of its population by the end of this year.</p>\n<p>It has previously said it will allow private companies and hospitals to import and sell Covid-19 vaccinations as long as those shots have been approved by the nation’s Food and Drug Administration.</p>\n<p>Thailand’s health regulatorendorsedAstraZeneca’s vaccine for emergency use, the health minister said on Jan. 21. It’s the first to win approval in Thailand, which also has ordered shots developed by China’s Sinovac Biotech. Johnson &amp; Johnson has begun the process of seeking domestic approval for its vaccine.</p>\n<p>The Southeast Asian nation plans to distribute shots free of cost, while the imports by private firms would allow those who can afford to pay for inoculations along with non-Thais an alternative pathway to get shots. It won’t procure vaccines through the WHO-backed Covax program for now because theconditionsare too strict.</p>\n<ul>\n <li>The government has so far approved plans to purchase a total of 63 million doses, and the National Vaccine Institute is in talks with several manufacturers for additional supplies for delivery as early as the first quarter. These include 2 million doses from Sinovac and 61 million doses from AstraZeneca</li>\n <li>Not wanting to rely solely on inoculations from abroad, Thailand is also developing its own anti-coronavirus shot</li>\n</ul>\n<p>TIMELINE:</p>\n<p>February, 2021: Sinovac</p>\n<ul>\n <li>The country has said it plans to roll out 200,000 doses of Sinovac vaccines in February, 800,000 in March, and 1 million in April</li>\n</ul>\n<p>February, 2021: AstraZeneca</p>\n<ul>\n <li>Thailand has an advance agreement with AstraZeneca to secure Covid-19 vaccines, which are expected to be distributed by mid-2021, the prime minister has said</li>\n <li>The government expects 50,000 doses to arrive in February</li>\n <li>The government has ordered 61 million shots. The regulatory nod already given will also open the door for imports by private Thai companies for administering the doses to people who can afford to pay</li>\n <li>The country said early January it plans to roll out locally-produced AstraZeneca vaccines in May</li>\n <li>Under agreement with AstraZeneca, Siam Bioscience will produce vaccines at its facilities, and Thailand will receive technology transfer</li>\n <li>Thailand’s prime minister has said the country will supply coronavirus vaccines at “reasonable prices” to Myanmar, Laos, Cambodia and Vietnam when it begins production.</li>\n</ul>\n<p>VIETNAM</p>\n<p>STRATEGY:</p>\n<p>Vietnam is working on developing vaccines and will collaborate with suppliers when doses are available, according to a spokeswoman at the foreign affairs ministry.</p>\n<ul>\n <li>It signed a deal with AstraZeneca to acquire about 30 million doses of the Covid-19 vaccine, Deputy Health Minister Truong Quoc Cuong said during a government briefing in January</li>\n <li>It has also been negotiating to buy vaccines from Pfizer and companies from Russia and China, Cuong said</li>\n <li>Vietnam has four companies and institutes working on developing vaccines.Nanogen Pharmaceutical Biotechnologybegan its human vaccine trials Dec. 17. The Institute of Vaccines and Medical Biologicals started human trials Jan. 21, according to the health ministry.</li>\n</ul>\n<p>TIMELINE:</p>\n<p>1Q 2021: AstraZeneca</p>\n<ul>\n <li>Under the deal with AstraZeneca for about 30 million doses, Vietnam expects to receive vaccines each quarter this year, the deputy health minister said Jan. 4</li>\n <li>In addition, Vietnam expects to receive between 4.9 million to 8.25 million AstraZeneca vaccine doses through the WHO-backed Covax program during the first and second quarters, according to a government posting citing Covax.</li>\n</ul>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna Gets Added to Southeast Asia’s Vaccine Arsenal</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna Gets Added to Southeast Asia’s Vaccine Arsenal\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-02-08 17:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=http://bloomberg.com/news/articles/2021-02-08/moderna-gets-added-to-arsenal-southeast-asia-vaccine-tracker?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Moderna Inc. won approval from Singapore for its Covid vaccine and signed a deal to sell doses to the Philippines, becoming the fourth supplier to get regulatory clearance in Southeast Asia.\nShots by ...</p>\n\n<a href=\"http://bloomberg.com/news/articles/2021-02-08/moderna-gets-added-to-arsenal-southeast-asia-vaccine-tracker?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"http://bloomberg.com/news/articles/2021-02-08/moderna-gets-added-to-arsenal-southeast-asia-vaccine-tracker?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1126813487","content_text":"Moderna Inc. won approval from Singapore for its Covid vaccine and signed a deal to sell doses to the Philippines, becoming the fourth supplier to get regulatory clearance in Southeast Asia.\nShots by AstraZeneca Plc,Pfizer Inc.-BioNTech SEandSinovac Biotech Ltd.have also been approved by at least one country in the region as inoculations roll out. China and India are giving somefreevaccines to countries like the Philippines, Myanmar and Cambodia.\nIndonesia, Southeast Asia’s biggest and most populous economy,startedits coronavirus vaccination program on Jan. 13, with President Joko Widodo taking thefirst Sinovac jab. More than 784,000 people have received their first dose.\nWealthier but smaller Singapore -- the first in Southeast Asia to start an official Covid-19 vaccination program -- began inoculatinghealthcareworkers with the Pfizer shot on Dec. 30 and has given the first shot to more than 175,000 people since then. Its prime minister got his first dose on Jan. 8 and has also received his second shot.\nStrategies are evolving across the region as different supply deals are sealed. In the Philippines, President Rodrigo Duterte has said he will take a Russian or Chinese vaccine, but his government’s first approval was for the Pfizer shot.\nIndonesia, which is battling the worst outbreak in Southeast Asia, ended 2020 by switching up who’s on its priority list for shots -- focusing on the elderly first instead of the young as previously announced. It was the earliest in the region to receive a vaccine shipment with a Sinovac supply in December.\nSome countries are also involved in vaccine development and manufacturing, a testament to the variety of strategies employed by Southeast Asian nations. Here’s how the region of more than 650 million people is dealing with differing fiscal, demographic and distribution challenges in their vaccination efforts.\nINDONESIA\nSTRATEGY:\nIndonesia seeks to vaccinate 181.5 million people -- about two-thirds of the population -- by March 2022 and President Widodo has called on the cabinet to complete the program by end-2021.\nThe nation expects its vaccination program to cost more than 73 trillion rupiah ($5.2 billion). It plans to be able to vaccinate 16 million people a month; the initial phase of inoculations will target more than 1.5 million health workers by the end of February.\nThe country will offerfree vaccinesto people. With about 13,000 community health centers and 9,000 hospitals across the country, the government said it will be able to complete its targeted vaccination to achieve mass immunity.\n\nThe world’s fourth most populous nation is banking on both Western and Chinese vaccines, ordering 125.5 million doses from Sinovac, 50 million fromAstraZenecaand another 50 million fromNovavax Inc., while developing 57.6 million of its own Merah Putih\nIt is set to get as many as 23.1 million AstraZeneca doses from the GAVI alliance, after requesting 108 million free doses from the global vaccine facility\nTalks are also on with Pfizer for 50 million doses and loaned cold storage facilities for the vaccine\n\nTIMELINE:\nJanuary, 2021: Sinovac\n(More than 784,000 people have received their first dose.)\n\nPresident Widodo got his first dose of the Sinovac shot on Jan. 13 along with public and army representatives, which kicked off Indonesia’s inoculation program\nMore than 784,000 people have received their first dose as of Feb. 7, with over 139,000 of them completing their second shot\nChina’s Sinovac Biotech shipped 3 million doses of vaccines to the country in December; the local food and drug regulator approved them for emergency use in January, and has since also given the nod for its use among theelderly\nEven before the regulator’s approval, the government started distributing the vaccines to its 34 provinces spread across the world’s largest archipelago\nSinovac has shipped raw material for 55 million doses to be manufactured by Indonesia’s PT Bio Farma so far. The state firm aims to produce 24 million doses a month\nBio Farma plans to also produce shots for other countries through the Coalition for Epidemic Preparedness Innovations as early as the fourth quarter, according to Indonesia’s state-owned enterprises ministry. Bio Farma will produce 100 million doses a year for CEPI.\n\nMarch, 2021: AstraZeneca\n\nIndonesia willreceivean initial allocation of between 13.7 million and 23.1 million shots of the AstraZeneca vaccine in the first half through the global Covax initiative\nThe vaccines will arrive in stages, with 25%-35% by March and the remainder in the second quarter, according to the government. The shots can be used once the WHO approves the AstraZeneca inoculation for emergency use\nUnder a separate deal with the company directly, Indonesia will also get the AstraZeneca vaccines delivered in stages starting from as early as April through the first quarter of 2022. The deal also includes the option for the country to purchase an additional 50 million doses.\n\nMALAYSIA\nSTRATEGY:\nMalaysia is spending $504 million to buy enough shots to cover 26.5 million people, or about 80% of its population. It will start vaccinations from February, according to Prime Minister Muhyiddin Yassin. The government aims to get as many people inoculated within a year of getting the first batch of vaccines in February, Science Minister Khairy Jamaluddin said mid-January.\nThe first phase of vaccinations, which will begin by end of February and last until April, will focus on inoculating 500,000 frontline workers, followed by the elderly and high-risk groups between April and August. The third leg will run from May through February 2022 for thoseaged18 and above, the prime minister has said.\nThe country will have a “slight extra”stockpileof vaccines as only those 18 years old and above will be inoculated. The excess vaccines will be administered to migrant workers, expatriates, and non-Malaysian residents, the cost of which must be borne by their employers.\nPfizer vaccines will probably be administered to those in urban areas due to the need for ultra-cold storage, while AstraZeneca vaccines will be deployed to rural areas.\n\nMalaysia hassecured12.8 million doses of the AstraZeneca vaccine through the Covax facility and directly, enough to inoculate 20% of the country’s population, according to the government\nThe country has secured 25 million doses of the Pfizer-BioNTech vaccine, enough to cover 39% of the population\nIt has also signed agreements for 12 million doses of China’s Sinovac andup to6.4 million doses of Russia’s Sputnik V vaccine\nSolution Group Bhd.signeda deal to supply the Malaysian government with 3.5 million doses of the Recombinant Ad5-nCoV coronavirus vaccine jointly developed by China’sCanSino Biologics Inc.and Beijing Institute of Biotechnology under the Academy of Military Medical Sciences. The purchase is subject to Solution obtaining product registration and market authorization of the vaccine in the country by April\nThe government has also been in talks with Moderna and Johnson & Johnson, according to officials\nMalaysia was due to conduct its first vaccine trial involving 3,000 volunteers in late January. It would be a phase-III trial on a vaccine candidate developed by the Institute of Medical Biology Chinese Academy of Medical Sciences\nMalaysia signed an agreement with China inOctoberto be given priority access to Covid-19 vaccines that China develops.\n\nTIMELINE:\nFebruary, 2021: Pfizer\n\nThe government secured 12.8 million doses from Pfizer-BioNTech SEin a deal signed in late 2020. The country in January agreed to buy an additional 12.2 million doses\nThe first batch is due to arrive on Feb. 26\nThe agreement with Pfizer is contingent on the vaccine being approved by the U.S. FDA and Malaysia’s regulator. Malaysia’s National Pharmaceutical Regulatory Agency has granted conditional approval for the vaccine, subject to further information from Pfizer, according to a local media report.\n\nMarch/April, 2021: Sinovac\n\nChina’s Sinovac signed an agreement to supply 14 million doses to Malaysia, which may be ready for distribution by the end of March\nAs part of this deal,Pharmaniaga Bhd.will supply a total of 12 million doses developed by China’s Sinovac Life Sciences Co. starting in April, the health ministry said in January\n\n1Q 2021: Sputnik V\n\nDuopharma Co. (M) will supplyup to6.4 million doses of Russia’s Sputnik V vaccines produced by Gamaleya Research Institute toward the end of March\n\n2Q 2021: AstraZeneca\n\nMalaysia hassecured6.4 million doses of the AstraZeneca vaccine through the Covax facility, and another 6.4 million directly\nThe first batch is expected in the second quarter of 2021\n\nMYANMAR\nSTRATEGY:\nMyanmar began inoculating its nearly 55 million population at theend ofJanuary. Before the military coup in early February, Aung San Suu Kyi’s administration had said frontline health workers and key government officials would be prioritized in the first phase of vaccinations, to be followed by vulnerable groups such as those older than 65 years.\nMyanmar kicked off vaccination for the general public on Feb. 5, less than a week after the coup. Interim President Myint Swe and officials from all ministries with the rank of director or above were also inoculated, along with the elderly in townships with the highest infection rates, according to the health and sports ministry. Suu Kyi, who is under detention at her residence, was also vaccinated on Feb. 6, according to her party officials.\nMyanmar has vowed to inoculate 38.4 million people older than 18 by the end of this year.\nThe previous government had also been cooperating with GAVI, the vaccine alliance, to get shots for 20% of its population through the Covax facility. The Southeast Asian nation was also planning to allow the private sector to import World Health Organization-approved vaccines later this year.\n\nOther than the AstraZeneca deal it has signed, Myanmar also expected vaccines from Chinese developers to arrive in early 2021, with some doses from the Covax facility expected before April 7.\n\nTIMELINE:\nJanuary, 2021: AstraZeneca\n(At least 103,142 health workers and volunteers have received shots)\n\nMyanmarordered30 million doses of the AstraZeneca vaccine produced under license bySerum Institute of Indiato vaccinate 15 million people. The country expects the first batch of this order to arrive in the second week of February\nThe country expects an additional 27 million doses from the Covax facility from March\nIt nevertheless began vaccinations at the end of January, with a separate 1.5 million doses that were donated by India having arrived Jan. 22\nThe nation inoculated 103,142 health workers and volunteers as of Feb. 2, official data show.\n\nPHILIPPINES\nSTRATEGY:\n\nThe Philippines plans to buy 148 million vaccine doses to inoculateup to70 million people this year, or more than half of its population. But it is negotiating for 178 million doses, enough to inoculate 92 million people, to take into account possible delays in deliveries, according to the finance secretary. The government seeks to vaccinate its entire population of more than 100 million by 2023.\nThe nation is eyeing 82.5 billion pesos ($1.7 billion) in vaccinepurchasesthat it plans to fund with financing from multilateral agencies, state-owned banks and companies and bilateral sources, vaccine czar Carlito Galvez said.\nA number of mayors in Metropolitan Manila have separately drafted plans to provide shots to their constituents while waiting for guidelines on how local government units can purchase the vaccines.\nPriority for vaccinations will be given to medical frontliners and workers in industries deemed critical, including low-income groups and those identified as at risk.\n\nThe government has signed deals for 30 million doses of the Covovax vaccine from the Serum Institute of India, and for 17 million doses from AstraZeneca\nIt is also in talks with Pfizer, Johnson & Johnson, Sinovac Biotech and Russia’s Gamaleya, according to Galvez\nThe Philippines has signed apreliminaryagreement with Moderna following negotiations for as many as 20 million vaccine doses. A final supply deal with Moderna will likely be finished in February\nThe nation is also expecting to receive fewer doses from the World Health Organization-backed Covax Facility, Galvez said\nChina will donate 500,000 coronavirus vaccine doses to the Philippines\nPfizer and AstraZeneca have been approved for emergency use by the local FDA, while Gamaleya and Sinovac have applied for the same authorization\nIndia-basedBharat Biotech International Ltd.has applied for emergency use authorization in the Philippines for its coronavirus vaccine, ABS-CBN News reported, citing the Food and Drug Administration head.\n\nTIMELINE:\n1Q 2021: Sinovac, Sputnik V\n\nVaccinations could start as early as the first quarter of 2021 using Sinovac and Russia’s Sputnik V shots, according to Galvez\nSinovac, Sputnik V are yet to receive the local FDA approval.\n\n1Q 2021: Pfizer, AstraZeneca\n\nAt least 5.6 million coronavirus vaccine doses produced by Pfizer-BioNTech and AstraZeneca are expected to arrive in the country within the first quarter through the Covax facility\nThe country will also receive as early as May 2.6 million doses of AstraZeneca vaccines purchased by local companies which pooled about800 million pesosto buy 3 million shots.\n\nSINGAPORE\nSTRATEGY:\nThe city-state has set aside roughly S$1 billion ($750 million) for vaccines, tapping the likes ofArcturus Therapeutics Holdings Inc.,Moderna, Pfizer and Sinovac for supplies. It estimates it should haveenoughfor its around 5.5 million-strong population by the third quarter of 2021.\nThe city-state is prioritizinghealthcareworkers, the elderly and those in jobs or settings where risk of a super-spreading event is high -- such as the construction, marine and process sector, including migrant workers. For the elderly, it began with seniorsaged70 and above.\nSingapore aims to vaccinate the entire adult population, though this will be voluntary. Vaccines will be free for all Singaporeans and long-term residents. It is setting up vaccination centers across the island.\nTIMELINE:\nDecember, 2020: Pfizer\n(More than 175,000 people given first dose)\n\nSingapore started vaccinations on Dec. 30, 2020\nPrime Minister Lee Hsien Loong got a first dose of the vaccine on Jan. 8, making him the first member of cabinet to get the coronavirus vaccine shot\nThe government said more than 175,000 people have received their first dose of the Covid-19 vaccine as of Feb. 2. Roughly 6,000 have received their second vaccine dose\nThe city-state received its first shipment of the Pfizer-BioNTech vaccine on Dec. 21\nThose who have received shots include staff working inhealthcare, frontline and essential services, as well as staff and senior citizens in nursing homes. Some employees at the National Centre for Infectious Diseases have also received their second dose.\nPilot vaccinations for senior citizensstartedJan. 27.\n\nMarch, 2021: Moderna\n\nSingapore granted interim authorization in February for Moderna’s Covid-19 vaccine to be used in the city-state. Moderna is the second vaccine to be authorized in Singapore\nSingapore’s Ministry of Health said that the country will roll out the Moderna vaccine for individualsaged18 years and above when shipments of the vaccine arrive\nIf there are no disruptions to the schedule, the first shipment should arrive around March.\n\nEarly 2021: Arcturus\n\nArcturus and Singapore’s Economic Development Board have entered into a supply agreement for the right to buy the ARCT-021 vaccine\nArcturus may ship the first batch of the Covid-19 vaccine it’s developing with local scientists early 2021\nResults so far show that the vaccine could be effective as a single dose, the Straits Times reported, citing a professor who co-developed the vaccine with Arcturus.\n\nTHAILAND\nSTRATEGY:\nThailand wants to inoculate about 50% of its population by the end of this year.\nIt has previously said it will allow private companies and hospitals to import and sell Covid-19 vaccinations as long as those shots have been approved by the nation’s Food and Drug Administration.\nThailand’s health regulatorendorsedAstraZeneca’s vaccine for emergency use, the health minister said on Jan. 21. It’s the first to win approval in Thailand, which also has ordered shots developed by China’s Sinovac Biotech. Johnson & Johnson has begun the process of seeking domestic approval for its vaccine.\nThe Southeast Asian nation plans to distribute shots free of cost, while the imports by private firms would allow those who can afford to pay for inoculations along with non-Thais an alternative pathway to get shots. It won’t procure vaccines through the WHO-backed Covax program for now because theconditionsare too strict.\n\nThe government has so far approved plans to purchase a total of 63 million doses, and the National Vaccine Institute is in talks with several manufacturers for additional supplies for delivery as early as the first quarter. These include 2 million doses from Sinovac and 61 million doses from AstraZeneca\nNot wanting to rely solely on inoculations from abroad, Thailand is also developing its own anti-coronavirus shot\n\nTIMELINE:\nFebruary, 2021: Sinovac\n\nThe country has said it plans to roll out 200,000 doses of Sinovac vaccines in February, 800,000 in March, and 1 million in April\n\nFebruary, 2021: AstraZeneca\n\nThailand has an advance agreement with AstraZeneca to secure Covid-19 vaccines, which are expected to be distributed by mid-2021, the prime minister has said\nThe government expects 50,000 doses to arrive in February\nThe government has ordered 61 million shots. The regulatory nod already given will also open the door for imports by private Thai companies for administering the doses to people who can afford to pay\nThe country said early January it plans to roll out locally-produced AstraZeneca vaccines in May\nUnder agreement with AstraZeneca, Siam Bioscience will produce vaccines at its facilities, and Thailand will receive technology transfer\nThailand’s prime minister has said the country will supply coronavirus vaccines at “reasonable prices” to Myanmar, Laos, Cambodia and Vietnam when it begins production.\n\nVIETNAM\nSTRATEGY:\nVietnam is working on developing vaccines and will collaborate with suppliers when doses are available, according to a spokeswoman at the foreign affairs ministry.\n\nIt signed a deal with AstraZeneca to acquire about 30 million doses of the Covid-19 vaccine, Deputy Health Minister Truong Quoc Cuong said during a government briefing in January\nIt has also been negotiating to buy vaccines from Pfizer and companies from Russia and China, Cuong said\nVietnam has four companies and institutes working on developing vaccines.Nanogen Pharmaceutical Biotechnologybegan its human vaccine trials Dec. 17. The Institute of Vaccines and Medical Biologicals started human trials Jan. 21, according to the health ministry.\n\nTIMELINE:\n1Q 2021: AstraZeneca\n\nUnder the deal with AstraZeneca for about 30 million doses, Vietnam expects to receive vaccines each quarter this year, the deputy health minister said Jan. 4\nIn addition, Vietnam expects to receive between 4.9 million to 8.25 million AstraZeneca vaccine doses through the WHO-backed Covax program during the first and second quarters, according to a government posting citing Covax.","news_type":1},"isVote":1,"tweetType":1,"viewCount":41,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":389530601,"gmtCreate":1612786034203,"gmtModify":1703764968867,"author":{"id":"3573940420673790","authorId":"3573940420673790","name":"Zyl13","avatar":"https://static.tigerbbs.com/abc0f03108ec1f9a9c459181df989db8","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573940420673790","authorIdStr":"3573940420673790"},"themes":[],"htmlText":"Hahaahah","listText":"Hahaahah","text":"Hahaahah","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/389530601","repostId":"1163750848","repostType":4,"isVote":1,"tweetType":1,"viewCount":34,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":389086567,"gmtCreate":1612622197159,"gmtModify":1703764036103,"author":{"id":"3573940420673790","authorId":"3573940420673790","name":"Zyl13","avatar":"https://static.tigerbbs.com/abc0f03108ec1f9a9c459181df989db8","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573940420673790","authorIdStr":"3573940420673790"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/389086567","repostId":"2109726787","repostType":4,"isVote":1,"tweetType":1,"viewCount":16,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":389086334,"gmtCreate":1612622109928,"gmtModify":1703764034896,"author":{"id":"3573940420673790","authorId":"3573940420673790","name":"Zyl13","avatar":"https://static.tigerbbs.com/abc0f03108ec1f9a9c459181df989db8","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573940420673790","authorIdStr":"3573940420673790"},"themes":[],"htmlText":"&nbsp;Wow","listText":"&nbsp;Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/389086334","repostId":"2109727286","repostType":4,"isVote":1,"tweetType":1,"viewCount":54,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":317169959,"gmtCreate":1612429054671,"gmtModify":1703761701484,"author":{"id":"3573940420673790","authorId":"3573940420673790","name":"Zyl13","avatar":"https://static.tigerbbs.com/abc0f03108ec1f9a9c459181df989db8","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573940420673790","authorIdStr":"3573940420673790"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/317169959","repostId":"2108713067","repostType":4,"isVote":1,"tweetType":1,"viewCount":9,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}